Clinical Trials

• I PREVENT - Irbesartan In Hypertensive Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00362258 - Recruiting
  Hypertension
  
• I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00335673 - Active, not recruiting
  Hypertension
  
• I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy
  ClinicalTrials.gov Identifier: NCT00362037 - Recruiting
  Hypertension
  
• I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00001771 - Completed
  Healthy; Mental Disorder; Obsessive Compulsive Disorder; Schizophrenia; Tourette Syndrome
  
• I-125 Versus Pd-103 for Low Risk Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00494039 - Active, not recruiting
  Prostate Cancer
  
• I-125 Versus Pd-103 for Medium Risk Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00486499 - Recruiting
  Prostate Cancer
  
• I-STOP TOMS - Trans Obturator Male Sling
  ClinicalTrials.gov Identifier: NCT00442078 - Recruiting
  Male Urinary Incontinence
  
• I3LTE4: Intensive Insulin Therapy and Production of LTE4 in Patients With Diabetes
  ClinicalTrials.gov Identifier: NCT00324792 - Recruiting
  Diabetes Mellitus; Leucotrienes
  
• Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
  ClinicalTrials.gov Identifier: NCT00326820 - Recruiting
  Breast Cancer; Hypercalcemia; Metastatic Cancer
  
• Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation.
  ClinicalTrials.gov Identifier: NCT00423384 - Recruiting
  Renal Transplant
  
• Ibritumomab Tiuxetan + Rituximab Maintenance
  ClinicalTrials.gov Identifier: NCT00582166 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Ibritumomab Tiuxetan for Early Stage Indolent Lymphomas
  ClinicalTrials.gov Identifier: NCT00493467 - Recruiting
  Lymphoma
  
• Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas
  ClinicalTrials.gov Identifier: NCT00493454 - Active, not recruiting
  Lymphoma
  
• Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever
  ClinicalTrials.gov Identifier: NCT00267293 - Recruiting
  Fever
  
• Ibuprofen and Renal Function in Premature Infants
  ClinicalTrials.gov Identifier: NCT00217191 - Completed
  Premature Infants; Patent Ductus Arteriosus
  
• Ibuprofen in Sepsis Study
  ClinicalTrials.gov Identifier: NCT00000574 - Completed
  Acute Respiratory Distress Syndrome; Lung Diseases; Shock, Septic
  
• Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA
  ClinicalTrials.gov Identifier: NCT00485160 - Completed
  Patent Ductus Arteriosus
  
• Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial
  ClinicalTrials.gov Identifier: NCT00219700 - Active, not recruiting
  Osteoarthritis
  
• IC14 Antibodies to Treat Individuals With Acute Lung Injury
  ClinicalTrials.gov Identifier: NCT00233207 - Terminated
  Respiratory Distress Syndrome, Adult; Lung Diseases
  
• Ice Chips Or Saline Mouth Rinse in Reducing Or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00118339 - Completed
  oral complications of cancer and cancer therapy; Drug Toxicity; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• ICG Angiography in Amniotic Membrane Graft and Conjunctival Autograft After Pterygium Excision
  ClinicalTrials.gov Identifier: NCT00383825 - Completed
  Pterygium
  
• ICI 182780 in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00012025 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00010153 - Completed
  stage I breast cancer; stage II breast cancer
  
• ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial
  ClinicalTrials.gov Identifier: NCT00148226 - Completed
  Colorectal Cancer Screening
  
• ICMR-Indiaclen Trial on Amoxycillin vs Cotrimoxazole for Non-Severe Pneumonia
  ClinicalTrials.gov Identifier: NCT00396526 - Completed
  Non-Severe Pneumonia; Under-Fives; Children
  
• ICP Versus Intracranial Compliance Guided Management in SAH
  ClinicalTrials.gov Identifier: NCT00248690 - Recruiting
  Subarachnoid Hemorrhage (SAH)
  
• ICP Waveform Analysis in Stroke Patients
  ClinicalTrials.gov Identifier: NCT00509119 - Recruiting
  Stroke
  
• ICTUS Study: International Citicoline Trial on acUte Stroke
  ClinicalTrials.gov Identifier: NCT00331890 - Recruiting
  Acute Stroke; Cerebral Infarction
  
• ICU (Intensive Care Unit)-Acquired Paresis and the Risk for Mortality and Recurrent ICU Admission
  ClinicalTrials.gov Identifier: NCT00106665 - Completed
  Muscle Weakness; Critical Illness
  
• ICU Nutrition Study Bern
  ClinicalTrials.gov Identifier: NCT00574431 - Not yet recruiting
  Critical Illness; Starvation; Enteral Nutrition
  
• ICU Turning RCT Pilot
  ClinicalTrials.gov Identifier: NCT00542321 - Recruiting
  Pneumonia, Ventilator-Associated
  
• ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients.
  ClinicalTrials.gov Identifier: NCT00396461 - Recruiting
  Critical Illness
  
• Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00096148 - Completed
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
  
• Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00528398 - Recruiting
  Leukemia
  
• Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00193973 - Active, not recruiting
  Primary Central Nervous System Lymphoma
  
• Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00077116 - Active, not recruiting
  adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes
  
• Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00096122 - Active, not recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
  
• IdB 1016 Treatment for Hepatitis C Disease
  ClinicalTrials.gov Identifier: NCT00055445 - Completed
  Hepatitis C, Chronic
  
• IDE Clinical Trial Comparing Coflex vs. Fusion to Treat Lumbar Spinal Stenosis
  ClinicalTrials.gov Identifier: NCT00534235 - Recruiting
  Lumbar Spinal Stenosis
  
• IDE Study for the Approval of CLS and CRT Pacing Therapies for the Treatment of AF With Ablate and Pace
  ClinicalTrials.gov Identifier: NCT00356057 - Recruiting
  Atrial Fibrillation; Congestive Heart Failure
  
• IDEA-033 Open Label Study
  ClinicalTrials.gov Identifier: NCT00372333 - Active, not recruiting
  Joint Pain; Musculoskeletal Pain; Stiffness; Soft Tissue Inflammation in Designated Target Area(s)
  
• IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA
  ClinicalTrials.gov Identifier: NCT00316784 - Completed
  Osteoarthritis; Knee
  
• Ideal Dose of Phenylephrine to Treat Low Blood Pressure During Cesarean Section
  ClinicalTrials.gov Identifier: NCT00379691 - Completed
  Hypotension; Nausea
  
• IDEAL Study
  ClinicalTrials.gov Identifier: NCT00128518 - Recruiting
  Hypertension
  
• Idebenone to Treat Friedreich's Ataxia
  ClinicalTrials.gov Identifier: NCT00229632 - Active, not recruiting
  Friedreich Ataxia
  
• Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00223483 - Recruiting
  Hematologic Diseases; Healthy Volunteers
  
• Identification and Characterization of Novel Proteins in Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00230308 - Recruiting
  Head and Neck Cancer
  
• Identification and Impact of Vaginal Flora Anomalies Among Pregnant Woman
  ClinicalTrials.gov Identifier: NCT00484653 - Recruiting
  Vaginosis, Bacterial
  
• Identification and therapy efficacy of Type 2 diabetes in Hispanic patients
  ClinicalTrials.gov Identifier: NCT00004572 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Identification and Therapy of Postpartum Depression
  ClinicalTrials.gov Identifier: NCT00282776 - Recruiting
  Depression
  
• Identification and Treatment of Feeder Vessels in Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00018070 - Completed
  Macular Degeneration
  
• Identification and Treatment of Men With BPH in the Primary Care Setting
  ClinicalTrials.gov Identifier: NCT00211640 - Completed
  No Conditions for This Study. All Male Patients 18 Years of Age or Older Were Administered the LUTS, MSHQ, and Patient Demographics Questionnaire
  
• Identification and Treatment of the Liability to Develop Schizophrenia
  ClinicalTrials.gov Identifier: NCT00305474 - Recruiting
  Schizophrenia
  
• Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study
  ClinicalTrials.gov Identifier: NCT00282529 - Recruiting
  Breast Cancer; Lymphedema
  
• Identification of an Asthma Susceptibility Gene on 3P
  ClinicalTrials.gov Identifier: NCT00006510 - Active, not recruiting
  Asthma; Lung Diseases
  
• Identification of Biomarkers Associated with Human Hepatocellular Carcinoma by SELDI
  ClinicalTrials.gov Identifier: NCT00154531 - Recruiting
  Hepatocellular Carcinoma; Hepatitis B; Hepatitis C
  
• Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients
  ClinicalTrials.gov Identifier: NCT00568282 - Recruiting
  Lung Cancer
  
• Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
  ClinicalTrials.gov Identifier: NCT00330109 - Recruiting
  Glioma
  
• Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis
  ClinicalTrials.gov Identifier: NCT00285441 - Recruiting
  Tuberculosis; HIV Infections; Rheumatoid Arthritis
  
• Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus
  ClinicalTrials.gov Identifier: NCT00015639 - Completed
  Thrombocytopenia
  
• Identification of Gene Polymorphism in Patients With Sick Sinus Syndrome in Chinese Population in Taiwan
  ClinicalTrials.gov Identifier: NCT00314223 - Recruiting
  Sinus Arrhythmia
  
• Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
  ClinicalTrials.gov Identifier: NCT00003329 - Recruiting
  Breast Cancer; Colorectal Cancer; Lung Cancer; Prostate Cancer
  
• Identification of Genes Associated with Lung Disease in Patients with Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00001885 - Recruiting
  Healthy; Pulmonary Fibrosis; Rheumatoid Arthritis
  
• Identification of Genes Expressed in Atherosclerotic Plaque
  ClinicalTrials.gov Identifier: NCT00353730 - Active, not recruiting
  Atherosclerosis
  
• Identification of Genes Predisposing to Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00059098 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Identification of Hepatic Lesions
  ClinicalTrials.gov Identifier: NCT00307866 - Completed
  Hepatic Neoplasms
  
• Identification of Key Blood Molecular Markers for Immunotherapy
  ClinicalTrials.gov Identifier: NCT00507702 - Recruiting
  Cancer
  
• Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00373347 - Recruiting
  Liver Cancer; Hepatic Cancer
  
• Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data
  ClinicalTrials.gov Identifier: NCT00578409 - Recruiting
  Prostate Cancer
  
• Identification of Prostate Cancer Genes
  ClinicalTrials.gov Identifier: NCT00342784 - Active, not recruiting
  Prostate Cancer
  
• Identification of Risk Allels for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00323388 - Active, not recruiting
  Prostate Cancer
  
• Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope
  ClinicalTrials.gov Identifier: NCT00314405 - Recruiting
  Infiltrative Breast Cancer
  
• Identification of Serum Markers for Tumor Hypoxia in Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00185822 - Recruiting
  Lip Cancer; Oral Cancer; Pharynx Cancer
  
• Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
  ClinicalTrials.gov Identifier: NCT00185913 - Active, not recruiting
  Carcinoma, Non-Small Cell Lung
  
• Identification of Serum Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancer
  ClinicalTrials.gov Identifier: NCT00568490 - Recruiting
  Head and Neck Cancer; Lung Cancer
  
• Identification of Sleep-Disordered Breathing in Children
  ClinicalTrials.gov Identifier: NCT00233194 - Recruiting
  Sleep; Sleep Apnea Syndromes
  
• Identification of the Cranberry Juice Compounds that Prevent Urinary Tract Infections
  ClinicalTrials.gov Identifier: NCT00087828 - Completed
  Urinary Tract Infections
  
• Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)
  ClinicalTrials.gov Identifier: NCT00145964 - Recruiting
  Liver Cirrhosis, Biliary; Biliary Cirrhosis, Primary
  
• Identification of Viruses Associated With Diseases of Unknown Cause
  ClinicalTrials.gov Identifier: NCT00359268 - Recruiting
  Viral Diseases
  
• Identifying Characteristics of Bone Marrow Failure Syndromes
  ClinicalTrials.gov Identifier: NCT00315419 - Recruiting
  Bone Marrow Failure Syndromes; Anemia, Aplastic; Myelodysplastic Syndromes; Hemoglobinuria, Paroxysmal; Red-Cell Aplasia, Pure; Purpura, Thrombocytopenic; Leukemia, Lymphocytic
  
• Identifying Emergency Room Patients Who Have Recently Been Infected with HIV
  ClinicalTrials.gov Identifier: NCT00001130 - Completed
  HIV Infections
  
• Identifying Factors That Predict Antidepressant Treatment Response
  ClinicalTrials.gov Identifier: NCT00360399 - Recruiting
  Depression
  
• Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
  ClinicalTrials.gov Identifier: NCT00450593 - Recruiting
  Hereditary Melanoma 1 and 2 (cdkn2, cdk4); Melanoma (Skin)
  
• Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCOR
  ClinicalTrials.gov Identifier: NCT00005325 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Identifying Genes That May Increase the Risk for Heart Disease in African Americans
  ClinicalTrials.gov Identifier: NCT00344136 - Completed
  Heart Diseases
  
• Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00458562 - Recruiting
  Cervical Cancer; Precancerous/Nonmalignant Condition
  
• Identifying Genetic Characteristics That Increase the Risk of Developing Primary Graft Dysfunction Following Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00457847 - Recruiting
  Primary Graft Dysfunction; Lung Transplantation
  
• Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00515047 - Recruiting
  Atopic Dermatitis
  
• Identifying Genetic Markers for Esophageal Cancer and Stomach Cancer in Chinese Populations
  ClinicalTrials.gov Identifier: NCT00558415 - Recruiting
  Esophageal Cancer; Gastric Cancer
  
• Identifying High Risk Patients With Syncope
  ClinicalTrials.gov Identifier: NCT00005202 - Completed
  Cardiovascular Diseases; Arrhythmia; Death, Sudden, Cardiac; Heart Diseases; Syncope
  
• Identifying High- and Low-Risk Heart Failure Patients in the Emergency Department (The Stratify Study)
  ClinicalTrials.gov Identifier: NCT00508638 - Recruiting
  Cardiovascular Diseases
  
• Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00394940 - Active, not recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Identifying Low-Risk Patients with Pulmonary Embolism
  ClinicalTrials.gov Identifier: NCT00086151 - Active, not recruiting
  Pulmonary Embolism; Lung Diseases
  
• Identifying Methylation Biomarkers for Monitoring Bladder Tumors
  ClinicalTrials.gov Identifier: NCT00244205 - Recruiting
  Bladder Cancer
  
• Identifying New Families With Multiple Members Affected by Chordoma
  ClinicalTrials.gov Identifier: NCT00558714 - Recruiting
  Chordoma
  
• Identifying Patients With Dementia in Primary Care
  ClinicalTrials.gov Identifier: NCT00289471 - Recruiting
  Dementia; Memory Disorders
  
• Identifying Residential Hazards Using Home Test Kits
  ClinicalTrials.gov Identifier: NCT00285532 - Recruiting
  Lead Poisoning
  
• Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00438022 - Recruiting
  Atopic Dermatitis; Eczema Herpeticum
  
• Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis
  ClinicalTrials.gov Identifier: NCT00560989 - Completed
  Sarcoidosis; Berylliosis
  
• Identifying the Anti-Blood-Clotting Compounds in Garlic
  ClinicalTrials.gov Identifier: NCT00200785 - Completed
  Arteriosclerosis; Intracranial Arteriosclerosis
  
• Identifying the Relative Change in Ventilation in Newborns With Placement in Car Bed or Car Seat
  ClinicalTrials.gov Identifier: NCT00382876 - Recruiting
  Apnea
  
• Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood Disorders
  ClinicalTrials.gov Identifier: NCT00325065 - Recruiting
  Mood Disorders
  
• Identifying Vulnerable Plaques in Blood Vessels of the Heart Using a New Imaging Technique
  ClinicalTrials.gov Identifier: NCT00540761 - Recruiting
  Coronary Arteriosclerosis
  
• Identity Development and HIV Risk in Gay/Bisexual/Questioning Male Youth
  ClinicalTrials.gov Identifier: NCT00103441 - Recruiting
  Healthy; Risk Behavior; HIV Infections
  
• Idiopathic Anemia of Aging (IAA)
  ClinicalTrials.gov Identifier: NCT00104169 - Active, not recruiting
  Anemia; Aging
  
• Idiopathic Dilated Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00005201 - Completed
  Heart Diseases; Cardiomyopathy, Congestive
  
• Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00063869 - Active, not recruiting
  Pulmonary Fibrosis
  
• Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
  ClinicalTrials.gov Identifier: NCT00005317 - Completed
  Lung Diseases; Pulmonary Fibrosis; Lung Diseases, Interstitial; Scleroderma, Systemic
  
• Idiopathic Pulmonary Fibrosis: a Case-control Study
  ClinicalTrials.gov Identifier: NCT00005295 - Completed
  Lung Diseases; Pulmonary Fibrosis; Lung Diseases, Interstitial
  
• Idiotype Vaccine Following High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation for Patients With Lymphoma Who Had Failed Induction Chemotherapy
  ClinicalTrials.gov Identifier: NCT00574886 - Active, not recruiting
  Lymphoma
  
• Idiotype Vaccine for Low-grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00036426 - Active, not recruiting
  Lymphoma, Low-Grade
  
• Idiotypic Vaccination for Follicular Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00530140 - Recruiting
  Follicular Lymphoma; First Relapse/Progression
  
• Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)
  ClinicalTrials.gov Identifier: NCT00069641 - Completed
  Mucopolysaccharidosis II
  
• IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00300586 - Recruiting
  Stage IV Non-Small Cell Lung Cancer
  
• IFM 2005-01: Velcade/Dexamethasone Versus Vincristine/Adriamycin (Doxorubicin)/Dexamethasone (VAD) for the Treatment of Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00200681 - Recruiting
  Multiple Myeloma
  
• IFM 99-02 Thalidomide in Myeloma
  ClinicalTrials.gov Identifier: NCT00222053 - Active, not recruiting
  Multiple Myeloma
  
• IFN/RBV for Prevention of HCC Recurrence
  ClinicalTrials.gov Identifier: NCT00375661 - Recruiting
  Hepatitis C, Chronic
  
• Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00484601 - Recruiting
  Refractory Nasopharyngeal Carcinoma
  
• Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00334854 - Recruiting
  Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
  
• Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003198 - Completed
  unspecified adult solid tumor, protocol specific
  
• Ifosfamide in Treating Patients With Meningeal Tumors
  ClinicalTrials.gov Identifier: NCT00003292 - Suspended
  Chondrosarcoma; adult fibrosarcoma; adult leiomyosarcoma; adult rhabdomyosarcoma; adult malignant meningioma; ...
  
• Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00003212 - Active, not recruiting
  Soft Tissue Sarcoma; Uterine Cancer
  
• Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00086970 - Completed
  unspecified adult solid tumor, protocol specific
  
• Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00003128 - Active, not recruiting
  stage III uterine sarcoma; stage IV uterine sarcoma; recurrent uterine sarcoma; uterine carcinosarcoma
  
• Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00354107 - Suspended
  Lymphoma
  
• Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004916 - Active, not recruiting
  recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; ...
  
• Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00193505 - Active, not recruiting
  Non-Hodgkins Lymphoma
  
• Ig NextGen 10% in ITP Patients
  ClinicalTrials.gov Identifier: NCT00362349 - Recruiting
  Idiopathic Thrombocytopenic Purpura (ITP)
  
• Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)
  ClinicalTrials.gov Identifier: NCT00405184 - Recruiting
  Primary Immune Deficiency (PID)
  
• IGF-1 Therapy in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00566241 - Recruiting
  Cystic Fibrosis
  
• IGF-1/ALS Trial
  ClinicalTrials.gov Identifier: NCT00035815 - Completed
  Amyotrophic Lateral Sclerosis
  
• IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome
  ClinicalTrials.gov Identifier: NCT00368173 - Active, not recruiting
  Growth Hormone Insensitivity Syndrome (GHIS); Laron Syndrome
  
• IGF1 Generation Test
  ClinicalTrials.gov Identifier: NCT00145457 - Completed
  Growth Hormone Deficiency
  
• IGFBP-3 in Ovarian Cancer Invasion
  ClinicalTrials.gov Identifier: NCT00154986 - Recruiting
  Ovarian Carcinoma
  
• IGIV Study for Chronic ITP Patients Ages 3-70
  ClinicalTrials.gov Identifier: NCT00511147 - Not yet recruiting
  Idiopathic Thrombocytopenic Purpura
  
• IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer
  ClinicalTrials.gov Identifier: NCT00100893 - Recruiting
  Breast Cancer
  
• IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer
  ClinicalTrials.gov Identifier: NCT00041223 - Active, not recruiting
  Radiation Fibrosis; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• IL 6 Measurement Using a New Densitometric Bedside (POC) Test
  ClinicalTrials.gov Identifier: NCT00525369 - Completed
  Sepsis, Septic Shock
  
• IL-1 Trap for Treatment of CIAS1 Associated Periodic Syndromes (CAPS)
  ClinicalTrials.gov Identifier: NCT00288704 - Active, not recruiting
  Familial Cold Autoinflammatory Syndrome; Familial Cold Urticaria; Muckle-Wells Syndrome; Genetic Diseases, Inborn
  
• IL-1 Trap for Treatment of Familial Mediterranean Fever (FMF)
  ClinicalTrials.gov Identifier: NCT00582907 - Not yet recruiting
  Familial Mediterranean Fever
  
• IL-11 in Adults With Von Willebrand Disease Undergoing Surgery
  ClinicalTrials.gov Identifier: NCT00524225 - Recruiting
  Von Willebrand Disease
  
• IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia
  ClinicalTrials.gov Identifier: NCT00524342 - Recruiting
  Von Willebrand Disease
  
• IL-2 Gene Therapy for Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00059163 - Recruiting
  Melanoma
  
• IL-2 Therapy in Lymphodepleted Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00225771 - Active, not recruiting
  Metastatic Melanoma
  
• IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma
  ClinicalTrials.gov Identifier: NCT00003842 - Active, not recruiting
  adult glioblastoma multiforme; adult anaplastic astrocytoma; recurrent adult brain tumor
  
• IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00089427 - Active, not recruiting
  Glioblastoma Multiforme; Anaplastic Astrocytoma; Oligoastrocytoma
  
• ILF With/Without Cisplatin for Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00320294 - Active, not recruiting
  Stomach Neoplasm
  
• Ilioinguinal Nerve Excision in Open Mesh Repair of Inguinal Hernia,a Randomized Clinical Trial
  ClinicalTrials.gov Identifier: NCT00500214 - Completed
  Postoperative Pain; Postoperative Hyposthesia
  
• Illinois WISEWOMAN Project
  ClinicalTrials.gov Identifier: NCT00153387 - Completed
  CVD risk
  
• Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention
  ClinicalTrials.gov Identifier: NCT00345501 - Completed
  Renal Insufficiency, Chronic; Coronary Angiography; Angioplasty, Transluminal, Percutaneous Coronary
  
• Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
  ClinicalTrials.gov Identifier: NCT00084409 - Recruiting
  Non-small cell lung cancer; Small Cell Lung Cancer
  
• Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00235521 - Recruiting
  Pulmonary Hypertension
  
• ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00005645 - Active, not recruiting
  recurrent ovarian epithelial cancer; malignant ascites; peritoneal cavity cancer; liver metastases; Fallopian Tube Cancer; Malignant Pleural Effusion; ...
  
• ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00004926 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)
  ClinicalTrials.gov Identifier: NCT00136994 - Completed
  Schizophrenia
  
• IM-862 in Treating Patients With AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00003879 - Completed
  epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma; Quality of Life
  
• IM-862 in Treating Patients With Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003773 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease
  ClinicalTrials.gov Identifier: NCT00523159 - Recruiting
  Renal Cell Carcinoma
  
• Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute
  ClinicalTrials.gov Identifier: NCT00314470 - Recruiting
  Healthy
  
• Image Fusion PET, CT and 3D-Ultrasound Examinations
  ClinicalTrials.gov Identifier: NCT00302094 - Recruiting
  Anal Cancer
  
• Image Guided Radiation Therapy For Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00433706 - Recruiting
  Prostate Cancer
  
• Image Guided System for Orthopaedic Surgery
  ClinicalTrials.gov Identifier: NCT00022802 - Terminated
  Orthopaedic trauma; Hip Fracture
  
• IMAGE-Endocarditis
  ClinicalTrials.gov Identifier: NCT00144885 - Recruiting
  Endocarditis, Bacterial
  
• Image-Guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
  ClinicalTrials.gov Identifier: NCT00571415 - Not yet recruiting
  Cervix Cancer
  
• IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-Based Surveillance for Heart Transplant Rejection
  ClinicalTrials.gov Identifier: NCT00351559 - Recruiting
  Graft Rejection; Heart Diseases
  
• Images in Extracranial Artery Stenosis
  ClinicalTrials.gov Identifier: NCT00173927 - Recruiting
  Extracranial Atherosclerosis
  
• Images of a Healthy Worksite
  ClinicalTrials.gov Identifier: NCT00123513 - Recruiting
  Obesity; Cardiovascular Diseases
  
• Imaging Ahmed Glaucoma Tubes With a Pericardial Graft and Tissue Glue or Partial-Thickness Scleral Flap and Sutures
  ClinicalTrials.gov Identifier: NCT00453024 - Recruiting
  Advanced Glaucoma; Failed Trabeculectomies
  
• Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-Risk Families
  ClinicalTrials.gov Identifier: NCT00273351 - Recruiting
  Parkinson Disease; Parkinsonian Syndrome
  
• Imaging Characteristics of Breast Cancer in Women Under 40 Years of Age
  ClinicalTrials.gov Identifier: NCT00155038 - Recruiting
  Breast Cancer; Breast Neoplasms
  
• Imaging Colo-Rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging
  ClinicalTrials.gov Identifier: NCT00185081 - Recruiting
  Colonic Neoplasms
  
• Imaging of Brain Receptors in Healthy Volunteers and in Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00061789 - Completed
  Schizophrenia
  
• Imaging of Cannabinoid Receptors Using New Radioactive Tracer
  ClinicalTrials.gov Identifier: NCT00450021 - Recruiting
  Healthy
  
• Imaging of Islet Transplantation With PET and MRT
  ClinicalTrials.gov Identifier: NCT00417131 - Recruiting
  Islet Transplantation
  
• Imaging of Plaque with Magnetic Resonance Imaging (MRI)
  ClinicalTrials.gov Identifier: NCT00115856 - Active, not recruiting
  Arterial Occlusive Disease
  
• Imaging of Totally Blocked Arteries
  ClinicalTrials.gov Identifier: NCT00459446 - Recruiting
  Atherosclerosis; Peripheral Artery Disease; Intermittent Claudication; Chronic Total Aterial Occlusion
  
• Imaging of Vulnerable Plaques in Coronary Artery Disease by Multidetector Computed Tomography
  ClinicalTrials.gov Identifier: NCT00482651 - Not yet recruiting
  Atherosclerosis
  
• Imaging Predictors of Treatment Response in Depression
  ClinicalTrials.gov Identifier: NCT00367341 - Recruiting
  Major Depressive Disorder
  
• Imaging Procedures in Women With a Genetic Risk For Breast Cancer
  ClinicalTrials.gov Identifier: NCT00012415 - Active, not recruiting
  Breast Cancer; Hereditary Breast/Ovarian Cancer (brca1, brca2)
  
• Imaging Studies With GE C-Hawk Gamma Camera Compared to Routine Clinical Exam
  ClinicalTrials.gov Identifier: NCT00256581 - Recruiting
  Coronary Artery Disease; Chest Pain
  
• Imaging Study in Patients With Known Head and Neck Cancer, Lung Cancer, Lymphoma, or Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00323076 - Recruiting
  Head and Neck Neoplasms; Lung Neoplasms; Lymphoma, Malignant; Glioblastoma Multiforme
  
• Imaging Study of Automatic Movements
  ClinicalTrials.gov Identifier: NCT00031382 - Completed
  Healthy
  
• Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication
  ClinicalTrials.gov Identifier: NCT00388414 - Recruiting
  Back Pain Without Radiation; Low Back Pain
  
• Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients with Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00064779 - Active, not recruiting
  Malignant Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Mixed Oligoastrocytoma
  
• Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk
  ClinicalTrials.gov Identifier: NCT00181233 - Recruiting
  Sudden Cardiac Death
  
• Imaging Techniques in Body MRI
  ClinicalTrials.gov Identifier: NCT00362557 - Recruiting
  Clinically Indicated MR Imaging
  
• Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence
  ClinicalTrials.gov Identifier: NCT00376558 - Recruiting
  Cocaine Dependence
  
• Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution
  ClinicalTrials.gov Identifier: NCT00260767 - Not yet recruiting
  HIV
  
• Imatinib (Gleevec® (Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00076297 - Recruiting
  
  
• Imatinib in Adult Patients With Metastatic Ocular Melanoma
  ClinicalTrials.gov Identifier: NCT00421317 - Recruiting
  Melanoma
  
• Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
  ClinicalTrials.gov Identifier: NCT00354523 - Active, not recruiting
  Solid Tumor; Thyroid Cancer
  
• Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma
  ClinicalTrials.gov Identifier: NCT00424515 - Recruiting
  Mucosal Melanoma; Acral/Lentiginous Melanoma
  
• Imatinib in Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00506831 - Recruiting
  Scleroderma, Systemic
  
• Imatinib Mesylate (Gleevec; STI571) in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00041197 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia
  ClinicalTrials.gov Identifier: NCT00244829 - Completed
  Leukemia
  
• Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00248482 - Active, not recruiting
  Lung Cancer
  
• Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00066326 - Completed
  blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
  
• Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00425646 - Recruiting
  Lung Cancer
  
• Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00074308 - Recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma; unspecified adult solid tumor, protocol specific
  
• Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00253565 - Completed
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00087152 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00045604 - Completed
  extensive stage small cell lung cancer
  
• Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00028847 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00054431 - Completed
  accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ...
  
• Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00281996 - Completed
  Pancreatic Cancer
  
• Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
  ClinicalTrials.gov Identifier: NCT00354913 - Recruiting
  Brain and Central Nervous System Tumors
  
• Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00015847 - Completed
  relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00408460 - Recruiting
  Lung Cancer
  
• Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors
  ClinicalTrials.gov Identifier: NCT00573404 - Recruiting
  Gastrointestinal Stromal Tumor
  
• Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00354068 - Recruiting
  Brain and Central Nervous System Tumors
  
• Imatinib Mesylate and Zoledronic Acid in Patients with Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response
  ClinicalTrials.gov Identifier: NCT00210119 - Terminated
  Myeloid Leukemia, Chronic
  
• Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00403156 - Recruiting
  Choroidal Neovascularization
  
• Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00216112 - Completed
  Ovarian Cancer
  
• Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors
  ClinicalTrials.gov Identifier: NCT00417807 - Recruiting
  Refractory Desmoplastic Small Round Cell Tumors
  
• Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
  ClinicalTrials.gov Identifier: NCT00171912 - Recruiting
  Hypereosinophilic Syndrome; Systemic Mastocytosis; Chronic Myelomonocytic Leukemia; Dermatofibrosarcoma
  
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure
  ClinicalTrials.gov Identifier: NCT00026169 - Completed
  adult solid tumor; central nervous system cancer; Gastrointestinal Cancer; hematopoietic and lymphoid cancer
  
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00025415 - Completed
  adult solid tumor; Gastrointestinal Cancer; hematopoietic and lymphoid cancer
  
• Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma
  ClinicalTrials.gov Identifier: NCT00031915 - Completed
  Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; Osteosarcoma
  
• Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00030394 - Completed
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; childhood chronic myelogenous leukemia
  
• Imatinib Mesylate in Treating Patients With Chronic Myelomonocytic Leukemia or Atypical Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00079313 - Recruiting
  Leukemia
  
• Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00070499 - Recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00025246 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate in Treating Patients With Gliomas
  ClinicalTrials.gov Identifier: NCT00039364 - Active, not recruiting
  adult brain tumor
  
• Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00090987 - Active, not recruiting
  epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma
  
• Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00112632 - Recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
  ClinicalTrials.gov Identifier: NCT00085475 - Active, not recruiting
  recurrent adult soft tissue sarcoma; stage III adult soft tissue sarcoma; stage IV adult soft tissue sarcoma; adult fibrosarcoma; ...
  
• Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans (DFSP) or Transformed Fibrosarcomatous DFSP
  ClinicalTrials.gov Identifier: NCT00084630 - Active, not recruiting
  adult fibrosarcoma; recurrent adult soft tissue sarcoma; stage III adult soft tissue sarcoma; adult malignant fibrous histiocytoma; ...
  
• Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00045188 - Completed
  Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
  
• Imatinib Mesylate in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00027586 - Suspended
  Stage IV Melanoma; Recurrent Melanoma
  
• Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
  ClinicalTrials.gov Identifier: NCT00068783 - Suspended
  stage III Merkel cell carcinoma; recurrent Merkel cell carcinoma; stage II Merkel cell carcinoma
  
• Imatinib Mesylate in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00039416 - Active, not recruiting
  Polycythemia Vera; chronic idiopathic myelofibrosis; Essential Thrombocythemia; Chronic Myelomonocytic Leukemia
  
• Imatinib Mesylate in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00245128 - Active, not recruiting
  Chronic Myeloproliferative Disorders
  
• Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy
  ClinicalTrials.gov Identifier: NCT00509093 - Recruiting
  Leukemia
  
• Imatinib Mesylate in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00324636 - Active, not recruiting
  Leukemia
  
• Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00041041 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00042952 - Completed
  ovarian germ cell tumor; Testicular Cancer
  
• Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
  ClinicalTrials.gov Identifier: NCT00049127 - Recruiting
  adult anaplastic oligodendroglioma; recurrent adult brain tumor; Mixed Gliomas; Adult Oligodendroglioma
  
• Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor
  ClinicalTrials.gov Identifier: NCT00062205 - Active, not recruiting
  recurrent tumors of the Ewing's family
  
• Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
  ClinicalTrials.gov Identifier: NCT00010049 - Completed
  adult brain tumor
  
• Imatinib Mesylate in Treating Patients With Recurrent Meningioma
  ClinicalTrials.gov Identifier: NCT00045734 - Completed
  adult meningioma; recurrent adult brain tumor; grade III meningioma; grade I meningioma; grade II meningioma; adult meningeal hemangiopericytoma
  
• Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Carcinosarcoma
  ClinicalTrials.gov Identifier: NCT00075400 - Active, not recruiting
  uterine carcinosarcoma; recurrent uterine sarcoma
  
• Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
  ClinicalTrials.gov Identifier: NCT00287846 - Recruiting
  Desmoid Tumor
  
• Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00052949 - Completed
  Recurrent Small Cell Lung Cancer
  
• Imatinib Mesylate in Treating Patients With Refractory Metastatic and/or Unresectable Stomach or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00068380 - Active, not recruiting
  recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; stage IV esophageal cancer; stage III esophageal cancer; ...
  
• Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor
  ClinicalTrials.gov Identifier: NCT00039585 - Completed
  recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer; ovarian low malignant potential tumor
  
• Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood
  ClinicalTrials.gov Identifier: NCT00030667 - Active, not recruiting
  Ewing's family of tumors; childhood soft tissue sarcoma; Gastrointestinal Cancer; metastatic cancer; Neuroblastoma; Osteosarcoma
  
• Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
  ClinicalTrials.gov Identifier: NCT00045669 - Active, not recruiting
  recurrent salivary gland cancer; salivary gland adenoid cystic carcinoma; stage III salivary gland cancer; stage IV salivary gland cancer
  
• Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00470470 - Recruiting
  Melanoma (Skin)
  
• Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00036751 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00041340 - Completed
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00103168 - Recruiting
  gastrointestinal stromal tumor
  
• Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00022490 - Completed
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Imatinib Mesylate to Treat Myeloproliferative Hypereosinophilic Syndrome
  ClinicalTrials.gov Identifier: NCT00044304 - Recruiting
  Hypereosinophilic Syndrome
  
• Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors
  ClinicalTrials.gov Identifier: NCT00427583 - Recruiting
  Malignant Peripheral Nerve Sheath Tumors
  
• Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00324987 - Not yet recruiting
  Gastrointestinal Stromal Tumor
  
• Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Allogeneic Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00055874 - Recruiting
  chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
  
• Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma
  ClinicalTrials.gov Identifier: NCT00021229 - Active, not recruiting
  childhood central nervous system germ cell tumor; high-grade childhood cerebral astrocytoma; untreated childhood brain stem glioma; ...
  
• Imatinib Mesylate, Bevacizumab, and Cyclophosphamide in Treating Patients With Refractory Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00390156 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Imatinib Mesylate, Busulfan, Fludarabine, and ATG for CML Patients
  ClinicalTrials.gov Identifier: NCT00499889 - Recruiting
  Leukemia
  
• Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00268229 - Recruiting
  Leukemia
  
• Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00483366 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Imatinib Mesylate, Interferon Alfa, and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00363649 - Recruiting
  Leukemia
  
• Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00387933 - Recruiting
  Brain and Central Nervous System Tumors
  
• Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)
  ClinicalTrials.gov Identifier: NCT00514488 - Completed
  Chronic Myeloid Leukemia
  
• Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy
  ClinicalTrials.gov Identifier: NCT00297570 - Recruiting
  Leukemia, Myeloid, Philadelphia-Positive
  
• Imiquimod 5% Cream in Plaque-Type Morphea: A Pilot, Prospective Open-Label Study
  ClinicalTrials.gov Identifier: NCT00230373 - Active, not recruiting
  Morphea
  
• Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin
  ClinicalTrials.gov Identifier: NCT00453050 - Recruiting
  Melanoma (Skin); Metastatic Cancer
  
• Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer
  ClinicalTrials.gov Identifier: NCT00079300 - Active, not recruiting
  Non-Melanomatous Skin Cancer
  
• Imiquimod in Children with Plaque Morphea
  ClinicalTrials.gov Identifier: NCT00147771 - Recruiting
  Morphea (localized scleroderma)
  
• Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
  ClinicalTrials.gov Identifier: NCT00031759 - Active, not recruiting
  Cervical Cancer
  
• Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00257530 - Not yet recruiting
  Cutaneous Leishmaniasis
  
• IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency
  ClinicalTrials.gov Identifier: NCT00228852 - Recruiting
  T-Cell Immune Deficiency Diseases; Severe Combined Immunodeficiency
  
• Immediate Compared With Delayed Chemotherapy in Treating Patients With Advanced Colorectal Cancer Without Signs or Symptoms of Disease
  ClinicalTrials.gov Identifier: NCT00002570 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)
  ClinicalTrials.gov Identifier: NCT00413829 - Completed
  Age Related Macular Degeneration
  
• Immediate Implant Placement in the Molar Regions
  ClinicalTrials.gov Identifier: NCT00226148 - Active, not recruiting
  Periodontitis; Dental Caries; Periapical Periodontitis
  
• Immediate Load of Dental Implants, Placed in Atrophic Upper and/or Lower Jaw of Partial or Complete Edentate Patients, According to Flapless Technique
  ClinicalTrials.gov Identifier: NCT00136123 - Recruiting
  Dental Implantation
  
• Immediate Loading of Implants in Totally Edentate Upper and Lower Jaw. A Retrospective Trial to Evaluate Survival of the Implants and Bridges, Quality of Prothetic Work and Patient Satisfaction
  ClinicalTrials.gov Identifier: NCT00147992 - Recruiting
  Dental Implants
  
• Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00287196 - Recruiting
  Malignant Melanoma; Lymph Node Disease
  
• Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00206128 - Completed
  Schizophrenia
  
• Immediate Treatment Vs Colposcopic Follow-Up for Biopsy-Proven CIN 1
  ClinicalTrials.gov Identifier: NCT00156026 - Completed
  Cervical Intraepithelial Neoplasia
  
• IMMEDIATE Trial: Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency care Trial
  ClinicalTrials.gov Identifier: NCT00091507 - Recruiting
  Angina, Unstable; Cardiovascular Diseases; Heart Diseases; Coronary Disease; Myocardial Infarction; Heart Failure
  
• Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
  ClinicalTrials.gov Identifier: NCT00433719 - Recruiting
  HIV Infections; Tuberculous Meningitis
  
• Immediate Versus Deferred Start of Anti-HIV Therapy in HIV Infected Adults Being Treated for Tuberculosis
  ClinicalTrials.gov Identifier: NCT00108862 - Recruiting
  HIV Infections; Tuberculosis
  
• Immediate Versus Delayed IUD Insertion Following First Trimester Suction Aspiration Procedures
  ClinicalTrials.gov Identifier: NCT00562276 - Recruiting
  Contraception
  
• Immediate vs Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy.
  ClinicalTrials.gov Identifier: NCT00439751 - Recruiting
  Prostate Cancer
  
• Immediate Vs. Deferred Empirical Antifungal Treatment with Voriconazole
  ClinicalTrials.gov Identifier: NCT00150345 - Recruiting
  Neutropenia
  
• Immediate vs. Delayed Insertion of Copper T 380A IUD After Termination of Pregnancy Over 12-Weeks Gestation
  ClinicalTrials.gov Identifier: NCT00540046 - Recruiting
  Contraception Compliance
  
• Immobilization in External Rotation of Acute Shoulder Dislocations
  ClinicalTrials.gov Identifier: NCT00196560 - Active, not recruiting
  Anterior Shoulder Dislocation
  
• Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
  ClinicalTrials.gov Identifier: NCT00271934 - Completed
  Systemic Lupus Erythematosus
  
• Immune Ablation and Stem Cell Support for Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00179842 - Recruiting
  Crohn Disease
  
• Immune Abnormalities in Sporadic Inclusion Body Myositis
  ClinicalTrials.gov Identifier: NCT00030212 - Completed
  Sporadic; Inclusion Body; Myositis
  
• Immune Activity Against CVM Retinitis
  ClinicalTrials.gov Identifier: NCT00001611 - Completed
  Acquired Immunodeficiency Syndrome; Cytomegalovirus Retinitis; HIV Infection
  
• Immune and Endocrine Function in Post-traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00100490 - Completed
  Post-Traumatic Stress Disorders
  
• Immune and Viral Outcomes of HIV-1 Therapy Interruption
  ClinicalTrials.gov Identifier: NCT00051818 - Completed
  HIV Infections
  
• Immune and Viral Status of HIV-Infected Patients after Stopping Combination Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00001899 - Active, not recruiting
  HIV Infection
  
• Immune Cell Response to Stimuli
  ClinicalTrials.gov Identifier: NCT00397280 - Not yet recruiting
  Healthy
  
• Immune Dysfunction in Allergic Asthma
  ClinicalTrials.gov Identifier: NCT00189228 - Recruiting
  Asthma
  
• Immune Dysregulation in Children and Adults with Asthma
  ClinicalTrials.gov Identifier: NCT00135681 - Completed
  Asthma; Lung Diseases
  
• Immune Function of Infants with HIV
  ClinicalTrials.gov Identifier: NCT00073229 - Recruiting
  HIV Infections
  
• Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  ClinicalTrials.gov Identifier: NCT00220740 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00220779 - Completed
  Multiple Sclerosis, Relapsing-Remitting
  
• Immune Indicators of Uveitis
  ClinicalTrials.gov Identifier: NCT00089739 - Recruiting
  GITR; GITR Ligand; Uveitis; Immunosuppression; Suppressor of Cytokine Secretion
  
• Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.
  ClinicalTrials.gov Identifier: NCT00333450 - Completed
  Prophylaxis Pneumococcal Vaccine
  
• Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants
  ClinicalTrials.gov Identifier: NCT00169442 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases
  
• Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.
  ClinicalTrials.gov Identifier: NCT00386659 - Terminated
  HIV Infection
  
• Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00286767 - Recruiting
  HIV Infections
  
• Immune Regulation in Patients with Common Variable Immunodeficiency and Related Syndromes
  ClinicalTrials.gov Identifier: NCT00001244 - Recruiting
  Agammaglobulinemia; Common Variable Immunodeficiency; Immunologic Deficiency Syndrome
  
• Immune Regulation in Ulcerative Colitis or Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00001184 - Recruiting
  Crohn's Disease; Inflammatory Bowel Disease; Ulcerative Colitis
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Diphtheria, Tetanus & Pertussis Vaccine (DTaP) Vaccine & a Haemophilus Influenza Type B (Hib) Vaccine in Healthy Children 15 m of Age
  ClinicalTrials.gov Identifier: NCT00197236 - Active, not recruiting
  Hepatitis A
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Measles/Mumps/Rubella Vaccine & a Varicella (Chickenpox) Vaccine in Healthy Children
  ClinicalTrials.gov Identifier: NCT00197015 - Recruiting
  Hepatitis A
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age
  ClinicalTrials.gov Identifier: NCT00197002 - Completed
  Hepatitis A
  
• Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2
  ClinicalTrials.gov Identifier: NCT00363012 - Recruiting
  Breast Cancer
  
• Immune Response on Neoadjuvant Therapy in NSCLC
  ClinicalTrials.gov Identifier: NCT00406302 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Immune Response Regulation in People Infected Concurrently With Malarial and Filarial Parasites
  ClinicalTrials.gov Identifier: NCT00341666 - Active, not recruiting
  Malaria; Filarial Infection
  
• Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients with Acute or Recent HIV Infection
  ClinicalTrials.gov Identifier: NCT00183261 - Active, not recruiting
  HIV Infections
  
• Immune Response to Cytomegalovirus
  ClinicalTrials.gov Identifier: NCT00034437 - Completed
  Cytomegalovirus Infections
  
• Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.
  ClinicalTrials.gov Identifier: NCT00456625 - Recruiting
  Hepatitis B
  
• Immune Response to Hepatitis C Virus
  ClinicalTrials.gov Identifier: NCT00006301 - Recruiting
  Hepatitis C
  
• Immune Response to Hepatitis C Virus
  ClinicalTrials.gov Identifier: NCT00165919 - Recruiting
  Hepatitis C; HIV Infections
  
• Immune Response to Influenza Vaccination
  ClinicalTrials.gov Identifier: NCT00551837 - Recruiting
  Solid Organ Transplantation; Chronic Kidney Disease
  
• Immune Response to Influenza Vaccine in HIV-Infected Individuals
  ClinicalTrials.gov Identifier: NCT00069914 - Completed
  HIV Infections
  
• Immune Response to Mycobacterium Tuberculosis Infection
  ClinicalTrials.gov Identifier: NCT00257907 - Recruiting
  Latent Tuberculosis
  
• Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected Adults
  ClinicalTrials.gov Identifier: NCT00562939 - Recruiting
  HIV Infections
  
• Immune Response to Varicella Vaccination in Children With Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00406081 - Recruiting
  Atopic Dermatitis
  
• Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452
  ClinicalTrials.gov Identifier: NCT00006495 - Completed
  HIV Infections
  
• Immune Responses to Antigens in Non-Infectious Eye Inflammatory Diseases
  ClinicalTrials.gov Identifier: NCT00357071 - Recruiting
  Eye Diseases
  
• Immune Responses to BCG Vaccination in Malawi and the UK
  ClinicalTrials.gov Identifier: NCT00241657 - Completed
  Immunity, Cellular; Hypersensitivity, Delayed Type
  
• Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers
  ClinicalTrials.gov Identifier: NCT00027482 - Recruiting
  Healthy; HIV Infection
  
• Immune Responses to Mycobacterium Tuberculosis
  ClinicalTrials.gov Identifier: NCT00340990 - Recruiting
  Mycobacterium Tuberculosis
  
• Immune Responses to Smallpox Vaccination
  ClinicalTrials.gov Identifier: NCT00325975 - Recruiting
  Smallpox Vaccine
  
• Immune Responses to Two Dose Varivax +/- MMR-II
  ClinicalTrials.gov Identifier: NCT00258726 - Terminated
  Measles; Mumps; Rubella; Varicella
  
• Immune Restoration by Lipoic Acid in AIDS
  ClinicalTrials.gov Identifier: NCT00033176 - Completed
  Acquired Immunodeficiency Syndrome; HIV Infections
  
• Immune Suppression Of Infants Treated With Steroids
  ClinicalTrials.gov Identifier: NCT00433940 - Recruiting
  Hemangioma
  
• Immune System and Gut Abnormalities in Patients with Common Variable Immunodeficiency with and without Gastrointestinal Symptoms
  ClinicalTrials.gov Identifier: NCT00015431 - Recruiting
  Common Variable Immunodeficiency
  
• Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00257127 - Active, not recruiting
  HIV Infections
  
• Immune System Related Kidney Disease
  ClinicalTrials.gov Identifier: NCT00001979 - Recruiting
  Glomerulonephritis; Lupus Nephritis; Membranous Glomerulonephritis; Nephritis; Nephrotic Syndrome
  
• Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load
  ClinicalTrials.gov Identifier: NCT00013663 - Completed
  HIV Infections
  
• Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients
  ClinicalTrials.gov Identifier: NCT00492739 - Recruiting
  Liver Disease; Liver Transplantation; Varicella
  
• Immunity to Human Cholera in Bangladesh
  ClinicalTrials.gov Identifier: NCT00401934 - Recruiting
  Cholera
  
• Immunization Against Tumor Cells in Sezary Syndrome
  ClinicalTrials.gov Identifier: NCT00099593 - Recruiting
  Cutaneous T-Cell Lymphoma; Sezary Syndrome
  
• Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides
  ClinicalTrials.gov Identifier: NCT00365937 - Recruiting
  Melanoma
  
• Immunization of HLA-A201 Patients with Metastatic Melanoma Using a Combination of Immunodominant Peptides from Three Melanoma Antigens, MART-1, GP100 and Tyrosinase
  ClinicalTrials.gov Identifier: NCT00001685 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization of Patients with Metastatic Melanoma Using DNA Encoding the GP100 Melanoma Antigen
  ClinicalTrials.gov Identifier: NCT00001692 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization of Patients with Metastatic Melanoma Using Immunodominant Peptides from the Tyrosinase Protein, Tyrosinase Related Protein-1 (TRP1), or GP100 Protein
  ClinicalTrials.gov Identifier: NCT00001684 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization of Patients with Metastatic Melanoma Using MART-1 and GP100 Peptides Modified to Increase Binding to HLA-0201
  ClinicalTrials.gov Identifier: NCT00001808 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization of Patients with Metastatic Melanoma Using Recombinant Fowlpox and Vaccinia Viruses Encoding the Tyrosinase Antigen
  ClinicalTrials.gov Identifier: NCT00001811 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization of Patients with Metastatic Melanoma Using Recombinant Fowlpox Virus Encoding a gp100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
  ClinicalTrials.gov Identifier: NCT00001800 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization of Patients with Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
  ClinicalTrials.gov Identifier: NCT00001705 - Completed
  Melanoma; Neoplasm Metastasis
  
• Immunization with 8 Peptides Mixed with Adjuvant CpG 7909 in HLA-A2 Patients with Metastatic Cutaneous Melanoma
  ClinicalTrials.gov Identifier: NCT00145158 - Recruiting
  Malignant Melanoma
  
• Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00072085 - Completed
  Melanoma (Skin)
  
• Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00292045 - Completed
  Prostate Cancer
  
• Immunization with the MAGE-3.A1 Peptide Mixed with the Adjuvant CpG 7909 in Patients with Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00145145 - Terminated
  Malignant Melanoma
  
• Immuno & Safety Study of GSK Biologicals’ Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs
  ClinicalTrials.gov Identifier: NCT00343915 - Active, not recruiting
  Prophylaxis of Hepatitis B
  
• Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.
  ClinicalTrials.gov Identifier: NCT00316680 - Completed
  Prophylaxis for Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Influenzae Type b Diseases
  
• Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00231712 - Recruiting
  Leukemia; Medulloblastoma
  
• Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients
  ClinicalTrials.gov Identifier: NCT00323557 - Recruiting
  Leukemia
  
• Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients
  ClinicalTrials.gov Identifier: NCT00356616 - Completed
  HIV Infections
  
• Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
  ClinicalTrials.gov Identifier: NCT00179764 - Recruiting
  Tumors; Malignant Melanoma; Hematological Malignancies; Myelogenous Leukemia, Chronic; Leukemia, Lymphoblastic, Acute
  
• Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)
  ClinicalTrials.gov Identifier: NCT00146432 - Completed
  Septicemia
  
• Immunobiology of Diabetes and Tuberculosis
  ClinicalTrials.gov Identifier: NCT00568854 - Recruiting
  Tuberculosis; Diabetes Mellitus
  
• Immunochemotherapy for Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00226798 - Recruiting
  Adenocarcinoma Clear Cell
  
• Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Relapsed or Refractory Follicular Lymphoma
  ClinicalTrials.gov Identifier: NCT00366275 - Recruiting
  Follicular Lymphoma
  
• Immunocompetency and Nutritive Status in Inpatient Gero-Rehabilitation
  ClinicalTrials.gov Identifier: NCT00105625 - Completed
  Infection; Geriatrics; Rehabilitation
  
• Immunogenecity of Booster Hepatitis B Vaccines in Children After Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00147459 - Recruiting
  Liver Transplantation
  
• Immunogenetic Factors of Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00005184 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Hypertension; Obesity; Diabetes Mellitus; Hypothyroidism
  
• Immunogenetics of Visceral Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00342823 - Recruiting
  Visceral Leishmaniasis
  
• Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.
  ClinicalTrials.gov Identifier: NCT00548171 - Recruiting
  Diphtheria; Tetanus; Pertussis
  
• Immunogenicity & Safety of GSK’s Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules
  ClinicalTrials.gov Identifier: NCT00316147 - Completed
  Healthy; Infant
  
• Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.
  ClinicalTrials.gov Identifier: NCT00317161 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).
  ClinicalTrials.gov Identifier: NCT00352963 - Completed
  Prophylaxis of DTPa-HBV-IPV-Hib & MenC Diseases
  
• Immunogenicity & Safety Study to Evaluate the Response to a Booster Dose of GSK Biologicals'' Tritanrix™-HepB/Hib-MenAC Vaccine at 15-24 Months and to Evaluate the Response to Mencevax™ ACWY at 24-30 Months in Healthy Children Primed with
  ClinicalTrials.gov Identifier: NCT00136604 - Completed
  Prophylaxis diphtheria, tetanus, pertussis, hepatits B, Haemophilus influenzae type b and meningococcal serogroup A & C disease
  
• Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac
  ClinicalTrials.gov Identifier: NCT00450554 - Recruiting
  Vaccination
  
• Immunogenicity and Reactogenicity of a Meningococcal B Outer Membrane Vesicle Vaccine Given in a 0,6,12 Month Schedule to Health UK Adults
  ClinicalTrials.gov Identifier: NCT00197795 - Completed
  Neisseria Meningitidis
  
• Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil
  ClinicalTrials.gov Identifier: NCT00524745 - Not yet recruiting
  Papillomavirus Infections
  
• Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above
  ClinicalTrials.gov Identifier: NCT00476307 - Completed
  Influenza
  
• Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders
  ClinicalTrials.gov Identifier: NCT00153543 - Completed
  Pneumococcal Infections [C01.252.410.890.670]
  
• Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00219362 - Active, not recruiting
  HIV Infection
  
• Immunogenicity and Safety of a 1-Dose Regimen of a Zoster Vaccine Versus Different 2-Dose Regimens in Subjects ≥ 70 Years
  ClinicalTrials.gov Identifier: NCT00561080 - Recruiting
  Prevention of : Herpes-Zoster
  
• Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
  ClinicalTrials.gov Identifier: NCT00127010 - Completed
  Measles; Mumps; Rubella; Chickenpox
  
• Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
  ClinicalTrials.gov Identifier: NCT00126997 - Completed
  Measles; Mumps; Rubella; Chickenpox
  
• Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
  ClinicalTrials.gov Identifier: NCT00127023 - Completed
  Measles; Mumps; Rubella; Chickenpox
  
• Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age
  ClinicalTrials.gov Identifier: NCT00376779 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Poliomyelitis; Haemophilus Infections
  
• Immunogenicity and Safety of ADACEL™ in Taiwan
  ClinicalTrials.gov Identifier: NCT00258908 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis
  
• Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-Adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases
  ClinicalTrials.gov Identifier: NCT00519064 - Active, not recruiting
  Influenza Disease
  
• Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults
  ClinicalTrials.gov Identifier: NCT00545701 - Active, not recruiting
  Influenza; Orthomyxoviridae Infections
  
• Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route
  ClinicalTrials.gov Identifier: NCT00432523 - Completed
  Measles; Mumps; Varicella
  
• Immunogenicity and Safety of Different Doses of Fluzone Influenza
  ClinicalTrials.gov Identifier: NCT00253734 - Active, not recruiting
  Influenza
  
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.
  ClinicalTrials.gov Identifier: NCT00481767 - Recruiting
  HPV-16/18 Infections; Cervical Neoplasia
  
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 15 - 25 Years of Age
  ClinicalTrials.gov Identifier: NCT00552279 - Active, not recruiting
  HPV-16/18 Infections and Cervical Neoplasia
  
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
  ClinicalTrials.gov Identifier: NCT00578175 - Recruiting
  Diseases Caused by Measles, Mumps, Rubella and Varicella Viruses
  
• Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age
  ClinicalTrials.gov Identifier: NCT00492544 - Active, not recruiting
  Papillomavirus Infections; Cervical Cancer
  
• Immunogenicity and Safety of GSK's Meningococcal Vaccine Given as 1 or 2 Doses to Healthy Toddlers 9-12 Months of Age
  ClinicalTrials.gov Identifier: NCT00471081 - Recruiting
  Invasive Disease Caused by Neisseria Meningitidis Due to Serogroups A, C, W-135, Y
  
• Immunogenicity and Safety of GSK's Meningococcal Vaccine vs. Menactra in Healthy Adolescent/Adults Aged 10-25 Years
  ClinicalTrials.gov Identifier: NCT00454909 - Active, not recruiting
  Meningococcal Infections
  
• Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine
  ClinicalTrials.gov Identifier: NCT00313950 - Recruiting
  Measles; Mumps; Rubella; Hepatitis A
  
• Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV
  ClinicalTrials.gov Identifier: NCT00348387 - Active, not recruiting
  Poliomyelitis; Imovax Polio
  
• Immunogenicity and Safety of Men ACWY in Infants (6 & 12 Months)
  ClinicalTrials.gov Identifier: NCT00310856 - Active, not recruiting
  Meningococcal Meningitis
  
• Immunogenicity and Safety of Menactra Vaccine in Adolescents in Saudi Arabia
  ClinicalTrials.gov Identifier: NCT00444951 - Active, not recruiting
  Neisseria Meningitidis; Meningococcal Infections
  
• Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers.
  ClinicalTrials.gov Identifier: NCT00422292 - Recruiting
  Meningococcal Meningitis; Measles; Mumps; Rubella; Varicella
  
• Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months
  ClinicalTrials.gov Identifier: NCT00453570 - Active, not recruiting
  Diphtheria; Tetanus; Haemophilus Influenzae Type B; Pertussis; Poliomyelitis
  
• Immunogenicity and Safety of Pentaxim in South African Infants
  ClinicalTrials.gov Identifier: NCT00254969 - Active, not recruiting
  Diphtheria; Tetanus; Haemophilus Infections; Pertussis; Poliomyelitis
  
• Immunogenicity and Safety of PENTAXIM™ in Indian Population
  ClinicalTrials.gov Identifier: NCT00259337 - Active, not recruiting
  Diphtheria; Tetanus; Polio; Pertussis; Haemophilus Influenzae Type B
  
• Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand
  ClinicalTrials.gov Identifier: NCT00255021 - Active, not recruiting
  Diphtheria; Tetanus; Poliomyelitis; Haemophilus Infections; Pertussis
  
• Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose
  ClinicalTrials.gov Identifier: NCT00483470 - Active, not recruiting
  Hepatitis A
  
• Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV
  ClinicalTrials.gov Identifier: NCT00319852 - Active, not recruiting
  Pertussis; Diphtheria; Poliomyelitis; Tetanus
  
• Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
  ClinicalTrials.gov Identifier: NCT00329901 - Active, not recruiting
  Meningococcal Disease; Meningococcal Meningitis
  
• Immunogenicity and Safety of Trivalent Recombinant Baculovirus-Expressed Hemagglutinin Influenza Vaccine in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00328107 - Completed
  Influenza, Human
  
• Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine
  ClinicalTrials.gov Identifier: NCT00562237 - Active, not recruiting
  Healthy Subjects
  
• Immunogenicity and Safety of Verorab™ in Indian Population
  ClinicalTrials.gov Identifier: NCT00260351 - Active, not recruiting
  Rabies
  
• Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
  ClinicalTrials.gov Identifier: NCT00514059 - Completed
  Diphtheria; Tetanus; Pertussis; Polio
  
• Immunogenicity and Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12 -18 Years.
  ClinicalTrials.gov Identifier: NCT00137917 - Completed
  Prophylaxis meningococcal serogroup B disease
  
• Immunogenicity and Safety Study of a Rapid Immunization Schedule with FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years
  ClinicalTrials.gov Identifier: NCT00161954 - Completed
  Encephalitis, Tick-Borne
  
• Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)
  ClinicalTrials.gov Identifier: NCT00163540 - Completed
  Encephalitis, Tick-Borne
  
• Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule
  ClinicalTrials.gov Identifier: NCT00460486 - Active, not recruiting
  Encephalitis, Tick-Borne
  
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ 10-Valent Pneumococcal Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00345358 - Active, not recruiting
  Pneumococcal Infections
  
• Immunogenicity and Safety Study of Pneumococcal 7-Valent Conjugate Vaccine in Sickle Cell Disease Infants.
  ClinicalTrials.gov Identifier: NCT00368186 - Terminated
  Pneumococcal Infections
  
• Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly
  ClinicalTrials.gov Identifier: NCT00432042 - Recruiting
  Varicella; Measles; Mumps; Rubella; Diphtheria; Tetanus; Pertussis; Poliomyelitis; Hepatitis B; Haemophilus Infections
  
• Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis
  ClinicalTrials.gov Identifier: NCT00491608 - Recruiting
  Spine Surgery; Vascular Surgery
  
• Immunogenicity and Safety Study to Evaluate 2 Formulations of GSK Biologicals'' MenC-TT Vaccine and 2 Formulations of GSK Biologicals'' Hib-MenC-TT Vaccine in Infants in Their 3rd, 4th, 5th Months of Life
  ClinicalTrials.gov Identifier: NCT00135486 - Completed
  Prophylaxis meningococcal serogroup C disease, Hib diseases
  
• Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A.
  ClinicalTrials.gov Identifier: NCT00540592 - Recruiting
  Influenza Infection
  
• Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00190242 - Active, not recruiting
  HIV Infection
  
• Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of an Investigational Quadrivalent Vaccine
  ClinicalTrials.gov Identifier: NCT00092482 - Completed
  Cervical Cancer; Genital Warts
  
• Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection
  ClinicalTrials.gov Identifier: NCT00371878 - Completed
  Pneumonia; Meningitis; Invasive Pneumococcal Disease; HIV
  
• Immunogenicity of a Reduced Primary Schedule for Pneumococcal Conjugate Vaccine in UK Infants
  ClinicalTrials.gov Identifier: NCT00197769 - Completed
  Streptococcus Pneumoniae
  
• Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008
  ClinicalTrials.gov Identifier: NCT00518453 - Recruiting
  Influenza
  
• Immunogenicity of DTaP-IPV-HB-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule
  ClinicalTrials.gov Identifier: NCT00315055 - Active, not recruiting
  Hepatitis B; Polio; Diphtheria; Pertussis
  
• Immunogenicity of GSK Bio's HPV Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age
  ClinicalTrials.gov Identifier: NCT00423046 - Active, not recruiting
  Cervical Cancer; Papillomavirus Infections
  
• Immunogenicity of High-Dose Inactivated, Split-Virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly
  ClinicalTrials.gov Identifier: NCT00391053 - Active, not recruiting
  Orthomyxoviridae Infection; Influenza; Myxovirus Infection
  
• Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine
  ClinicalTrials.gov Identifier: NCT00419133 - Active, not recruiting
  Cholera; Diarrhea; Vibrio Infections
  
• Immunogenicity of the Booster Dose of Two MenC Vaccines
  ClinicalTrials.gov Identifier: NCT00392808 - Recruiting
  Meningococcal Infection
  
• Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly
  ClinicalTrials.gov Identifier: NCT00296829 - Active, not recruiting
  Orthomyxoviridae Infection; Influenza; Myxovirus Infection
  
• Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
  ClinicalTrials.gov Identifier: NCT00139113 - Completed
  Hepatitis A
  
• Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP HB PRP~T Combined Vaccine in Filipino Infants
  ClinicalTrials.gov Identifier: NCT00514709 - Recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Heamophilus Influenza
  
• Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™
  ClinicalTrials.gov Identifier: NCT00534833 - Recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Influenzae Type B
  
• Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants
  ClinicalTrials.gov Identifier: NCT00303316 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Poliomyelitis; Hepatitis B
  
• Immunogenicity Study of the Influenza Vaccine in Adults
  ClinicalTrials.gov Identifier: NCT00258934 - Active, not recruiting
  Orthomyxoviridae Infections; Influenza
  
• Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.
  ClinicalTrials.gov Identifier: NCT00544271 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis A
  
• Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects
  ClinicalTrials.gov Identifier: NCT00481065 - Recruiting
  Pandemic; Avian Influenza
  
• Immunogenicity, Safety and Tolerability of Two Doses of a Pre-Pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years
  ClinicalTrials.gov Identifier: NCT00537524 - Recruiting
  Prophylaxis of Avian Influenza
  
• Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects
  ClinicalTrials.gov Identifier: NCT00434733 - Recruiting
  Influenza
  
• Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age
  ClinicalTrials.gov Identifier: NCT00310674 - Completed
  Prevention of Meningococcal Infection
  
• Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults
  ClinicalTrials.gov Identifier: NCT00385255 - Completed
  Diphtheria; Tetanus; Pertussis; Influenza
  
• Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
  ClinicalTrials.gov Identifier: NCT00352898 - Completed
  Measles; Mumps; Rubella; Varicella
  
• Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
  ClinicalTrials.gov Identifier: NCT00353288 - Active, not recruiting
  Measles; Mumps; Rubella; Varicella
  
• Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok
  ClinicalTrials.gov Identifier: NCT00539981 - Recruiting
  Influenza
  
• Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children
  ClinicalTrials.gov Identifier: NCT00311415 - Active, not recruiting
  Prevention of Meningococcal Infection
  
• Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes
  ClinicalTrials.gov Identifier: NCT00351923 - Active, not recruiting
  Measles; Mumps; Rubella; Varicella
  
• Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter in Achival & Frozen Tissue Sample
  ClinicalTrials.gov Identifier: NCT00568438 - Recruiting
  Breast Cancer
  
• Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis
  ClinicalTrials.gov Identifier: NCT00173264 - Recruiting
  Monoclonal Gammopathy; Tuberculosis
  
• Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects with Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315
  ClinicalTrials.gov Identifier: NCT00000891 - Completed
  HIV Infections
  
• Immunologic and Virologic Response in HIV Infected HLA-B 57 Prgressors After Infusion of Lymphocytesfrom HIV Infected HLA-B 57 Elite Long Term Nonprogressors
  ClinicalTrials.gov Identifier: NCT00559416 - Recruiting
  HIV/AIDS
  
• Immunologic aspects of the pathogenesis of chronic sinusitis in children
  ClinicalTrials.gov Identifier: NCT00004638 - Completed
  Sinusitis
  
• Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
  ClinicalTrials.gov Identifier: NCT00367016 - Recruiting
  Asthma; Allergic Rhinitis; Atopic Dermatitis
  
• Immunologic Control of Drug Resistant HIV
  ClinicalTrials.gov Identifier: NCT00053404 - Active, not recruiting
  HIV Infections
  
• Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
  ClinicalTrials.gov Identifier: NCT00005102 - Recruiting
  DiGeorge Syndrome; Shprintzen syndrome; Chromosome Abnormalities; Abnormalities, Multiple; Conotruncal Cardiac Defects
  
• Immunologic Factors in Reflux Esophagitis and Barrett''s Esophagus
  ClinicalTrials.gov Identifier: NCT00155805 - Recruiting
  Reflux Esophagitis; Hiatal Hernia
  
• Immunologic Function in the Elderly After Injury
  ClinicalTrials.gov Identifier: NCT00447135 - Recruiting
  Over the Age of 65; Admitted to the Trauma Service
  
• Immunologic Memory (Supp. of ATN 024)
  ClinicalTrials.gov Identifier: NCT00142753 - Active, not recruiting
  Healthy subjects; HIV Infection
  
• Immunological and Clinical Responses to Zinc in Children With Diarrhoea
  ClinicalTrials.gov Identifier: NCT00408356 - Recruiting
  Diarrhoea
  
• Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100
  ClinicalTrials.gov Identifier: NCT00385957 - Completed
  HIV Infections
  
• Immunological Consequences of Obstructive Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00214071 - Active, not recruiting
  Obstructive Sleep Apnea
  
• Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00342134 - Active, not recruiting
  Multiple Sclerosis
  
• Immunology and Safety of Menactra in Children in Saudi Arabia
  ClinicalTrials.gov Identifier: NCT00539032 - Recruiting
  N Meningitidis
  
• Immunology of Non-Specific Effects of Vaccine
  ClinicalTrials.gov Identifier: NCT00168545 - Completed
  Immunology of measles and DTP vaccination
  
• Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2
  ClinicalTrials.gov Identifier: NCT00002017 - Completed
  HIV Infections
  
• Immunonutrition and Thoracoabdominal Aorta Aneurysm Repair
  ClinicalTrials.gov Identifier: NCT00339053 - Recruiting
  Thoracic Aortic Aneurysm; Respiratory Insufficiency
  
• Immunonutrition in Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00247793 - Completed
  Thoracic Surgery; Cardiac Surgery; Cardiopulmonary Bypass
  
• Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery
  ClinicalTrials.gov Identifier: NCT00512213 - Not yet recruiting
  Major Abdominal Surgery
  
• Immunopharmacological Effects of Rituximab in Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00267826 - Completed
  Dermatitis, Atopic
  
• Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00176059 - Completed
  Renal Failure, Chronic; Renal Transplantation
  
• Immunosuppression Impact on the Metabolic Control of First Kidney Transplant Recipients With Pre-Existing Type 2 Diabetes (DM)
  ClinicalTrials.gov Identifier: NCT00296296 - Recruiting
  Kidney Transplant; Diabetes Mellitus, Type 2; Diabetic Nephropathy
  
• Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00355862 - Recruiting
  Hepatocellular Carcinoma
  
• Immunosuppression with Campath-1H and Tacrolimus in Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00105235 - Active, not recruiting
  Liver Transplantation
  
• Immunosuppression With Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies or Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00078858 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer; ...
  
• Immunosuppressive Effects of Mycophenolate Mofetil and Valganciclovir in Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00198224 - Completed
  Renal Failure
  
• Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
  ClinicalTrials.gov Identifier: NCT00001637 - Active, not recruiting
  Chronic Lymphocytic Leukemia; Graft vs Host Disease; Leukemia; Myelodysplastic Syndrome; Myeloid Leukemia
  
• Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00016419 - Active, not recruiting
  Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; de novo myelodysplastic syndromes; ...
  
• Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00402532 - Recruiting
  Lung Transplantation
  
• Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00283829 - Completed
  Prostate Cancer
  
• Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
  ClinicalTrials.gov Identifier: NCT00002455 - Active, not recruiting
  Breast Cancer; Colon Cancer; Melanoma
  
• Immunotherapy Combined With Chemotherapy Followed by Radiation Therapy and Chemotherapy in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00059956 - Active, not recruiting
  primary central nervous system lymphoma
  
• Immunotherapy for AML, ALL, BP CML, and MDS Relapsed After Allogeneic Transplantation
  ClinicalTrials.gov Identifier: NCT00548847 - Recruiting
  Leukemia
  
• Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment
  ClinicalTrials.gov Identifier: NCT00154713 - Recruiting
  Colorectal Cancer
  
• Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants
  ClinicalTrials.gov Identifier: NCT00002956 - Completed
  Leukemia; Lymphoma
  
• Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
  ClinicalTrials.gov Identifier: NCT00576641 - Recruiting
  Brain Stem Glioma; Glioblastoma
  
• Immunotherapy for Peanut Allergy
  ClinicalTrials.gov Identifier: NCT00429429 - Active, not recruiting
  Allergy
  
• Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00002673 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Immunotherapy in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003432 - Active, not recruiting
  stage IV breast cancer
  
• Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer
  ClinicalTrials.gov Identifier: NCT00003433 - Completed
  liver metastases; stage IV colon cancer
  
• Immunotherapy of Cancer Using Donor Lymphocytes Labelled with in-Vitro Bispecific Antibodies.
  ClinicalTrials.gov Identifier: NCT00149019 - Recruiting
  Metastatic Solid Tumors
  
• Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells
  ClinicalTrials.gov Identifier: NCT00562666 - Not yet recruiting
  Hepatocellular Carcinoma
  
• Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients
  ClinicalTrials.gov Identifier: NCT00112229 - Recruiting
  Melanoma
  
• Immunotherapy of Melanoma Patients
  ClinicalTrials.gov Identifier: NCT00112216 - Recruiting
  Melanoma
  
• Immunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs)
  ClinicalTrials.gov Identifier: NCT00155766 - Recruiting
  Cervical Cancer
  
• Immunotherapy of Stage III/IV Melanoma Patients
  ClinicalTrials.gov Identifier: NCT00112242 - Recruiting
  Melanoma
  
• Immunotherapy of the Paraneoplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00378326 - Recruiting
  Paraneoplastic Syndromes
  
• Immunotherapy Using Cyclosporine, Interferon gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00070187 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma
  
• Immunotherapy with Autologous Dexosomes for Patients with Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00042497 - Suspended
  Melanoma
  
• Immunotherapy with BHT-3009 Alone or Combined with Atorvastatin in Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00103974 - Active, not recruiting
  Multiple Sclerosis
  
• Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT)
  ClinicalTrials.gov Identifier: NCT00537342 - Recruiting
  Rhinitis, Allergic, Seasonal; Conjunctivitis, Allergic
  
• Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense
  ClinicalTrials.gov Identifier: NCT00501527 - Recruiting
  Rhinitis, Allergic, Seasonal; Conjunctivitis, Allergic; Asthma
  
• Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00383994 - Recruiting
  Lymphoma; Leukemia
  
• Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00415818 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus
  ClinicalTrials.gov Identifier: NCT00529321 - Recruiting
  Hepatitis C, Chronic
  
• Immunotoxin in Treating Patients With Leukemia or Lymphoma
  ClinicalTrials.gov Identifier: NCT00002765 - Completed
  Leukemia; Lymphoma
  
• Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00036972 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; Mixed Gliomas
  
• Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma
  ClinicalTrials.gov Identifier: NCT00052624 - Active, not recruiting
  recurrent childhood cerebral astrocytoma
  
• Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas
  ClinicalTrials.gov Identifier: NCT00053040 - Completed
  recurrent childhood brain tumor
  
• Immunotoxin Therapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00006981 - Completed
  Cervical Cancer; Fallopian Tube Cancer; Head and Neck Cancer; Lung Cancer; Malignant Mesothelioma; Ovarian Cancer; Pancreatic Cancer; Peritoneal Cavity Cancer
  
• Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00066651 - Completed
  Cervical Cancer; Fallopian Tube Cancer; Head and Neck Cancer; Lung Cancer; Malignant Mesothelioma; Ovarian Cancer; Pancreatic Cancer; Peritoneal Cavity Cancer
  
• Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00021983 - Completed
  Leukemia
  
• Immunotoxin Therapy in Treating Patients With Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00006268 - Completed
  recurrent adult brain tumor; adult glioblastoma; adult anaplastic astrocytoma; Mixed Gliomas; adult giant cell glioblastoma; adult gliosarcoma
  
• Immunotoxin Therapy, Pemetrexed, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00575770 - Recruiting
  Malignant Mesothelioma
  
• IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)
  ClinicalTrials.gov Identifier: NCT00351949 - Recruiting
  Stage IV Renal Cell Carcinoma
  
• IMP321 Phase I Breast Carcinoma
  ClinicalTrials.gov Identifier: NCT00349934 - Recruiting
  Metastatic Breast Cancer
  
• Impact of 3-Year Lifestyle Intervention on Postprandial Glucose Metabolism: the SLIM Study
  ClinicalTrials.gov Identifier: NCT00381186 - Completed
  Impaired Glucose Tolerance; Type 2 Diabetes
  
• Impact of a Brief Motivational Interview on Drinking Behaviors of At Risk Drinkers Screened in the Emergency Room
  ClinicalTrials.gov Identifier: NCT00183183 - Completed
  Alcohol Abuse
  
• Impact of a Computerized Guidelines on the Management of Hypertension and Diabetes
  ClinicalTrials.gov Identifier: NCT00398944 - Not yet recruiting
  Diabetes Mellitus; Hypertension
  
• Impact of a Decision Aid Regarding Natural Health Products for Menopausal Symptoms
  ClinicalTrials.gov Identifier: NCT00325923 - Active, not recruiting
  Decision Making; Choice Behavior; Decision Support Techniques; Decision Aids
  
• Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00534053 - Recruiting
  Colon Cancer
  
• Impact of a PDA-Based Dietary Adherence Intervention On Interdialytic Weight Gain and Blood Pressure in Hemodialysis Patients
  ClinicalTrials.gov Identifier: NCT00447408 - Recruiting
  End-Stage Renal Disease; Hemodialysis
  
• Impact of a Psychological Biofeedback-Relaxation Intervention on Clinical, Physical and Psychological Outcomes in Patients With Heart Failure
  ClinicalTrials.gov Identifier: NCT00255931 - Recruiting
  Heart Failure
  
• Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients
  ClinicalTrials.gov Identifier: NCT00160823 - Recruiting
  Colonoscopy
  
• Impact of a Telephone-Based Support Intervention on the Long-Term Well-Being of Women Undergoing Termination of Pregnancy for Fetal Anomaly
  ClinicalTrials.gov Identifier: NCT00576212 - Not yet recruiting
  Psychological Sequelae of Termination of Pregnancy for Fetal Anomaly
  
• Impact of Adult Asthma
  ClinicalTrials.gov Identifier: NCT00005564 - Completed
  Asthma; Lung Diseases
  
• Impact of An Emergency Response System on Anxiety and Health-Care Use
  ClinicalTrials.gov Identifier: NCT00330720 - Completed
  Anxiety; Falls; Fear of Falling
  
• Impact of an IT-Based and Healthcare Professional Support Program on Patients With High Blood Pressure
  ClinicalTrials.gov Identifier: NCT00374829 - Active, not recruiting
  Hypertension
  
• Impact of Anti-HIV Treatment on Labor Productivity and Costs in South Africa
  ClinicalTrials.gov Identifier: NCT00270725 - Active, not recruiting
  HIV Infections
  
• Impact of Anti-Static Chamber/Mask
  ClinicalTrials.gov Identifier: NCT00307970 - Completed
  Asthma
  
• Impact of Anti-TNF Antibodies on the T-Lymphocyte and Macrophage Cooperation in the Crohn Disease
  ClinicalTrials.gov Identifier: NCT00561548 - Recruiting
  Crohn Disease
  
• Impact of Antibiotic Treatment On Outcome in Patients with Ventilator-Associated Tracheobronchitis
  ClinicalTrials.gov Identifier: NCT00122057 - Recruiting
  Respiratory Tract Diseases; Nosocomial Infections
  
• Impact of Antioxidant Micronutrients on ICU Outcome
  ClinicalTrials.gov Identifier: NCT00515736 - Terminated
  Critically Ill Patients; Cardiac Surgery; Trauma; Subarachnoid Hemorrhage
  
• Impact of Asthma Treatments on Daily Activities
  ClinicalTrials.gov Identifier: NCT00350376 - Recruiting
  Asthma; Allergies
  
• Impact of Attention Deficit/Hyperactivity Disorder and Substance Use Disorder on Motorcycle Traffic Accidents
  ClinicalTrials.gov Identifier: NCT00536419 - Recruiting
  Attention Deficit Hyperactivity Disorder
  
• Impact of Benfluorex Versus Metformin on Glucose Control and Insulin Secretion in Chinese Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00544518 - Recruiting
  Type 2 Diabetes
  
• Impact of Caregiver Depression on Asthma in the Child
  ClinicalTrials.gov Identifier: NCT00223288 - Active, not recruiting
  Depressive Disorder, Major; Asthma
  
• Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults
  ClinicalTrials.gov Identifier: NCT00482001 - Not yet recruiting
  Mental Health; Geriatrics
  
• Impact of Computerized Physician Order Entry on Medication Prescription Errors in the Intensive Care Unit: a Controlled Cross-Sectional Trial.
  ClinicalTrials.gov Identifier: NCT00287274 - Completed
  Medication Errors; Patient Safety
  
• Impact of Consumption of Orange-Fleshed Sweet Potatoes on the Vitamin A Status of Bangladeshi Women of Reproductive Age
  ClinicalTrials.gov Identifier: NCT00453648 - Recruiting
  Vitamin A Deficiency
  
• Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis
  ClinicalTrials.gov Identifier: NCT00406198 - Completed
  Bacteremia; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Pneumonia, Bacterial; Shock, Septic; Sepsis
  
• Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance
  ClinicalTrials.gov Identifier: NCT00137657 - Completed
  HIV; Malaria; Diarrhea; Pneumonia; Opportunistic Infections
  
• Impact of CPAP on Functional Outcomes in Milder Obstructive Sleep Apnea (CATNAP)
  ClinicalTrials.gov Identifier: NCT00089752 - Recruiting
  Lung Diseases; Sleep Apnea Syndromes; Sleep; Hypertension
  
• Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease
  ClinicalTrials.gov Identifier: NCT00495690 - Recruiting
  Pneumonia; Diarrhea; Any Severe Illness; All Cause Mortality
  
• Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects with Symptomatic Congestive Heart Failure (CHF) and Anemia
  ClinicalTrials.gov Identifier: NCT00117234 - Completed
  Congestive Heart Failure; Anemia
  
• Impact of Diabetes and Glucose Control During Rehabilitation After Stroke
  ClinicalTrials.gov Identifier: NCT00241956 - Recruiting
  Cerebrovascular Accident; Diabetes; Hyperglycemia
  
• Impact of Diet and Exercise Activity on Pregnancy Outcomes
  ClinicalTrials.gov Identifier: NCT00486629 - Recruiting
  Obesity; Gestational Diabetes; Type 2 Diabetes
  
• Impact of Different Dialysis on Sleep Apnea in Patients With Renal Failure
  ClinicalTrials.gov Identifier: NCT00380848 - Recruiting
  Sleep Apnea; End Stage Renal Disease
  
• Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00551655 - Completed
  Human Immunodeficiency Viruses; Kidney Failure; HIV Infections
  
• Impact of Early Parenteral Nutrition Completing Enteral Nutrition in Adult Critically Ill Patients
  ClinicalTrials.gov Identifier: NCT00512122 - Recruiting
  Critical Illness; Reduced Oral Intake; Starvation
  
• Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome
  ClinicalTrials.gov Identifier: NCT00348738 - Active, not recruiting
  Cervix Cancer
  
• Impact of Erythropoietin Treatment Versus Placebo on Quality-of-Life in Patients With Advanced Prostate Cancer.
  ClinicalTrials.gov Identifier: NCT00364455 - Completed
  Prostate; Carcinoma
  
• Impact of Exclusive Breast-Feeding in Guinea Bissau
  ClinicalTrials.gov Identifier: NCT00131625 - Completed
  Mortality; Morbidity; Nutritional status
  
• Impact of Exercise on Older Persons with Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00000434 - Completed
  Osteoarthritis
  
• Impact of Exercise Training Intensity on Abdominal Visceral Fat and Risk Factors Associated With the Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00350064 - Active, not recruiting
  Metabolic Syndrome
  
• Impact of Exercise Training on Endothelial Function in CAD
  ClinicalTrials.gov Identifier: NCT00176345 - Recruiting
  Coronary Artery Disease
  
• Impact of Exercise Training on Exercise Capacity in Patients With Severe Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00176384 - Completed
  Heart Failure
  
• Impact of Gastric Bypass Surgery on Risk of CVD in Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00444392 - Recruiting
  Obese Patients; Type 2 Diabetes Mellitus
  
• Impact of Gender on Patients
  ClinicalTrials.gov Identifier: NCT00170560 - Recruiting
  Hospital-Acquired Infections
  
• Impact of Genetics on Metformin Pharmacokinetics
  ClinicalTrials.gov Identifier: NCT00187798 - Recruiting
  Healthy Volunteer
  
• Impact of GERD on Daily Life (NIS)
  ClinicalTrials.gov Identifier: NCT00545883 - Completed
  GERD
  
• Impact of Gum Infection on Heart Disease
  ClinicalTrials.gov Identifier: NCT00093236 - Recruiting
  Cardiovascular Disease; Periodontal Disease
  
• Impact of Heart Rate Characteristics Monitoring in Neonates
  ClinicalTrials.gov Identifier: NCT00307333 - Recruiting
  Sepsis
  
• Impact of Heparin on the Need for Mechanical Ventilation in Neonates
  ClinicalTrials.gov Identifier: NCT00196469 - Recruiting
  Respiration, Artificial; Hemorrhage
  
• Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.
  ClinicalTrials.gov Identifier: NCT00432627 - Recruiting
  Hepatic Impairment
  
• Impact of HIV and Its Treatment on Reverse Cholesterol Transport
  ClinicalTrials.gov Identifier: NCT00168233 - Recruiting
  HIV Infections
  
• Impact of HIV on Measles and Measles Immunisation
  ClinicalTrials.gov Identifier: NCT00247091 - Completed
  HIV Infection; Measles; Children
  
• Impact of Home Zinc Treatment for Acute Diarrhea in Children
  ClinicalTrials.gov Identifier: NCT00530829 - Not yet recruiting
  Diarrhea
  
• Impact of Hydrocortisone Administration on White Blood Cell Gene Expression in Patients With Severe Sepsis
  ClinicalTrials.gov Identifier: NCT00185783 - Completed
  Sepsis; Relative Adrenal Insufficiency
  
• Impact of Hypoglycemia Unawareness on Brain Metabolism Cognition in T1DM
  ClinicalTrials.gov Identifier: NCT00575783 - Recruiting
  Type 1 Diabetes; Hypoglycemia
  
• Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine
  ClinicalTrials.gov Identifier: NCT00542776 - Recruiting
  Inflammatory Bowel Disease (IBD); Immunosuppressed or Non-Immunosuppressed; Influenza Vaccine; Antibody Titers; Seroprotective Titers
  
• Impact of Immunosuppressive Regimens on Polyoma-Virus Related Transplant Nephropathy.
  ClinicalTrials.gov Identifier: NCT00160966 - Recruiting
  Kidney Transplantation; BK polyomavirus; Immunosuppression
  
• Impact of Insecticide-Treated Curtains on Antimalarial Drug Resistance
  ClinicalTrials.gov Identifier: NCT00169078 - Completed
  Malaria
  
• Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke Incidence
  ClinicalTrials.gov Identifier: NCT00486915 - Recruiting
  Atrial Fibrillation; Thromboembolism; Cerebrovascular Accident
  
• Impact of Listening to Low Tones on Motor Function in Children With CP
  ClinicalTrials.gov Identifier: NCT00394641 - Not yet recruiting
  Cerebral Palsy; Hypertonia
  
• Impact of Literacy Level on Patient Education and Health Among People With Arthritis
  ClinicalTrials.gov Identifier: NCT00023205 - Completed
  Rheumatoid Arthritis; Psoriatic Arthritis; Polyarthritis
  
• Impact of Long Wavelength UVA and Visible Light on Melanocompetent Skin
  ClinicalTrials.gov Identifier: NCT00478751 - Recruiting
  Healthy
  
• Impact of Low Dose Naloxone on Fentanyl Requirements in Pediatric ICU Patients
  ClinicalTrials.gov Identifier: NCT00286052 - Completed
  Opioid Tolerance
  
• Impact of Lung Cancer Diagnosis on Relatives' Understanding of Genetic Risk and Receptivity to Quit Smoking
  ClinicalTrials.gov Identifier: NCT00341341 - Active, not recruiting
  Lung Cancer
  
• Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh
  ClinicalTrials.gov Identifier: NCT00198822 - Recruiting
  Vitamin A Deficiency
  
• Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
  ClinicalTrials.gov Identifier: NCT00224809 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy
  ClinicalTrials.gov Identifier: NCT00283816 - Recruiting
  Polycystic Ovary Syndrome
  
• Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression
  ClinicalTrials.gov Identifier: NCT00554398 - Not yet recruiting
  HIV Infections
  
• Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression
  ClinicalTrials.gov Identifier: NCT00205075 - Recruiting
  Hepatic Fibrogenesis; Hepatitis C
  
• Impact of Move to Clinical Research Center on Physical Activity of Employees
  ClinicalTrials.gov Identifier: NCT00095485 - Completed
  
  
• Impact of nCPAP Treatment on Liver Function in Patients with Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis
  ClinicalTrials.gov Identifier: NCT00152711 - Recruiting
  Sleep Apnea Syndrome; Nonalcoholic steatohepatitis
  
• Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department
  ClinicalTrials.gov Identifier: NCT00559338 - Completed
  Heart Failure, Congestive; Cardiomyopathy
  
• Impact of Non-Commercialism Policy in Seattle Schools
  ClinicalTrials.gov Identifier: NCT00065000 - Completed
  Obesity
  
• Impact of Non-Commercialism Policy in Seattle Schools
  ClinicalTrials.gov Identifier: NCT00063700 - Active, not recruiting
  Obesity
  
• Impact of Optimized Titration and Delivery of Bedtime Insulin on Prevention of Nocturnal Hypoglycemia
  ClinicalTrials.gov Identifier: NCT00475345 - Completed
  Type 1 Diabetes Mellitus
  
• Impact of Oral Ibandronate 150mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)
  ClinicalTrials.gov Identifier: NCT00271713 - Active, not recruiting
  Osteoporosis, Postmenopausal
  
• Impact of Parathyroid Hormone (PTH) on Osseous Cavity
  ClinicalTrials.gov Identifier: NCT00277706 - Recruiting
  Bone Loss With Moderate to Advanced Periodontitis
  
• Impact of Patient-Prosthesis-Mismatch on Coronary Flow Reserve
  ClinicalTrials.gov Identifier: NCT00310947 - Completed
  Coronary Artery Disease
  
• Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00444717 - Recruiting
  Metabolic Syndrome; Oxidative Stress; Inflammation
  
• Impact of Polymorphisms of OAT1, OAT3 and OCT2 on Transportation of Potential Nephrotoxic Drugs
  ClinicalTrials.gov Identifier: NCT00251017 - Not yet recruiting
  Subjects 16 Years of Age or Older, of Either Sex.; Subjects Have a Medication Including Vancomycin
  
• Impact of Positron Emission Tomography Imaging Prior to Liver Resection for Colorectal Adenocarcinoma Metastases(PETCAM)
  ClinicalTrials.gov Identifier: NCT00265356 - Recruiting
  Colorectal Cancer; Liver Metastases
  
• Impact of Pregnancy and the Postpartum Period on Women With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00320645 - Recruiting
  Bipolar Disorder
  
• Impact of Prenatal Vitamin/Mineral Supplements on Perinatal Mortality: A Randomized Controlled Trial in China
  ClinicalTrials.gov Identifier: NCT00133744 - Recruiting
  Stillbirths; Early neonatal deaths
  
• Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus Intestinal Carriage.
  ClinicalTrials.gov Identifier: NCT00437580 - Recruiting
  Vancomycin Resistant Enterococcus Intestinal Carriage
  
• Impact of Pushrim Activated Power Assist Wheelchairs on Mobility Among People With Tetraplegia
  ClinicalTrials.gov Identifier: NCT00281463 - Recruiting
  Wheelchair Users
  
• Impact of Race and Re-Transplantation
  ClinicalTrials.gov Identifier: NCT00229788 - Terminated
  Orthotopic Heart Transplantation
  
• Impact of Respiratory Muscle Unloading on Respiratory Muscle Endurance
  ClinicalTrials.gov Identifier: NCT00415896 - Recruiting
  Chronic Respiratory Failure
  
• Impact of Resynchronization Therapy on Sleep Disordered Breathing in Advanced Congestive Heart Failure
  ClinicalTrials.gov Identifier: NCT00521534 - Recruiting
  Sleep Related Breathing Disorder; Congestive Heart Failure
  
• Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00425932 - Recruiting
  Rheumatoid Arthritis
  
• Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00176332 - Completed
  Heart Failure
  
• Impact of Screening Patients With HIV for Kidney Disease
  ClinicalTrials.gov Identifier: NCT00392132 - Active, not recruiting
  HIV Infections; Renal Insufficiency, Chronic; Proteinuria
  
• Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00202033 - Active, not recruiting
  Type 2 Diabetes
  
• Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters
  ClinicalTrials.gov Identifier: NCT00318799 - Completed
  Pregnancy, Unplanned
  
• Impact of Sleep Disordered Breathing in Older Adults
  ClinicalTrials.gov Identifier: NCT00005378 - Completed
  Cardiovascular Diseases; Hypertension; Depression; Sleep Apnea Syndromes; Lung Diseases
  
• Impact of Sleep Disruption on the Menstrual Cycle
  ClinicalTrials.gov Identifier: NCT00456222 - Completed
  Sleep; Circadian Rhythm; Menstrual Cycle
  
• Impact of Smoking Cessation on Sleep - 1
  ClinicalTrials.gov Identifier: NCT00132821 - Recruiting
  Tobacco Use Cessation; Tobacco Use Disorder
  
• Impact of Sprinkles on Infectious Morbidity When Moderate to Severe Pediatric Malnutrition Is Highly Prevalent
  ClinicalTrials.gov Identifier: NCT00530374 - Not yet recruiting
  Malnutrition; Iron Deficiency
  
• Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy
  ClinicalTrials.gov Identifier: NCT00177112 - Recruiting
  Urinary Tract Infections
  
• Impact of Surfactant's Availability on Newborns
  ClinicalTrials.gov Identifier: NCT00005432 - Completed
  Lung Diseases; Respiratory Distress Syndrome
  
• Impact of Switching to Continuous Release Dopamine Agonists
  ClinicalTrials.gov Identifier: NCT00465452 - Recruiting
  Parkinson Disease
  
• Impact of Systemic Corticosteroid Therapy on Lens Transparency and Quantification of Lens Autofluorescence.
  ClinicalTrials.gov Identifier: NCT00337623 - Completed
  Patients With Systemic Inflammatory Diseases Receiving for the First Time a Protracted General Corticostroid Therapy
  
• Impact of Teledermatology on Health Services Outcomes in the VA
  ClinicalTrials.gov Identifier: NCT00488293 - Not yet recruiting
  Skin Diseases; Telemedicine; Quality of Life
  
• Impact of Tight Glycaemic Control in Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00237471 - Recruiting
  Myocardial Infarct; Hyperglycemia
  
• Impact of Training of GPs on Adherence of Hypertensive Individuals to Antihypertensive Medication
  ClinicalTrials.gov Identifier: NCT00330408 - Active, not recruiting
  Hypertension
  
• Impact of Treatment Induced Premature Menopause on Quality of Life
  ClinicalTrials.gov Identifier: NCT00185718 - Recruiting
  Menopause
  
• Impact of Umbilical Cord Cleansing With 4.0% Chlorhexidine on Neonatal Mortality and Omphalitis in Rural Sylhet District, Bangladesh
  ClinicalTrials.gov Identifier: NCT00434408 - Not yet recruiting
  Omphalitis; Infection
  
• Impact of Using Mini-Bronchoalveolar Lavage as a Diagnostic Test for Ventilator-Associated Pneumonia
  ClinicalTrials.gov Identifier: NCT00319644 - Recruiting
  Ventilator-Associated Pneumonia
  
• Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied
  ClinicalTrials.gov Identifier: NCT00301262 - Completed
  Impotence
  
• Impact of Water and Health Education Programs on Trachoma and Ocular C. Trachomatis in Niger
  ClinicalTrials.gov Identifier: NCT00348478 - Active, not recruiting
  Trachoma
  
• Impact of Weight Loss Following Bariatric Surgery on Pulmonary Function in Patients With Morbid Obesity
  ClinicalTrials.gov Identifier: NCT00532896 - Recruiting
  Bariatric Surgery; Obesity; Respiratory Diseases
  
• Impact of Zinc Supplementation in Low Birth Weight Infants on Severe Morbidity, Mortality and Zinc Status: A Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00272142 - Active, not recruiting
  Diarrhea; Respiratory Infection; Low Birth Weight
  
• Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 Months
  ClinicalTrials.gov Identifier: NCT00269542 - Completed
  Morbidity; Mortality; Diarrhea; Pneumonia
  
• Impact on Outcome of Early Endoscopic Extraction of Bile Duct Stones in Biliary Pancreatitis
  ClinicalTrials.gov Identifier: NCT00505128 - Not yet recruiting
  Biliary Pancreatitis
  
• IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment)
  ClinicalTrials.gov Identifier: NCT00268632 - Completed
  Osteoporosis
  
• IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients
  ClinicalTrials.gov Identifier: NCT00294515 - Active, not recruiting
  Cytomegalovirus Infections
  
• IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome
  ClinicalTrials.gov Identifier: NCT00434473 - Recruiting
  Sickle Cell Disease; Vaso-Occlusive Crisis; Acute Chest Syndrome
  
• Impaired Regulation of Energy Balance in Elderly People (Balance Study)
  ClinicalTrials.gov Identifier: NCT00561145 - Recruiting
  Anorexia of Ageing
  
• Impedance Threshold Device Tilt Study
  ClinicalTrials.gov Identifier: NCT00137319 - Terminated
  Burns; Orthostatic Hypotension
  
• IMPENDIA- PPEN VS DDDD Improved Metabolic Control In Diabetic CAPD Patients
  ClinicalTrials.gov Identifier: NCT00567398 - Not yet recruiting
  ESRD; Diabetes
  
• IMPENDIA- PPEN VS DDDD Improved Metabolic Control In Diabetic CAPD Patients
  ClinicalTrials.gov Identifier: NCT00567489 - Not yet recruiting
  ESRD; Diabetes; CAPD
  
• Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial
  ClinicalTrials.gov Identifier: NCT00243646 - Recruiting
  Prostate Cancer
  
• Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00534196 - Recruiting
  Prostate Cancer
  
• Implantable Cardioverter Defibrillators And Magnetic Resonance Imaging of the Heart at 1.5 Tesla
  ClinicalTrials.gov Identifier: NCT00356239 - Recruiting
  Defibrillators, Implantable; Heart Failure, Congestive
  
• Implantable Device for Male Reproductive Sterilization
  ClinicalTrials.gov Identifier: NCT00335361 - Active, not recruiting
  Male Sterilization
  
• Implantation and Cytokine Expression
  ClinicalTrials.gov Identifier: NCT00264992 - Active, not recruiting
  Infertility
  
• Implantation Failure and PGD
  ClinicalTrials.gov Identifier: NCT00547781 - Recruiting
  IMPLANTATION
  
• Implantation of Gold Beads to Relieve Discomfort From Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00487370 - Completed
  Osteoarthritis, Knee
  
• Implantation of Porous Titanium Prothesis in Laryngeal Surgery
  ClinicalTrials.gov Identifier: NCT00213863 - Recruiting
  Male or Female More Than 18 Years Old
  
• Implanted Myoelectric Control for Restoration of Hand Function in Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00583804 - Recruiting
  Spinal Cord Injury; Tetraplegia
  
• Implementation and Evaluation of "Mindfulness-Based Cognitive Therapy" in a Health Care Region in Flanders
  ClinicalTrials.gov Identifier: NCT00259506 - Recruiting
  Depressive Symptoms
  
• Implementation and Evaluation of a Medical Reconciliation Protocol at Brigham and Women's Hospital
  ClinicalTrials.gov Identifier: NCT00296426 - Not yet recruiting
  Medication Reconciliation
  
• Implementation of a New Strategy to Identify HNPCC Patients
  ClinicalTrials.gov Identifier: NCT00141466 - Recruiting
  Colorectal Neoplasms; Hereditary Nonpolyposis Colorectal Cancer
  
• Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs
  ClinicalTrials.gov Identifier: NCT00509717 - Active, not recruiting
  Cardiovascular Diseases
  
• Implementation of an Evidence Based Smoking Cessation Strategy (SMOCC) for Patients With COPD in Primary Care
  ClinicalTrials.gov Identifier: NCT00294905 - Recruiting
  COPD
  
• IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study
  ClinicalTrials.gov Identifier: NCT00416611 - Recruiting
  High Blood Pressure
  
• Implementation of Ischemic Heart Disease Clinical Practice Guidelines
  ClinicalTrials.gov Identifier: NCT00013104 - Completed
  Myocardial Ischemia; Heart Disease; Coronary Disease
  
• Implementation of Quality of Life Diagnostics and Therapy
  ClinicalTrials.gov Identifier: NCT00141635 - Completed
  Breast Neoplasms
  
• Implementation Strategies for a Simple Intervention to Reduce Longterm Benzodiazepine Use in Dutch Community Pharmacies
  ClinicalTrials.gov Identifier: NCT00268775 - Active, not recruiting
  Benzodiazepines Therapeutic Use
  
• Implementation Study of Dementia Guidelines in Primary Care
  ClinicalTrials.gov Identifier: NCT00459784 - Recruiting
  Dementia
  
• Implementation Study of the PostOperative Nausea and Vomiting Prediction Rule
  ClinicalTrials.gov Identifier: NCT00293618 - Recruiting
  Postoperative Nausea and Vomiting
  
• Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects
  ClinicalTrials.gov Identifier: NCT00101959 - Terminated
  Relapsing-Remitting Multiple Sclerosis
  
• Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
  ClinicalTrials.gov Identifier: NCT00137280 - Recruiting
  Schizophrenic Disorder; Chronic Illness; Schizoaffective Disorder; Weight Gain; Psychotic Disorder
  
• Implementing Evidence in the Detection and Treatment of Post Stroke Depression
  ClinicalTrials.gov Identifier: NCT00296140 - Not yet recruiting
  Mental Health; Neurology; Health Services
  
• Implementing Evidence-Based Treatment of Hypertension
  ClinicalTrials.gov Identifier: NCT00265538 - Recruiting
  Hypertension
  
• Implementing Hospital-Based Active Surveillance Procedures for Vaccine Safety Monitoring at IMSS Hospitals in Mexico
  ClinicalTrials.gov Identifier: NCT00436358 - Recruiting
  Intussusception; LRTI-Related Post Neonatal Deaths
  
• Implementing Smoking Cessation Guidelines: A Randomized Trial of Evidence-Based Quality Improvement
  ClinicalTrials.gov Identifier: NCT00012987 - Completed
  Smoking; Smoking Cessation; Quality Improvement
  
• Implementing Telemedicine-Based Collaborative Care for MDD in Contract CBOCs
  ClinicalTrials.gov Identifier: NCT00317018 - Not yet recruiting
  Depression
  
• Implementing the Assent Requirement for Research with Children
  ClinicalTrials.gov Identifier: NCT00102076 - Completed
  
  
• Implementing Tobacco Control in Dental Practice
  ClinicalTrials.gov Identifier: NCT00297700 - Active, not recruiting
  Smoking
  
• Implitapide in Patients with Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy
  ClinicalTrials.gov Identifier: NCT00079859 - Terminated
  Familial Hypercholesterolemia
  
• Implitapide in Patients with Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy
  ClinicalTrials.gov Identifier: NCT00079846 - Terminated
  Familial Hypercholesterolemia
  
• Implitapide in Patients with Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-lowering Therapy
  ClinicalTrials.gov Identifier: NCT00080132 - Terminated
  Hypertriglyceridemia
  
• Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment
  ClinicalTrials.gov Identifier: NCT00534443 - Recruiting
  Peptic Ulcer
  
• Importance of Forces and Safety Features in Car Crash Multitrauma
  ClinicalTrials.gov Identifier: NCT00204204 - Completed
  Multiple Trauma
  
• Importance of Hand Washing After Each NAET® Treatment
  ClinicalTrials.gov Identifier: NCT00292656 - Completed
  Allergy
  
• Importance of Non-Acid Reflux in Asthma in Children
  ClinicalTrials.gov Identifier: NCT00200980 - Recruiting
  Asthma; Gastroesophageal Reflux
  
• IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting
  ClinicalTrials.gov Identifier: NCT00303979 - Active, not recruiting
  Heart Failure, Congestive; Myocardial Infarction; Ventricular Dysfunction, Left
  
• Improve Speech Using an in-the-Ear Device in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00488657 - Recruiting
  Parkinson's Disease; Dysarthria
  
• IMPROVE Study(The Individualized Management With PEGASYS and Ribavirin Offering Viral Eradication): A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Non-Genotype 2/3.
  ClinicalTrials.gov Identifier: NCT00483938 - Recruiting
  Hepatitis C, Chronic
  
• IMPROVE-IT: Examining Outcomes in Subjects with Acute Coronary Syndrome:Vytorin (Ezetimibe/Simvastatin) Vs Simvastatin
  ClinicalTrials.gov Identifier: NCT00202878 - Recruiting
  Hypercholesterolemia; Myocardial Infarction
  
• IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis
  ClinicalTrials.gov Identifier: NCT00307645 - Terminated
  ANCA Associated Systemic Vasculitis Including Wegener’s; Granulomatosis and Microscopic Polyangiitis and; Renal Limited Vasculitis
  
• Improved Delivery of Cardiovascular Care Through Outreach Facilitation
  ClinicalTrials.gov Identifier: NCT00574808 - Recruiting
  Hypertension; Dyslipidemia; Diabetes; Chronic Kidney Disease; Cardiovascular Disease; Stroke; Transient Ischemic Attacks
  
• Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn
  ClinicalTrials.gov Identifier: NCT00399256 - Terminated
  Chronic Kidney Failure
  
• Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software
  ClinicalTrials.gov Identifier: NCT00552734 - Completed
  Diabetes
  
• Improved ICU Outcomes With Protocolized Management of Analgesia, Sedation and Delirium
  ClinicalTrials.gov Identifier: NCT00506649 - Completed
  Critical Care
  
• Improved Induction and Maintenance Immunosuppression in Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00556933 - Enrolling by invitation
  End-Stage Renal Disease; Renal Transplantation
  
• Improved Language Acquisition with Levodopa
  ClinicalTrials.gov Identifier: NCT00103805 - Active, not recruiting
  Healthy
  
• Improved Management and in-Hospital Mortality
  ClinicalTrials.gov Identifier: NCT00465777 - Completed
  Mortality; Malaria
  
• Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
  ClinicalTrials.gov Identifier: NCT00001529 - Recruiting
  Graft vs Host Disease; Healthy; Lymphopenia
  
• Improved Preoperative Selection of Cold Thyroid Nodules
  ClinicalTrials.gov Identifier: NCT00297297 - Not yet recruiting
  Thyroid Nodules
  
• Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and Caregiver
  ClinicalTrials.gov Identifier: NCT00272727 - Active, not recruiting
  Asthma
  
• Improved Stroke Outcome at 6 Months
  ClinicalTrials.gov Identifier: NCT00122798 - Completed
  Stroke
  
• Improved Use of Antibiotic Guidelines in Hospital Environment
  ClinicalTrials.gov Identifier: NCT00512772 - Recruiting
  Community-Acquired Pneumonia; Community-Acquired Pyelonephritis
  
• Improvement After Botulinum Toxin Injections to the Arms in Children With Cerebral Palsy
  ClinicalTrials.gov Identifier: NCT00549471 - Recruiting
  Cerebral Palsy
  
• Improvement in Baroreflex Sensitivity in OSAS
  ClinicalTrials.gov Identifier: NCT00284037 - Recruiting
  Obstructive Sleep Apnea Syndrome
  
• Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression
  ClinicalTrials.gov Identifier: NCT00234117 - Recruiting
  Bronchial Asthma; Gastroesophageal Reflux
  
• Improvement of Certain Symptoms Associated With Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00350259 - Recruiting
  Hepatitis C
  
• Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors
  ClinicalTrials.gov Identifier: NCT00382161 - Recruiting
  Impotence
  
• Improvement of Motor Performance in Chronic Stroke Patients by Combined Transcranial DC Stimulation and Somatosensory Stimulation
  ClinicalTrials.gov Identifier: NCT00110175 - Recruiting
  
  
• Improvement of Physical Activity and Correction of Body Mass Index in School Children
  ClinicalTrials.gov Identifier: NCT00176371 - Recruiting
  Overweight
  
• Improvement of Use Dependent Plasticity in Chronic Stroke Patients
  ClinicalTrials.gov Identifier: NCT00072735 - Completed
  Healthy; Cerebrovascular Accident
  
• ImproveR International
  ClinicalTrials.gov Identifier: NCT00290849 - Completed
  Thrombin-Specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI)
  
• Improving ADHD Treatment Adherence and Outcome in Primary Care Settings
  ClinicalTrials.gov Identifier: NCT00179894 - Recruiting
  Attention Deficit Disorder With Hyperactivity
  
• Improving Adherence in Patients With Hypertension - A Novel Use of Communication Technology
  ClinicalTrials.gov Identifier: NCT00277381 - Not yet recruiting
  Hypertension
  
• Improving Adherence to Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00222716 - Recruiting
  HIV Infections
  
• Improving Adherence to Blood Pressure Guidelines
  ClinicalTrials.gov Identifier: NCT00201019 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Improving Adherence to Interventions for Hypertension
  ClinicalTrials.gov Identifier: NCT00005708 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Obesity
  
• Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00406718 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Improving Antibiotic Use in Acute Care Treatment
  ClinicalTrials.gov Identifier: NCT00144040 - Completed
  Respiratory Infections
  
• Improving Antipsychotic Adherence Among Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00057135 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Improving Arm Mobility and Use after Stroke
  ClinicalTrials.gov Identifier: NCT00057018 - Active, not recruiting
  Cerebrovascular Accident
  
• Improving Aspirin Use in Diabetes: A Cluster Randomized Trial
  ClinicalTrials.gov Identifier: NCT00262977 - Completed
  Diabetes Mellitus
  
• Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy
  ClinicalTrials.gov Identifier: NCT00127816 - Recruiting
  -prostate cancer
  
• Improving Asthma Care for Minority Children in Head Start
  ClinicalTrials.gov Identifier: NCT00094276 - Recruiting
  Asthma; Lung Diseases
  
• Improving Asthma Care for Very Low Birth Weight Infants
  ClinicalTrials.gov Identifier: NCT00156507 - Recruiting
  Asthma
  
• Improving Asthma Communication in Minority Families
  ClinicalTrials.gov Identifier: NCT00133666 - Recruiting
  Asthma
  
• Improving Asthma Outcomes in an Urban Pediatric Population
  ClinicalTrials.gov Identifier: NCT00140439 - Active, not recruiting
  Asthma
  
• Improving Attention Skills of Children with Autism
  ClinicalTrials.gov Identifier: NCT00065910 - Completed
  Autism
  
• Improving Basic and Social Cognition in Veterans With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00470106 - Not yet recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Improving Blood Pressure in Colorado
  ClinicalTrials.gov Identifier: NCT00520988 - Recruiting
  Hypertension
  
• Improving Blood Pressure Management in Patients With Diabetes
  ClinicalTrials.gov Identifier: NCT00374270 - Completed
  Hypertension; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
  
• Improving Body Image in Middle Schoolers
  ClinicalTrials.gov Identifier: NCT00067652 - Completed
  
  
• Improving Bone Health in Adolescent Girls: The Youth Osteoporosis and Understanding Total Health (YOUTH) Study
  ClinicalTrials.gov Identifier: NCT00067600 - Active, not recruiting
  Osteoporosis
  
• Improving Brain Development in Medically Healthy Premature Infants
  ClinicalTrials.gov Identifier: NCT00065364 - Completed
  Premature Birth
  
• Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines
  ClinicalTrials.gov Identifier: NCT00012896 - Completed
  Pain; Cancer
  
• Improving Cardiac Rehabilitation Participation in Women and Men
  ClinicalTrials.gov Identifier: NCT00336830 - Active, not recruiting
  Myocardial Infarction; Unstable Angina; Coronary Disease
  
• Improving Cardiovascular Risk Prediction Using Hand Held Carotid Ultrasonography Study
  ClinicalTrials.gov Identifier: NCT00574457 - Enrolling by invitation
  Atherosclerosis; Cardiovascular Risk; Stroke
  
• Improving Care for Nursing Home Pneumonia in Nursing Home Care Units (NHCUs) and Veterans'' Homes
  ClinicalTrials.gov Identifier: NCT00120068 - Completed
  Pneumonia
  
• Improving Care for Patients with Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00222755 - Not yet recruiting
  Bipolar Disorder
  
• Improving Care for Patients With Diabetes and Poor Numeracy Skills
  ClinicalTrials.gov Identifier: NCT00311922 - Active, not recruiting
  Diabetes
  
• Improving Care for Primary Care Patients With Diabetes and Poor Literacy and Numeracy Skills
  ClinicalTrials.gov Identifier: NCT00469105 - Recruiting
  Type 2 Diabetes
  
• Improving Chronic Disease Care with PatientSite
  ClinicalTrials.gov Identifier: NCT00130416 - Recruiting
  Depression; Pain; Mobility Difficulty
  
• Improving Chronic Pain Treatment in Primary Care
  ClinicalTrials.gov Identifier: NCT00129480 - Active, not recruiting
  pain and chronic disease; Depression
  
• Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder
  ClinicalTrials.gov Identifier: NCT00541502 - Not yet recruiting
  Psychotic Disorders
  
• Improving Communication With Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00276822 - Recruiting
  Breast Cancer; Psychosocial Effects/Treatment
  
• Improving Compliance with Metformin
  ClinicalTrials.gov Identifier: NCT00018616 - Completed
  Diabetes
  
• Improving Control and Reducing the Risk of Hypoglycemic Episodes in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00315939 - Recruiting
  Diabetes Mellitus, Type 1
  
• Improving Coronary Prevention in a County Health System
  ClinicalTrials.gov Identifier: NCT00128687 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Coronary Heart Disease Risk Reduction; Heart Diseases
  
• Improving Depression Treatment for Older Minority Adults
  ClinicalTrials.gov Identifier: NCT00570427 - Recruiting
  Depression
  
• Improving Diabetes Care Collaboratively in the Community
  ClinicalTrials.gov Identifier: NCT00359996 - Active, not recruiting
  Diabetes
  
• Improving Diabetes Care for African Americans
  ClinicalTrials.gov Identifier: NCT00436176 - Active, not recruiting
  Diabetes
  
• Improving Diabetes Care Via Telephone Assessment and Patient Education
  ClinicalTrials.gov Identifier: NCT00012649 - Completed
  Diabetes Mellitus
  
• Improving Diabetes Efforts Across Language and Literacy (IDEALL)
  ClinicalTrials.gov Identifier: NCT00214474 - Active, not recruiting
  Diabetes
  
• Improving Diabetes in Primary Care (IMPACT)
  ClinicalTrials.gov Identifier: NCT00108927 - Completed
  Diabetes Mellitus; Type 2 Diabetes Mellitus; Hypertension
  
• Improving Diabetes Outcomes With Activity, Nutrition and Medication
  ClinicalTrials.gov Identifier: NCT00179374 - Recruiting
  Diabetes Mellitus, Type 2
  
• Improving Diabetes Outcomes: a Couples Intervention
  ClinicalTrials.gov Identifier: NCT00250731 - Recruiting
  Diabetes
  
• Improving Diabetes Quality of Care:Effectiveness of Physician Profiling and Care Coordination by a Diabetes Resource Nurse
  ClinicalTrials.gov Identifier: NCT00258674 - Completed
  Diabetes Mellitus
  
• Improving Diabetes Risk Factors in Mexican-American Persons With Schizophrenia by Switching to Ziprasidone
  ClinicalTrials.gov Identifier: NCT00538642 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Improving Diabetic Foot Ulcers with atorvaStatin
  ClinicalTrials.gov Identifier: NCT00134550 - Active, not recruiting
  Diabetes Mellitus; Foot Ulcer
  
• Improving Drug Use for Elderly Heart Failure Patients
  ClinicalTrials.gov Identifier: NCT00388622 - Completed
  Heart Failure
  
• Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00383279 - Active, not recruiting
  Cervical Cancer; Ovarian Cancer; Sarcoma
  
• Improving Executive Functions After Traumatic Brain Injury (TBI): A Clinical Trial of the "Executive Plus" Program
  ClinicalTrials.gov Identifier: NCT00233129 - Recruiting
  Traumatic Brain Injury
  
• Improving Follow-up After an Emergency Visit for Asthma
  ClinicalTrials.gov Identifier: NCT00113633 - Completed
  Asthma; Lung Diseases
  
• Improving Followup of Abnormal Colon Cancer Screening Tests
  ClinicalTrials.gov Identifier: NCT00436137 - Active, not recruiting
  Colorectal Cancer
  
• Improving Function in Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00572039 - Enrolling by invitation
  Age-Related Macular Degeneration
  
• Improving Functional Health Literacy in Older Veterans
  ClinicalTrials.gov Identifier: NCT00038337 - Completed
  Visual And Cognitive Disability
  
• Improving Functional Recovery After Hip Fracture
  ClinicalTrials.gov Identifier: NCT00000436 - Completed
  Unilateral hip fracture
  
• Improving Functioning in Peripheral Arterial Disease
  ClinicalTrials.gov Identifier: NCT00106327 - Recruiting
  Cardiovascular Diseases; Peripheral Vascular Diseases
  
• Improving Gait in Patients with Spinal Cord Injuries
  ClinicalTrials.gov Identifier: NCT00060983 - Completed
  Spinal Cord Injuries
  
• Improving Geriatric Drug Safety in Underserved Practices
  ClinicalTrials.gov Identifier: NCT00277173 - Recruiting
  Cardiovascular Diseases
  
• Improving Glycemic Control on GMS: A Quality Improvement Study
  ClinicalTrials.gov Identifier: NCT00271700 - Not yet recruiting
  Diabetes Mellitus
  
• Improving Hand Movement Training Through Electrical Stimulation of the Brain
  ClinicalTrials.gov Identifier: NCT00331318 - Recruiting
  Metaplasticity
  
• Improving Health Behavior and Outcomes After Angioplasty
  ClinicalTrials.gov Identifier: NCT00248976 - Completed
  Angioplasty
  
• Improving Health Behaviors Through Telephone Linked Care
  ClinicalTrials.gov Identifier: NCT00314197 - Completed
  Diet; Physical Activity; Smoking; Alcohol Abuse
  
• Improving Health Habits in Impoverished Populations
  ClinicalTrials.gov Identifier: NCT00569595 - Not yet recruiting
  Diabetes; Chronic Diseases
  
• Improving Health in Low Income Women Following the Birth of a Child
  ClinicalTrials.gov Identifier: NCT00061386 - Completed
  Health Education; Health Promotion
  
• Improving Health Outcomes for New Mothers and Babies
  ClinicalTrials.gov Identifier: NCT00360204 - Recruiting
  Hyperbilirubinemia; Jaundice; Dehydration; Postpartum Depression
  
• Improving Health Outcomes of Diabetic Veterans: A Diabetic Self-Management Program
  ClinicalTrials.gov Identifier: NCT00013052 - Completed
  Diabetes
  
• Improving Health Services for Veterans with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00012961 - Completed
  Schizophrenia
  
• Improving Heart Failure Care in Minority Communities
  ClinicalTrials.gov Identifier: NCT00211874 - Completed
  Congestive Heart Failure (CHF); Systolic Dysfunction
  
• Improving Hepatitis C Treatment in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00148031 - Recruiting
  Hepatitis C; Intravenous Drug Abuse; Liver Diseases; Drug Abuse; Alcoholism
  
• Improving Hispanic Retention in Antidepressant Therapy
  ClinicalTrials.gov Identifier: NCT00057642 - Active, not recruiting
  Depression; Depressive Disorder
  
• Improving HIV Prevention Skills in People With Serious Mental Illnesses
  ClinicalTrials.gov Identifier: NCT00356291 - Not yet recruiting
  HIV Infections
  
• Improving HIV Screening by Nurse Rapid Testing, Streamlined Counseling
  ClinicalTrials.gov Identifier: NCT00119548 - Completed
  Health Care Quality, Access, and Evaluation; Delivery of Health Care; Immune System Disease; HIV Infections
  
• Improving Hypertension Care for Inner City Minorities
  ClinicalTrials.gov Identifier: NCT00005707 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Improving Hypertension Control in East and Central Harlem
  ClinicalTrials.gov Identifier: NCT00211666 - Completed
  Hypertension
  
• Improving Hypertension Control in the Inner City
  ClinicalTrials.gov Identifier: NCT00005699 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Improving Immunosuppressive Treatment for Patients with Severe Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00061360 - Active, not recruiting
  Aplastic Anemia
  
• Improving Influenza Vaccination Rates Among Health Care Professionals
  ClinicalTrials.gov Identifier: NCT00404664 - Completed
  Influenza
  
• Improving Informed Consent in Childhood Cancer Trials
  ClinicalTrials.gov Identifier: NCT00228709 - Recruiting
  Eligible Subjects Are Parents of Newly Diagnosed Leukemia Pts Asked to Give Permission for Their Child to Participate in a Frontline Treatment Study.
  
• Improving Insulin Therapy With Enhanced Care Management
  ClinicalTrials.gov Identifier: NCT00320112 - Recruiting
  Diabetes
  
• Improving Management of Patients at High Risk for Osteoporotic Fractures
  ClinicalTrials.gov Identifier: NCT00139438 - Active, not recruiting
  Osteoporosis
  
• Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-Way Pagers
  ClinicalTrials.gov Identifier: NCT00392236 - Recruiting
  Schizophrenia
  
• Improving Medication Adherence in Comorbid Conditions
  ClinicalTrials.gov Identifier: NCT00072891 - Completed
  Diabetes Mellitus, Type 2; Hypertension; Hyperlipidemia
  
• Improving Medication Adherence in Post-ACS Patients
  ClinicalTrials.gov Identifier: NCT00576160 - Recruiting
  Medication Adherence; Acute Coronary Syndrome
  
• Improving Medication Adherence Through Graphically Enhanced Interventions in Acute Coronary Syndromes (IMAGE-ACS)
  ClinicalTrials.gov Identifier: NCT00399880 - Not yet recruiting
  Acute Coronary Syndrome (ACS)
  
• Improving Medication Use in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00388817 - Completed
  Hypertension
  
• Improving Memory in Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00062972 - Recruiting
  Multiple Sclerosis
  
• Improving Mental Health Services for Economically Disadvantaged Children: Training Teachers
  ClinicalTrials.gov Identifier: NCT00069563 - Completed
  Psychopathology
  
• Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
  ClinicalTrials.gov Identifier: NCT00105352 - Completed
  Diabetes Mellitus, Type 1
  
• Improving Metabolic Control in Diabetic Young Children
  ClinicalTrials.gov Identifier: NCT00439985 - Recruiting
  Type 1 Diabetes Mellitus
  
• Improving Metabolism With HDL Cholesterol
  ClinicalTrials.gov Identifier: NCT00395148 - Recruiting
  Heart Disease
  
• Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
  ClinicalTrials.gov Identifier: NCT00255866 - Active, not recruiting
  Dementia; Alzheimer Disease
  
• Improving Motor Learning in Stroke Patients
  ClinicalTrials.gov Identifier: NCT00067197 - Recruiting
  Cerebrovascular Accident
  
• Improving Otitis Media Care With Clinical Decision Support
  ClinicalTrials.gov Identifier: NCT00581711 - Not yet recruiting
  Otitis Media
  
• Improving Outcomes and Quality of Life After CABG
  ClinicalTrials.gov Identifier: NCT00005690 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Improving Outcomes and Quality of Life After CABG
  ClinicalTrials.gov Identifier: NCT00256620 - Completed
  Coronary Artery Bypass Graft Surgery Patients
  
• Improving Outcomes Following Limb Loss: PALS Plus
  ClinicalTrials.gov Identifier: NCT00447655 - Not yet recruiting
  Amputation
  
• Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control
  ClinicalTrials.gov Identifier: NCT00460499 - Recruiting
  Glycemic Control
  
• Improving Outcomes in Patients With Kidney Disease Due to Diabetes
  ClinicalTrials.gov Identifier: NCT00381134 - Completed
  Diabetes; Kidney Disease; Hypertension
  
• Improving Outcomes of Depression in Primary Care
  ClinicalTrials.gov Identifier: NCT00105833 - Completed
  Depression
  
• Improving Outcomes of Hospitalized Elders and Caregivers
  ClinicalTrials.gov Identifier: NCT00178412 - Recruiting
  Acute Illness
  
• Improving Outcomes Using Collaborative Group Clinics to Empower Older Patients
  ClinicalTrials.gov Identifier: NCT00481286 - Recruiting
  Diabetes; Hypertension
  
• Improving Pain Management in Patients With Nonhematologic Cancer
  ClinicalTrials.gov Identifier: NCT00036829 - Completed
  unspecified adult solid tumor, protocol specific; Pain
  
• Improving Parental Understanding of Medication Instructions Through a Pictogram-Based Intervention
  ClinicalTrials.gov Identifier: NCT00537433 - Completed
  Medication Errors
  
• Improving Patient-Clinician Communication About End-of-Life Care
  ClinicalTrials.gov Identifier: NCT00374010 - Active, not recruiting
  End-Stage Renal Disease
  
• Improving Pediatric Safety and Quality with Health Care Information Technology
  ClinicalTrials.gov Identifier: NCT00134823 - Active, not recruiting
  MEDICATION ERRORS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PATIENT SAFETY; QUALITY IMPROVEMENT
  
• Improving Perinatal Care in Latin America
  ClinicalTrials.gov Identifier: NCT00070720 - Completed
  Episiotomy; Pregnancy
  
• Improving Practice Patterns for the Treatment of Hypertension
  ClinicalTrials.gov Identifier: NCT00265044 - Completed
  Hypertension
  
• Improving Preventive Service Delivery at Adult Complete Health Check-Ups
  ClinicalTrials.gov Identifier: NCT00316394 - Completed
  Preventive Health Care
  
• Improving Primary Care in Patients With Mental Disorders
  ClinicalTrials.gov Identifier: NCT00183313 - Recruiting
  Mental Disorders
  
• Improving Primary Care to Prevent Childhood Obesity
  ClinicalTrials.gov Identifier: NCT00377767 - Recruiting
  Overweight in Preschool Age Children; Risk of Overweight in Preschool Age Children
  
• Improving Provider Counseling Interventions in HIV Practice
  ClinicalTrials.gov Identifier: NCT00538993 - Active, not recruiting
  HIV Infections
  
• Improving Quality of Colonoscopy Using a 3D-Imager
  ClinicalTrials.gov Identifier: NCT00519129 - Recruiting
  Colonoscopy
  
• Improving Quality of Life for African American Female Adolescents With Lupus
  ClinicalTrials.gov Identifier: NCT00068874 - Recruiting
  Lupus
  
• Improving Quality of Life for Veterans Undergoing Interferon Treatment
  ClinicalTrials.gov Identifier: NCT00117559 - Not yet recruiting
  Hepatitis C; Depression
  
• Improving Quality of Life Using Cognitive Behavioral Therapy in Depressed Youth With Inflammatory Bowel Disease
  ClinicalTrials.gov Identifier: NCT00534911 - Recruiting
  Inflammatory Bowel Disease; Subsyndromal Depression
  
• Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders
  ClinicalTrials.gov Identifier: NCT00102427 - Completed
  Panic Disorder; Anxiety Disorder
  
• Improving Quality With Outpatient Decision Support
  ClinicalTrials.gov Identifier: NCT00225628 - Completed
  Diabetes Mellitus; Coronary Artery Disease; Osteoporosis; Hypertension; Hyperlipidemia
  
• Improving Risk Factors for Diabetes Complications in Primary Care
  ClinicalTrials.gov Identifier: NCT00482768 - Recruiting
  Type 2 Diabetes
  
• Improving Safety and Quality With Outpatient Order Entry
  ClinicalTrials.gov Identifier: NCT00243334 - Not yet recruiting
  Ambulatory Care Information Systems; Clinical Decision Support Systems
  
• Improving Safety By Computerizing Outpatient Prescribing
  ClinicalTrials.gov Identifier: NCT00235027 - Completed
  Impact of Electronic Prescribing on Medication Safety
  
• Improving Safety of Antivenom in People Bitten by Snakes
  ClinicalTrials.gov Identifier: NCT00270777 - Recruiting
  Snake Bites
  
• Improving Self-Monitoring in Weight Loss With Technology
  ClinicalTrials.gov Identifier: NCT00277771 - Recruiting
  Obesity; Overweight
  
• Improving Service Delivery through Access Points
  ClinicalTrials.gov Identifier: NCT00012623 - Completed
  Hypertension; Angina Pectoris; Diabetes
  
• Improving Sleep and Psychological Functioning in People With Depression and Insomnia
  ClinicalTrials.gov Identifier: NCT00247624 - Recruiting
  Sleep Initiation and Maintenance Disorders; Depression
  
• Improving Sleep in Nursing Homes
  ClinicalTrials.gov Identifier: NCT00576927 - Recruiting
  Sleep Deprivation
  
• Improving Smoking Cessation Outcomes in Heavy Drinkers - 1
  ClinicalTrials.gov Identifier: NCT00107575 - Recruiting
  Tobacco Use Disorder
  
• Improving Substance Abuse Treatment Aftercare Adherence and Outcome
  ClinicalTrials.gov Identifier: NCT00057187 - Completed
  Substance Dependence
  
• Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin
  ClinicalTrials.gov Identifier: NCT00177580 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Improving the Frequency of Colonoscopy in Patients With a Previous Colorectal Polyp
  ClinicalTrials.gov Identifier: NCT00397969 - Active, not recruiting
  Colorectal Cancer; Precancerous/Nonmalignant Condition
  
• Improving the Health of People With Disabilities
  ClinicalTrials.gov Identifier: NCT00164515 - Recruiting
  Mobility Limitations; Obesity
  
• Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy
  ClinicalTrials.gov Identifier: NCT00402805 - Recruiting
  Lung Transplantation; Influenza Vaccines
  
• Improving the Management of Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00105664 - Completed
  Angina Pectoris; Myocardial Ischemia
  
• Improving The Nutritional Status Of The Malnourished Chronic Hemodialysis Patients In The State Of Tennessee
  ClinicalTrials.gov Identifier: NCT00179153 - Recruiting
  End Stage Renal Disease
  
• Improving the Outpatient Referral Process with Electronic Communications
  ClinicalTrials.gov Identifier: NCT00129064 - Completed
  Referral communication
  
• Improving the Quality of Care in Nursing Homes
  ClinicalTrials.gov Identifier: NCT00572221 - Enrolling by invitation
  Underperforming Nursing Homes
  
• Improving the Quality of End-of-Life Communication for Patients with Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00106080 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Improving the Quality of Patient Care by Using a Clinical Expert System.
  ClinicalTrials.gov Identifier: NCT00430755 - Recruiting
  Hypertension; Diabetes; Hypercholesterolemia; Vasculitis; Coronary Heart Diseases
  
• Improving the Results of Bone Marrow Transplantation for Patients with Severe Congenital Anemias
  ClinicalTrials.gov Identifier: NCT00061568 - Recruiting
  Congenital Hemolytic Anemia; Diamond-Blackfan Anemia
  
• Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%
  ClinicalTrials.gov Identifier: NCT00090194 - Completed
  Kidney Failure, Chronic
  
• Improving Treatment Adherence in HIV-Infected Individuals
  ClinicalTrials.gov Identifier: NCT00247611 - Recruiting
  HIV Infections; Health Behavior
  
• Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00282828 - Recruiting
  Social Phobia
  
• Improving Vision and Quality of Life in the Nursing Home
  ClinicalTrials.gov Identifier: NCT00347620 - Completed
  Refractive Error; Cataract
  
• Improving Vitamin D Status In Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00450073 - Recruiting
  Cystic Fibrosis
  
• Improving Vocational Outcomes in Arthritis
  ClinicalTrials.gov Identifier: NCT00000407 - Completed
  Arthritis; Musculoskeletal Diseases; Rheumatic Diseases
  
• Improving Walking in Older Adults With Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00583245 - Recruiting
  Knee Osteoarthritis
  
• Impulsivity in Pathological Gambling
  ClinicalTrials.gov Identifier: NCT00580567 - Recruiting
  Pathological Gambling
  
• Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals
  ClinicalTrials.gov Identifier: NCT00217997 - Recruiting
  Cocaine Abuse; Cocaine-Related Disorders
  
• IMR for Veterans With SMI
  ClinicalTrials.gov Identifier: NCT00515671 - Not yet recruiting
  Schizophrenia
  
• IMRT Lower Limb Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00188175 - Recruiting
  Sarcoma
  
• IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
  ClinicalTrials.gov Identifier: NCT00158678 - Recruiting
  Oral Cancer; Oropharynx Cancer; Hypopharynx Cancer
  
• Imuran (azathioprine) Dose-Ranging Study in Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00098111 - Recruiting
  Crohn's Disease
  
• Imuran Dosing Study
  ClinicalTrials.gov Identifier: NCT00113503 - Active, not recruiting
  Crohn''s Disease
  
• IN CONTROL--Hypertension Reduction in Inner City Seattle
  ClinicalTrials.gov Identifier: NCT00005698 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• In Home Hospital Care Program
  ClinicalTrials.gov Identifier: NCT00234780 - Completed
  Common Acute Problems
  
• In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)
  ClinicalTrials.gov Identifier: NCT00177190 - Completed
  Cutaneous T-Cell Lymphoma; Sezary Syndrome; Mycosis Fungoides
  
• In Vitro Fertilization After Use of Chemotherapy
  ClinicalTrials.gov Identifier: NCT00520364 - Recruiting
  Cancer
  
• In Vitro Maturation of Immature Oocytes
  ClinicalTrials.gov Identifier: NCT00480337 - Recruiting
  Polycystic Ovary Syndrome; Ovarian Hyperstimulation Syndrome
  
• In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
  ClinicalTrials.gov Identifier: NCT00001336 - Completed
  Immunologic Deficiency Syndrome; Leukemia; Lymphoma; Neoplasm
  
• In Vitro Studies on Pharmacological Regulation and Genetic Risk Factors of Peripheral Human Nociceptors
  ClinicalTrials.gov Identifier: NCT00223366 - Recruiting
  Pain
  
• In Vitro Study of Peripheral Blood Mononuclear Cell Function in Healthy Individuals and Patients
  ClinicalTrials.gov Identifier: NCT00342485 - Active, not recruiting
  Cell Function
  
• In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00086723 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• In Vivo Confocal Imaging of Oral Mucosa
  ClinicalTrials.gov Identifier: NCT00502125 - Recruiting
  Oral Tumors
  
• In Vivo Confocal Scanning Laser Microscopy of Benign Nevi
  ClinicalTrials.gov Identifier: NCT00487864 - Completed
  Nevus
  
• In Vivo Quantification of Dental Demineralisation Using Optical Coherence Tomography Before and After Double-Blind, Randomised Treatment With Esomeprazole or Placebo of Patients With Dental Erosions
  ClinicalTrials.gov Identifier: NCT00564330 - Recruiting
  Tooth Erosion
  
• In-Exsufflator Cough Assist Device in Patients With Symptomatic Bronchiectasis
  ClinicalTrials.gov Identifier: NCT00452114 - Recruiting
  Bronchiectasis
  
• In-Home Weight Loss Program for Adults With Type 2 Diabetes Delivered by Interactive Cable Television Technology
  ClinicalTrials.gov Identifier: NCT00277277 - Completed
  Diabetes Mellitus, Type 2
  
• In-Hospital Hyperglycemia: Effects of Treatment on Glycemic Control and Clinical Outcome
  ClinicalTrials.gov Identifier: NCT00302874 - Completed
  Diabetes; Hyperglycemia
  
• In-Patient Study in Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00259896 - Completed
  Type 2 Diabetes Mellitus
  
• In-Patient Study In Schizophrenic Patients
  ClinicalTrials.gov Identifier: NCT00197093 - Completed
  Schizophrenia
  
• In-Patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00354536 - Completed
  Non-Insulin-Dependent Diabetes Mellitus
  
• In-Vitro Maturation of Oocytes From Polycystic Ovarian Patients Undergoing IVF
  ClinicalTrials.gov Identifier: NCT00561808 - Not yet recruiting
  Polycystic Ovarian Syndrome
  
• In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00144352 - Completed
  Malaria; HIV; AIDS
  
• Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses
  ClinicalTrials.gov Identifier: NCT00417560 - Not yet recruiting
  Influenza
  
• Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age
  ClinicalTrials.gov Identifier: NCT00231920 - Active, not recruiting
  Influenza
  
• Inactivity and Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00572676 - Not yet recruiting
  Metabolic Syndrome X; Insulin Resistance; Hypertension; Hypercholesterolemia; Obesity
  
• Inamed 410 Style Silicone Breast Implant Study
  ClinicalTrials.gov Identifier: NCT00557674 - Enrolling by invitation
  Benefits and Risks of Receiving the Style 410 Silicone Implant
  
• INCA - Intervention and Neuropsychology in Cannabis Abuse
  ClinicalTrials.gov Identifier: NCT00279604 - Recruiting
  Marijuana Abuse
  
• Incentive Programs for Female Substance Abusers Who Smoke - 3
  ClinicalTrials.gov Identifier: NCT00064922 - Active, not recruiting
  Tobacco Use Disorder
  
• Incidence and Factors Associated With the Development and Severity of Oral Mucositis
  ClinicalTrials.gov Identifier: NCT00575809 - Recruiting
  Peripheral Blood Stem Cell Transplantation
  
• Incidence and Mortality of Childhood Cancer Among Children of Farmer Pesticide Applications
  ClinicalTrials.gov Identifier: NCT00339378 - Completed
  Pesticide Exposure
  
• Incidence and Nature of Heparin-Induced Skin Lesions in Medical Patients
  ClinicalTrials.gov Identifier: NCT00510432 - Recruiting
  Patients Reciving sc Heparin Therapy; Age Over 18 Years; Recruitment Will Stop When 20 Patients With Skin Lesions Are Included
  
• Incidence and Outcomes of Venous Thromboembolism
  ClinicalTrials.gov Identifier: NCT00005351 - Completed
  Cardiovascular Diseases; Lung Diseases; Pulmonary Embolism; Venous Thromboembolism
  
• Incidence and Severity of Cardiorespiratory Events in Infants at Increased Epidemiological Risk for Sudden Infant Death Syndrome (SIDS)
  ClinicalTrials.gov Identifier: NCT00004392 - Completed
  Sudden Infant Death Syndrome; Apnea
  
• Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage
  ClinicalTrials.gov Identifier: NCT00556634 - Active, not recruiting
  HIV-1 Infections; HIV Infections
  
• Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma, DCIS or ADH in Patients with Lobular Neoplasia of the Breast
  ClinicalTrials.gov Identifier: NCT00146536 - Recruiting
  Lobular neoplasia of the breast
  
• Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
  ClinicalTrials.gov Identifier: NCT00433602 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; Gastric Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Thromboembolism
  
• Incidence of Cardiovascular Diseases in Patients With Hypopituitarims
  ClinicalTrials.gov Identifier: NCT00442858 - Completed
  Cardiovascular Diseases
  
• Incidence of Delirium in Hip Fracture Patients Randomized to Regular Hypnotics Vs Placebo
  ClinicalTrials.gov Identifier: NCT00286936 - Recruiting
  Hip Fracture; Delirium
  
• Incidence of Diabetes and Cardiovascular Disease in Mexican Americans
  ClinicalTrials.gov Identifier: NCT00005205 - Completed
  Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Angina Pectoris; Death, Sudden, Cardiac; Cerebrovascular Disorders; ...
  
• Incidence of Group A Strep Pharyngitis in School Children in Fiji
  ClinicalTrials.gov Identifier: NCT00284882 - Active, not recruiting
  Streptococcus Group A
  
• Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas
  ClinicalTrials.gov Identifier: NCT00374335 - Recruiting
  Hemangioma
  
• Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™
  ClinicalTrials.gov Identifier: NCT00306982 - Completed
  Influenza
  
• Incidence of Neo-Aortic Insufficiency
  ClinicalTrials.gov Identifier: NCT00268073 - Terminated
  Congenital Disorders
  
• Incidence of Obstructive Sleep Apnea in Pregnancy
  ClinicalTrials.gov Identifier: NCT00462306 - Recruiting
  Obstructive Sleep Apnea; Pregnancy
  
• Incidence of Parkinson's Disease Among Veterans
  ClinicalTrials.gov Identifier: NCT00100438 - Completed
  Parkinson's Disease
  
• Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury
  ClinicalTrials.gov Identifier: NCT00124293 - Completed
  Traumatic Brain Injury
  
• Incisional Hernia Outcomes Study
  ClinicalTrials.gov Identifier: NCT00459602 - Recruiting
  Incisional Hernia
  
• Incisionless Treatment for Patients With Inadequate Weight Loss Following Roux-en-Y Gastric Bypass
  ClinicalTrials.gov Identifier: NCT00394212 - Recruiting
  Obesity
  
• Incisions for Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00229892 - Terminated
  Cardiac Surgery; Cardiac Diseases
  
• Incontinence Ring on Stress Urinary Incontinence
  ClinicalTrials.gov Identifier: NCT00427778 - Recruiting
  Stress Urinary Incontinence; Urinary Incontinence
  
• Incorporating Flow Limitation into the Diagnosis and Quantification of Sleep Disordered Breathing
  ClinicalTrials.gov Identifier: NCT00004569 - Completed
  Sleep-Disordered Breathing
  
• Incorporation of Muscle Qualities in Biomechanical Models of the Upper Limbs
  ClinicalTrials.gov Identifier: NCT00284388 - Recruiting
  Shoulder Prosthesis
  
• Increase Infusion Rates of Intravenous Fat Emulsions
  ClinicalTrials.gov Identifier: NCT00516997 - Completed
  Hypertriglyceridemia; Hyperglycemia
  
• Increased Access to Emergency Contraceptive Pills
  ClinicalTrials.gov Identifier: NCT00060463 - Active, not recruiting
  Pregnancy; Sexually Transmitted Diseases
  
• Increased Calorie Intake to Reverse Energy Deficiency in Exercising Women: Impact on Bone and Menstrual Cyclicity
  ClinicalTrials.gov Identifier: NCT00392873 - Recruiting
  Menstrual Irregularity; Exercise
  
• Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD)
  ClinicalTrials.gov Identifier: NCT00082238 - Recruiting
  Cystic Fibrosis; Diabetes Mellitus
  
• Increased Physical Activity in African-American Women
  ClinicalTrials.gov Identifier: NCT00005744 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Increasing Condom Use in People at Risk for HIV Infection
  ClinicalTrials.gov Identifier: NCT00080093 - Active, not recruiting
  HIV Infections
  
• Increasing Contingency Management Success in Smoking Cessation
  ClinicalTrials.gov Identifier: NCT00273793 - Recruiting
  Smoking
  
• Increasing Evidence-Based Clinical Practices in VA
  ClinicalTrials.gov Identifier: NCT00366028 - Active, not recruiting
  Handwashing
  
• Increasing Fluids in Older Adults to Prevent & Treat Pressure Ulcers
  ClinicalTrials.gov Identifier: NCT00507650 - Completed
  Pressure Ulcers
  
• Increasing Folate Status of a General Population(FOLSUPP STUDY)
  ClinicalTrials.gov Identifier: NCT00372645 - Recruiting
  Healthy
  
• Increasing HAART-Induced Immune Restoration with Cyclosporine
  ClinicalTrials.gov Identifier: NCT00031070 - Completed
  HIV Infections
  
• Increasing Infant Preventive Health Service Delivery in an Inner City Population
  ClinicalTrials.gov Identifier: NCT00221507 - Recruiting
  Healthy
  
• Increasing Physical Activity as Part of a Smoking Cessation Program
  ClinicalTrials.gov Identifier: NCT00403312 - Recruiting
  Smoking Cessation
  
• Increasing Physical Activity Levels in Low-Income Women
  ClinicalTrials.gov Identifier: NCT00065026 - Active, not recruiting
  Healthy
  
• Increasing Screening for Type 2 Diabetes in Women With Previous Gestational Diabetes.
  ClinicalTrials.gov Identifier: NCT00212914 - Active, not recruiting
  Gestational Diabetes
  
• Increasing Stroke Treatment Through Interactive Behavioral Change Tactics (INSTINCT) Study
  ClinicalTrials.gov Identifier: NCT00349479 - Active, not recruiting
  Stroke
  
• Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use Disorders
  ClinicalTrials.gov Identifier: NCT00237822 - Recruiting
  Diagnosis, Dual (Psychiatry); Psychiatric Diagnosis; Drug Use Disorders
  
• Increasing Walking Following Cardiac Rehabilitation
  ClinicalTrials.gov Identifier: NCT00281424 - Recruiting
  Cardiac Diseases; Walking
  
• Incretins in Impaired Fasting Glucose
  ClinicalTrials.gov Identifier: NCT00364377 - Recruiting
  Impaired Fasting Glucose
  
• Incurable Ill Patients Attitudes to Euthanasia and Assisted Suicide
  ClinicalTrials.gov Identifier: NCT00495482 - Recruiting
  Incurable Cancer Diseases; Other Incurable Diseases; Malignant Diseases
  
• Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00396604 - Completed
  Pulmonary Disease, Chronic Obstructive; COPD; Lung Diseases, Obstructive
  
• Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome
  ClinicalTrials.gov Identifier: NCT00069550 - Recruiting
  Rett Syndrome
  
• Indiaclen Short Course Amoxycillin Therapy for Pneumonia With Wheeze
  ClinicalTrials.gov Identifier: NCT00407394 - Completed
  Non-Severe Pneumonia With Wheeze
  
• Indicated Prevention of Psychotic Disorders With Low-Dose Lithium
  ClinicalTrials.gov Identifier: NCT00202306 - Recruiting
  Schizophrenia; Bipolar Disorder; Psychotic Disorders
  
• Indicated Prevention with At-Risk Gamblers
  ClinicalTrials.gov Identifier: NCT00078273 - Active, not recruiting
  Gambling
  
• Indicated Prevention With Omega-3 Fatty Acids in Adolescents With ‘At-Risk-Mental-State’ for Psychosis
  ClinicalTrials.gov Identifier: NCT00396643 - Completed
  Schizophrenia; Prodrome
  
• Indications and Related Factors for Caesarean Delivery, 1996 to 2002.
  ClinicalTrials.gov Identifier: NCT00172978 - Completed
  Labor
  
• Indices of Severity and Prognosis for Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00005467 - Completed
  Anemia, Sickle Cell; Blood Disease
  
• Indigenous Outreach Among Injection Drug Users to Treat and Control TB
  ClinicalTrials.gov Identifier: NCT00005741 - Completed
  Lung Diseases; Tuberculosis
  
• Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success with Nelfinavir
  ClinicalTrials.gov Identifier: NCT00002220 - Completed
  HIV Infections
  
• Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-Based Contrast
  ClinicalTrials.gov Identifier: NCT00230295 - Recruiting
  Head and Neck Cancer
  
• Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00002947 - Active, not recruiting
  Lung Cancer; Renal Cell Cancer; Head and Neck Cancer; Melanoma; Thyroid Cancer; Eye Cancer; Kidney Cancer
  
• Individual and Environmental Mechanisms of PA Change
  ClinicalTrials.gov Identifier: NCT00432133 - Recruiting
  Physical Activity; Behavior Change
  
• Individual and Family Therapy for Children with Anxiety Disorders
  ClinicalTrials.gov Identifier: NCT00081406 - Completed
  Anxiety
  
• Individual Counseling and/or Computer-Based Counseling in Helping Healthy Women Adopt a Cancer Prevention Diet
  ClinicalTrials.gov Identifier: NCT00217490 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Individual Versus Standard Follicle Stimulating Hormone Dose for Controlled Ovarian Stimulation and Insemination
  ClinicalTrials.gov Identifier: NCT00374634 - Recruiting
  Infertility
  
• Individual Workload Perception Scale (IWPS)
  ClinicalTrials.gov Identifier: NCT00196014 - Recruiting
  Healthy
  
• Individual- and Community-Based Behavioral Interventions to Improve Quality of Life For HIV Infected Individuals in Fuyang, Anhui Province, China
  ClinicalTrials.gov Identifier: NCT00479141 - Active, not recruiting
  HIV Infections
  
• Individualized Chiropractic and Integrative Care for Low Back Pain
  ClinicalTrials.gov Identifier: NCT00567333 - Recruiting
  Sub-Acute and Chronic Low Back Pain
  
• Individualized Drug Treatment Selection Process for Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00276744 - Recruiting
  Pancreatic Cancer
  
• Individualized Exercise Program for Treatment of Fatigue in Patients After HSCT.
  ClinicalTrials.gov Identifier: NCT00156871 - Recruiting
  Malignant disease; Transplant
  
• Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00499759 - Recruiting
  Depression; Fatigue; Leukemia; Musculoskeletal Complications; Psychosocial Effects/Treatment
  
• Individualized Interventions to Improve Asthma Adherence
  ClinicalTrials.gov Identifier: NCT00115323 - Recruiting
  Asthma; Lung Diseases
  
• Individualized Management of Alzheimer''s Patients and Caregiver Training
  ClinicalTrials.gov Identifier: NCT00120874 - Recruiting
  Alzheimer''s Disease
  
• Individualized Motivational Print Materials to Encourage More Physical Activity
  ClinicalTrials.gov Identifier: NCT00367029 - Recruiting
  Healthy
  
• Individualized Risk-Based Education in Promoting Breast Cancer Screening in Healthy Women
  ClinicalTrials.gov Identifier: NCT00416975 - Active, not recruiting
  Breast Cancer
  
• Individualized Treatment Program for Alcohol Problems
  ClinicalTrials.gov Identifier: NCT00298792 - Recruiting
  Alcohol Dependence
  
• Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
  ClinicalTrials.gov Identifier: NCT00396097 - Recruiting
  Idiopathic Short Stature
  
• Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection
  ClinicalTrials.gov Identifier: NCT00351403 - Recruiting
  Hepatitis C, Chronic
  
• Individually Adapted Therapy of Alcoholism
  ClinicalTrials.gov Identifier: NCT00317031 - Recruiting
  Alcoholism
  
• Individually Tailored Web-Based Program to Improve Blood Pressure Control
  ClinicalTrials.gov Identifier: NCT00377208 - Not yet recruiting
  Hypertension
  
• Individuals' Patterns of Disclosure About Huntington's Disease (HD) and the Association With Adaptation to HD
  ClinicalTrials.gov Identifier: NCT00491842 - Recruiting
  Huntington's Disease
  
• Indocyangreen Elimination in Cirrhosis and Acute Liver Failure
  ClinicalTrials.gov Identifier: NCT00245310 - Recruiting
  Acute Liver Failure; Liver Cirrhosis
  
• Indocyanine Green or Trypan Blue for Delamination of the Internal Limiting Membrane in Macular Hole Surgery
  ClinicalTrials.gov Identifier: NCT00419185 - Completed
  Idiopathic Macular Hole
  
• Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer
  ClinicalTrials.gov Identifier: NCT00033345 - Completed
  Breast Cancer
  
• Indole-3-carbinol in Preventing Cancer in Healthy Participants
  ClinicalTrials.gov Identifier: NCT00100958 - Completed
  unspecified adult solid tumor, protocol specific
  
• Indometacin and Risk of Falling
  ClinicalTrials.gov Identifier: NCT00462111 - Recruiting
  Healthy
  
• Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrage (GMH/IVH) Prevention Trial
  ClinicalTrials.gov Identifier: NCT00033917 - Active, not recruiting
  intraventricular hemorrhage (IVH); bleeding in the brain; prematurity; very low birth weight infants
  
• Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma
  ClinicalTrials.gov Identifier: NCT00002535 - Completed
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Indomethacin Versus Nifedipine for Preterm Labor Tocolysis
  ClinicalTrials.gov Identifier: NCT00486824 - Recruiting
  Obstetric Labor, Premature
  
• Indomethacin vs. Placebo in Women With PPROM
  ClinicalTrials.gov Identifier: NCT00466128 - Recruiting
  Preterm Premature Rupture of Membranes
  
• Indoor Temperature and Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00544752 - Recruiting
  Obstructive Sleep Apnea
  
• Induced Hypertension for Acute Ischemic Stroke
  ClinicalTrials.gov Identifier: NCT00227448 - Recruiting
  Acute Ischemic Stroke
  
• Induction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected Patients
  ClinicalTrials.gov Identifier: NCT00287677 - Recruiting
  HIV Infections
  
• Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients
  ClinicalTrials.gov Identifier: NCT00338039 - Recruiting
  Pancreatic Cancer
  
• Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00273546 - Completed
  Cancer
  
• Induction Chemotherapy Followed By Chemoradiotherapy in Treating Patients With Locally Advanced Adenocarcinoma of the Rectum
  ClinicalTrials.gov Identifier: NCT00070434 - Active, not recruiting
  stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
  
• Induction Chemotherapy Prior to Radio-Immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial
  ClinicalTrials.gov Identifier: NCT00502463 - Recruiting
  Head and Neck Cancer
  
• Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00070200 - Completed
  recurrent neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma; localized resectable neuroblastoma; regional neuroblastoma; ...
  
• Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00077103 - Completed
  anaplastic thyroid cancer
  
• Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim Followed by Radiotherapy and Paclitaxel/Carboplatin/ZD1839 in Locally Advanced Unresectable Stage IIIA/B Non-Small Cell Carcinoma of the Lung
  ClinicalTrials.gov Identifier: NCT00280787 - Completed
  Non Small Cell Lung Cancer
  
• Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma
  ClinicalTrials.gov Identifier: NCT00169182 - Completed
  Larynx Cancer; Hypopharynx Cancer
  
• Induction Dosing With Pegylated Interferon Alfa 2a and Ribavirin in Patients With Chronic Hepatitis C Genotype 1
  ClinicalTrials.gov Identifier: NCT00192647 - Active, not recruiting
  Chronic Hepatitis C
  
• Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002756 - Completed
  untreated childhood acute lymphoblastic leukemia; acute undifferentiated leukemia
  
• Induction Maintenance of Lopinavir/r in HIV-Infected Subjects
  ClinicalTrials.gov Identifier: NCT00159224 - Recruiting
  HIV-1 infection
  
• Induction of Cytokines in Human Monocytes by SARS-CoV in Adults and Children
  ClinicalTrials.gov Identifier: NCT00173563 - Recruiting
  Immunology
  
• Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes
  ClinicalTrials.gov Identifier: NCT00223067 - Recruiting
  Renal Transplantation
  
• Induction of Drug Metabolism: In Vivo Comparison of Carbamazepine and Oxcarbazepine.
  ClinicalTrials.gov Identifier: NCT00260247 - Active, not recruiting
  Metabolic Clearance Rate
  
• Induction of Immunogenicity with Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen
  ClinicalTrials.gov Identifier: NCT00104377 - Completed
  Type I Hypersensitivity
  
• Induction of Immunogenicity with Different Doses of TreeMATA in Subjects Allergic to Tree Pollen
  ClinicalTrials.gov Identifier: NCT00113750 - Completed
  Type I Hypersensitivity
  
• Induction of Labor With a Foley Balloon Catheter: Inflation With 30ml Compared to 60ml
  ClinicalTrials.gov Identifier: NCT00451308 - Recruiting
  Induction of Labor
  
• Induction of Mild Hypothermia Following Out-of-Hospital Cardiac Arrest
  ClinicalTrials.gov Identifier: NCT00391469 - Recruiting
  Out-of-Hospital Cardiac Arrest
  
• Induction of Mild Hypothermia in Resuscitated Cardiac Arrest Patients
  ClinicalTrials.gov Identifier: NCT00282373 - Completed
  Cardiac Arrest
  
• Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil
  ClinicalTrials.gov Identifier: NCT00531635 - Recruiting
  Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil
  
• Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
  ClinicalTrials.gov Identifier: NCT00427700 - Not yet recruiting
  Polycystic Ovary Syndrome
  
• Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1)
  ClinicalTrials.gov Identifier: NCT00521924 - Recruiting
  Rheumatoid Arthritis
  
• Induction of Stable Chimerism for Sickle Cell Anemia
  ClinicalTrials.gov Identifier: NCT00029393 - Active, not recruiting
  Blood Disease; Hematopoietic Stem Cell Transplantation; Anemia, Sickle Cell
  
• Induction of Suction Blisters in Patients with Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00001150 - Completed
  Dermatitis; Healthy; Neoplasm; Urticaria; Vesiculobullous Skin Disease
  
• Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch
  ClinicalTrials.gov Identifier: NCT00275509 - Recruiting
  Kidney Failure, Chronic
  
• Induction Therapy Using Cisplatin, Etoposide, and Radiation Therapy Followed By Consolidation Therapy Using Gemcitabine With or Without Docetaxel in Treating Patients With Unresectable Stage IIIB Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00074217 - Recruiting
  Non-small cell lung cancer
  
• Induction Therapy Using Cytarabine, Daunorubicin, and, Optionally, Gemtuzumab Ozogamicin Followed By Consolidation Therapy With High-Dose Cytarabine and Postconsolidation Therapy With Gemtuzumab Ozogamicin Compared With No Additional Therapy in Patients W
  ClinicalTrials.gov Identifier: NCT00085709 - Recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
  
• Induction Therapy with a Single High Dose Bolus of Intravenous Methotrexate with Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting with a First Acute Demyelinating Event.
  ClinicalTrials.gov Identifier: NCT00037115 - Not yet recruiting
  Demyelinating Disorders; Multiple Sclerosis; Optic Neuritis; Myelitis; Neuritis
  
• Induction Tirapazamine Combined With Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00066742 - Active, not recruiting
  limited stage small cell lung cancer
  
• Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: a Comparative Trial.
  ClinicalTrials.gov Identifier: NCT00436722 - Recruiting
  Liver Diseases
  
• Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone
  ClinicalTrials.gov Identifier: NCT00268567 - Completed
  Nephritis, Lupus
  
• Induction-Maintenance with Atazanavir in HIV Naïve Patients (The INDUMA Study)
  ClinicalTrials.gov Identifier: NCT00207142 - Active, not recruiting
  HIV-1 infected treatment naive patients
  
• Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00440947 - Active, not recruiting
  HIV Infection
  
• INEC Study: Immuno-Modulating Enteral Nutrition in Cancer
  ClinicalTrials.gov Identifier: NCT00333099 - Recruiting
  Malnutrition; Esophageal Cancer; Head and Neck Cancer
  
• Infant Aphakia Treatment Study (IATS)
  ClinicalTrials.gov Identifier: NCT00212134 - Recruiting
  Unilateral Congenital Cataract
  
• Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest
  ClinicalTrials.gov Identifier: NCT00000470 - Completed
  Cardiovascular Diseases; Cerebral Anoxia; Cerebrovascular Disorders; Defect, Congenital Heart; Heart Diseases; Transposition of Great Vessels; ...
  
• Infant Learning Project
  ClinicalTrials.gov Identifier: NCT00077831 - Active, not recruiting
  Craniosynostosis
  
• Infant Medical Records: Case Report Proposal
  ClinicalTrials.gov Identifier: NCT00268060 - Terminated
  Congenital Disorders
  
• Infant Weight Gain With Trisomy 21 and CAVC
  ClinicalTrials.gov Identifier: NCT00327951 - Active, not recruiting
  Congenital Disorders
  
• Infant's Examination and Manipulation of Objects
  ClinicalTrials.gov Identifier: NCT00053469 - Recruiting
  Healthy; Infant
  
• Infection and Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00005547 - Completed
  Cardiovascular Diseases; Coronary Disease; Cerebrovascular Accident; Heart Diseases; Myocardial Infarction; Infection; Chlamydia Infections; ...
  
• Infection in DiGeorge Following CHD Surgery
  ClinicalTrials.gov Identifier: NCT00278005 - Active, not recruiting
  DiGeorge Syndrome; Congenital Heart Defects
  
• Infection Surveillance in Intensive Care Patients
  ClinicalTrials.gov Identifier: NCT00197847 - Active, not recruiting
  Infection; Pneumonia; Sepsis; Cross Infection
  
• Infections After Renal Transplantation: Diseases Pattern in Hong Kong
  ClinicalTrials.gov Identifier: NCT00498017 - Recruiting
  Kidney Transplantation; Infection
  
• Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00230204 - Recruiting
  Multiple Sclerosis
  
• Infections Caused by ESbL-Producing Enterobacteriaceae in Italy
  ClinicalTrials.gov Identifier: NCT00404625 - Recruiting
  Enterobacteriaceae Infections; Bacteremia; Pneumonia; Skin Diseases; Urinary Tract Infections
  
• Infections Related Central Venous Catheters
  ClinicalTrials.gov Identifier: NCT00554021 - Active, not recruiting
  SIRS
  
• Infectious Agents in Pediatric Crohn's
  ClinicalTrials.gov Identifier: NCT00237055 - Completed
  Crohn's Disease; Inflammatory Bowel Disease
  
• Infectious Etiology of Acute Exacerbations of COPD
  ClinicalTrials.gov Identifier: NCT00441389 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Infectious Outcomes Following Pancreas Transplantation
  ClinicalTrials.gov Identifier: NCT00332111 - Recruiting
  Pancreatic Transplantation
  
• Infectivity of Norovirus in Groundwater-Human Challenge Study
  ClinicalTrials.gov Identifier: NCT00313404 - Suspended
  Healthy
  
• Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-Alfa and Ribavirin
  ClinicalTrials.gov Identifier: NCT00456248 - Terminated
  Hepatitis C
  
• Infertility Markers in Serum, Urine, and Follicular Fluid
  ClinicalTrials.gov Identifier: NCT00194220 - Recruiting
  Infertility
  
• INFLAME: Inflammation and Exercise
  ClinicalTrials.gov Identifier: NCT00113061 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity; Coronary Heart Disease Risk Reduction
  
• Inflammation and Coronary Artery Disease. Role of AT1-Receptor Antagonism
  ClinicalTrials.gov Identifier: NCT00274144 - Completed
  Hypertension; Coronary Arteriosclerosis
  
• Inflammation and Corticosteroid Responsiveness in Severe Asthma
  ClinicalTrials.gov Identifier: NCT00180661 - Recruiting
  Asthma
  
• Inflammation and Infection in Trauma, Role in Posttraumatic Complications
  ClinicalTrials.gov Identifier: NCT00192907 - Active, not recruiting
  Trauma
  
• Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm
  ClinicalTrials.gov Identifier: NCT00513773 - Recruiting
  Aortic Aneurysm, Abdominal
  
• Inflammation and the Host Response to Injury (Burns)
  ClinicalTrials.gov Identifier: NCT00257244 - Recruiting
  Trauma; Burns; Multiple Organ Failure
  
• Inflammation and the Host Response to Injury (Trauma)
  ClinicalTrials.gov Identifier: NCT00257231 - Recruiting
  Trauma; Burns; Multiple Organ Failure
  
• Inflammation Genomics and Atherosclerosis - Ancillary to CARDIA
  ClinicalTrials.gov Identifier: NCT00046605 - Active, not recruiting
  Cardiovascular Diseases; Atherosclerosis; Coronary Arteriosclerosis; Inflammation; Heart Diseases; Thrombosis
  
• Inflammation in Children With Attention-Deficit/Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00391495 - Not yet recruiting
  Attention-Deficit/Hyperactivity Disorder
  
• Inflammation Markers Over Time in Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00005692 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Thrombosis; Inflammation
  
• Inflammation, Autonomic Dysfunction and Airway Disease
  ClinicalTrials.gov Identifier: NCT00005298 - Completed
  Lung Diseases; Asthma; Bronchitis; Inflammation
  
• Inflammation, Infection, and Future Cardiovascular Risk
  ClinicalTrials.gov Identifier: NCT00005496 - Completed
  Cardiovascular Diseases; Coronary Disease; Cerebrovascular Accident; Myocardial Infarction; Venous Thromboembolism; Heart Diseases; Infection; ...
  
• Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients
  ClinicalTrials.gov Identifier: NCT00420290 - Recruiting
  End Stage Renal Disease
  
• Inflammation: Correlates and Prognosis in Framingham
  ClinicalTrials.gov Identifier: NCT00006403 - Completed
  Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Coronary Disease; Inflammation
  
• Inflammatory Abnormalities in Muscle After Stroke: Effects of Exercise
  ClinicalTrials.gov Identifier: NCT00387712 - Recruiting
  Stroke; Inflammation
  
• Inflammatory and Fibrotic Markers and Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00173589 - Recruiting
  Atrial Fibrillation
  
• Inflammatory Breast Cancer (IBC) Registry
  ClinicalTrials.gov Identifier: NCT00477100 - Recruiting
  Breast Cancer
  
• Inflammatory Breast Cancer and Tumor Markers
  ClinicalTrials.gov Identifier: NCT00073567 - Recruiting
  Breast Neoplasms
  
• Inflammatory Cells in Asthma
  ClinicalTrials.gov Identifier: NCT00180726 - Recruiting
  Asthma
  
• Inflammatory Genomics in Human Carotid Artery Disease
  ClinicalTrials.gov Identifier: NCT00070668 - Active, not recruiting
  Cardiovascular Diseases; Atherosclerosis; Carotid Artery Diseases; Inflammation
  
• Inflammatory Markers in Exhaled Breath (Condensate) in Childhood Asthma
  ClinicalTrials.gov Identifier: NCT00404976 - Completed
  Asthma; Healthy; Children
  
• Inflammatory Markers in Patients With Active Migraine Headaches
  ClinicalTrials.gov Identifier: NCT00471861 - Not yet recruiting
  Migraine
  
• Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
  ClinicalTrials.gov Identifier: NCT00217854 - Recruiting
  Asthma
  
• Inflammatory Profiles of Children at High Risk for Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00115232 - Active, not recruiting
  Cardiovascular Disease; Metabolic Syndrome X; Hypercholesterolemia; Inflammation
  
• Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission
  ClinicalTrials.gov Identifier: NCT00323440 - Not yet recruiting
  Familial Mediterranean Fever
  
• Inflammatory Response During Anesthesia and Surgery.
  ClinicalTrials.gov Identifier: NCT00356746 - Recruiting
  Systemic Inflammatory Response Syndrome; Myocardial Ischemia
  
• Inflammatory Response to Anti Inflammatory Therapy in Children With Sleep Disordered Breathing
  ClinicalTrials.gov Identifier: NCT00299910 - Recruiting
  Sleep Disordered Breathing
  
• Inflammatory Responses in Normal Volunteers and Patients with Abnormal Immune Responses
  ClinicalTrials.gov Identifier: NCT00001257 - Recruiting
  Healthy; Inflammation; Vasculitis
  
• Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery
  ClinicalTrials.gov Identifier: NCT00336908 - Completed
  Inflammation; Cardiac Surgical Procedures
  
• Infliximab (Remicade® (Registered Trademark)) to Treat Dermatomyositis and Polymyositis
  ClinicalTrials.gov Identifier: NCT00033891 - Active, not recruiting
  Dermatomyositis; Polymyositis
  
• Infliximab (Remicade) for Patients With Acute Kawasaki Disease
  ClinicalTrials.gov Identifier: NCT00271570 - Recruiting
  Kawasaki Disease
  
• Infliximab and Methotrexate in Ankylosing Spondylitis
  ClinicalTrials.gov Identifier: NCT00507403 - Not yet recruiting
  Ankylosing Spondylitis
  
• Infliximab for the Prevention of Graft-Versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00201799 - Active, not recruiting
  Graft-Versus-Host Disease
  
• Infliximab for the Treatment of Early Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00006292 - Completed
  Rheumatoid Arthritis
  
• Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)
  ClinicalTrials.gov Identifier: NCT00254982 - Completed
  Psoriasis
  
• Infliximab in Patients with Chronic Sarcoidosis with Pulmonary Involvement
  ClinicalTrials.gov Identifier: NCT00073437 - Completed
  Sarcoidosis
  
• Infliximab in Treating Fatigue in Postmenopausal Women Who Have Undergone Treatment for Stage 0, Stage I, or Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00112749 - Recruiting
  stage I breast cancer; stage II breast cancer; breast cancer in situ; Fatigue
  
• Infliximab in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00074074 - Active, not recruiting
  refractory anemia with excess blasts; refractory anemia with ringed sideroblasts; Refractory Anemia; de novo myelodysplastic syndromes; ...
  
• Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00269867 - Completed
  Rheumatoid Arthritis
  
• Infliximab to Treat Children with Juvenile Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00029042 - Active, not recruiting
  Juvenile Rheumatoid Arthritis
  
• Infliximab to Treat Crohn's-Like Inflammatory Bowel Disease in Chronic Granulomatous Disease
  ClinicalTrials.gov Identifier: NCT00325078 - Recruiting
  Chronic Granulomatous Disease; Crohn's-Like IBD; Inflammatory Bowel Disease (IBD)
  
• Infliximab to Treat Non-Infectious Scleritis
  ClinicalTrials.gov Identifier: NCT00075075 - Completed
  Scleritis
  
• Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C
  ClinicalTrials.gov Identifier: NCT00512278 - Recruiting
  Hepatitis C
  
• Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00304954 - Recruiting
  Macular Degeneration; Neovascularization
  
• Influence of a Inhaled Corticosteroid Therapy Versus Corticosteroid + LABA Therapy on the FeNO of Asthmatic Children
  ClinicalTrials.gov Identifier: NCT00515775 - Recruiting
  Allergic Asthma
  
• Influence of a New Polycationic Disinfectant on Clostridium Difficile Incidence and Environmental Colonisation
  ClinicalTrials.gov Identifier: NCT00566306 - Active, not recruiting
  Clostridium Difficile
  
• Influence of a Silicone Gel (Dermatix®) on Thoracic Scar Formation After Harvesting of Autologous Rib Cartilage
  ClinicalTrials.gov Identifier: NCT00565552 - Recruiting
  Cicatrix, Hypertrophic; Keloid
  
• Influence of Age and Gender on Alcohol Metabolism and Responses
  ClinicalTrials.gov Identifier: NCT00070577 - Recruiting
  Metabolism
  
• Influence of Age on Hemispheric Lateralization of Language : a Longitudinal Study
  ClinicalTrials.gov Identifier: NCT00241293 - Completed
  Aging; Alzheimer's Disease
  
• Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)
  ClinicalTrials.gov Identifier: NCT00168909 - Active, not recruiting
  Osteoporosis
  
• Influence of Amlodipine on the Mortality of Patients with End-Stage Renal Failure
  ClinicalTrials.gov Identifier: NCT00124969 - Active, not recruiting
  Kidney Failure, Chronic
  
• Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients with Gastroenterological Tumors
  ClinicalTrials.gov Identifier: NCT00168987 - Not yet recruiting
  Colorectal Neoplasms; Hepatocellular Carcinoma; Cholangiocarcinoma
  
• Influence of Angiotensin Converting Enzyme (ACE) Genotype on Lung Diffusion in Heart Failure
  ClinicalTrials.gov Identifier: NCT00361127 - Recruiting
  Heart Failure, Congestive
  
• Influence of Area of Brain Damage on Brain Reorganization After Chronic Stroke
  ClinicalTrials.gov Identifier: NCT00474292 - Recruiting
  Central Nervous System Disease; Cerebrovascular Accident; Stroke
  
• Influence of Assistive Device Use While Performing Dual Task in Patients with Stroke
  ClinicalTrials.gov Identifier: NCT00173719 - Recruiting
  Stroke
  
• Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption
  ClinicalTrials.gov Identifier: NCT00355251 - Terminated
  HIV Infections
  
• Influence of Bedrest and Hypocaloric Nutrition on Endothelium-Dependent Vasoreactivity
  ClinicalTrials.gov Identifier: NCT00175968 - Completed
  Healthy
  
• Influence of Binge Drinking on Glucose Metabolism in Patients with Type 1 Diabetes - a Pilot Study.
  ClinicalTrials.gov Identifier: NCT00135915 - Completed
  Diabetes Mellitus Type 1
  
• Influence of Blue Light Filtering Intra Ocular Lenses on Daytime Levels of Melatonin
  ClinicalTrials.gov Identifier: NCT00444249 - Recruiting
  Age-Related Macular Degeneration
  
• Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda
  ClinicalTrials.gov Identifier: NCT00132535 - Completed
  Malaria in pregnancy; Birth Weight; Anaemia
  
• Influence of Corn Farming on the Immune System
  ClinicalTrials.gov Identifier: NCT00342121 - Active, not recruiting
  Cancer Risk
  
• Influence of CPB Temperature on CABG Morbidity
  ClinicalTrials.gov Identifier: NCT00000604 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia; Neurologic Manifestations
  
• Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00413608 - Recruiting
  Healthy
  
• Influence of Data Collection Mode on Self-Report Validity of Asthma Therapy Adherence
  ClinicalTrials.gov Identifier: NCT00233233 - Active, not recruiting
  Lung Diseases; Asthma
  
• Influence of Dexmedetomidine on the Evoked Potentials During Spine Surgery
  ClinicalTrials.gov Identifier: NCT00494832 - Not yet recruiting
  Evoked Potentials
  
• Influence of DHA-Rich Supplement on DHA-Status and Health Evolution of Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00221546 - Active, not recruiting
  Cystic Fibrosis
  
• Influence of diet and endurance running on intramuscular lipids measured at 4.1 TESLA
  ClinicalTrials.gov Identifier: NCT00000110 - Completed
  Obesity
  
• Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol
  ClinicalTrials.gov Identifier: NCT00327353 - Completed
  Asthma
  
• Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra
  ClinicalTrials.gov Identifier: NCT00176033 - Recruiting
  Healthy; Pharmacokinetics
  
• Influence of Epidural Analgesia in Elective Laparoscopic Colorectal Resections
  ClinicalTrials.gov Identifier: NCT00512395 - Completed
  Pain
  
• Influence of Fitness on Brain and Cognition
  ClinicalTrials.gov Identifier: NCT00438347 - Recruiting
  Aging; Cognition
  
• Influence of G-CSF and EPO on Associative Learning and Motor Skills
  ClinicalTrials.gov Identifier: NCT00298597 - Recruiting
  Chronic Stroke; Amyotrophic Lateral Sclerosis
  
• Influence of Garlic on Docetaxel Metabolism in Patients with Breast Cancer
  ClinicalTrials.gov Identifier: NCT00076193 - Recruiting
  Breast Neoplasms
  
• Influence of Genes on Sirolimus Metabolism in Patients With Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00352547 - Active, not recruiting
  Renal Transplant
  
• Influence of Genetic Polymorphisms on Ventricular Structure and Function in Patients With Single Ventricle Anatomy
  ClinicalTrials.gov Identifier: NCT00165984 - Recruiting
  Congenital Heart Disease
  
• Influence of Genetics in Pain Sensitivity
  ClinicalTrials.gov Identifier: NCT00001956 - Completed
  Healthy; Hyperalgesia; Pain
  
• Influence of Genetics on Vitamin Metabolism in Pregnant Women
  ClinicalTrials.gov Identifier: NCT00340366 - Completed
  Pregnancy; Birth Defects
  
• Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function
  ClinicalTrials.gov Identifier: NCT00538356 - Recruiting
  Ventricular Fibrillation; Ventricular Tachycardia; Symptomatic Heart Failure
  
• Influence of Hydrocortisone on Immunologic Markers and Health Care Related Quality of Life in Patients After Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00490828 - Recruiting
  Cardiac Surgery; Systemic Inflammatory Response Syndrome; Health Care Related Quality of Life; Posttraumatic Stress Disorder
  
• Influence of Hydroxyehtyl Starch (HES) on Hemorehology, Coagulation and Elimination Kinetics
  ClinicalTrials.gov Identifier: NCT00255957 - Completed
  Stroke Patients Presenting Within 24 Hrs of Onset of Symptoms
  
• Influence of Hygiene-Dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With Rabeprazol.
  ClinicalTrials.gov Identifier: NCT00511966 - Active, not recruiting
  Gastroesophageal Reflux
  
• Influence of Insulin on BP Change During Adolescence
  ClinicalTrials.gov Identifier: NCT00007098 - Active, not recruiting
  Cardiovascular Diseases; Hypertension; Obesity; Insulin Resistance; Diabetes Mellitus
  
• Influence of Insulin on BP Change During Adolescence
  ClinicalTrials.gov Identifier: NCT00143897 - Completed
  Obesity; Insulin Resistance
  
• Influence of Intestinal Transporter Genetic Variants on the Bioavailability of Gabapentin
  ClinicalTrials.gov Identifier: NCT00187707 - Recruiting
  Healthy Volunteer
  
• Influence of Leg Length Discrepancy on the Spinal Shape and Biomechanics in Functional and Idiopathic Scoliosis Patients
  ClinicalTrials.gov Identifier: NCT00155545 - Not yet recruiting
  functional scoliosis; idiopathic scoliosis; leg length discrepancy
  
• Influence of Marker of Insulin Resistance Upon HCV Treatment Responses to PEG Intron and Rebetol Therapy
  ClinicalTrials.gov Identifier: NCT00351871 - Active, not recruiting
  Chronic Hepatitis C
  
• Influence of Mechanical Stimulus on Distraction Osteogenesis
  ClinicalTrials.gov Identifier: NCT00154856 - Completed
  Leg Discrepancy
  
• Influence of Mild Therapeutic Hypothermia on Leukocyte Count
  ClinicalTrials.gov Identifier: NCT00520520 - Not yet recruiting
  Ventricular Fibrillation
  
• Influence of N-Acetylcysteine on Morbidity, Oxygenation and Cytokine Levels in Partial or Total Esophagectomy for Cancer. A Multicenter, Prospective, Randomised Double Blind, Placebo-Controlled Study
  ClinicalTrials.gov Identifier: NCT00512265 - Recruiting
  Pulmonary Morbidity
  
• Influence of nCPAP on Metabolic Consequences Associated With OSAS
  ClinicalTrials.gov Identifier: NCT00435643 - Completed
  Obstructive Sleep Apnea Syndrome; Obesity
  
• Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers
  ClinicalTrials.gov Identifier: NCT00172159 - Recruiting
  Colorectal Cancer
  
• Influence of Nutrition on Nosal and Bronchial Affliction in Patients With Allery on Grass-Pollen
  ClinicalTrials.gov Identifier: NCT00519740 - Active, not recruiting
  Bronchial Hyperreactivity; Hypersensitivity; Allergy; Bronchial Asthma
  
• Influence of Nutritional and Inflammational Status on Survival of Hemodialysis Patients
  ClinicalTrials.gov Identifier: NCT00410137 - Recruiting
  Inflammation; Body Composition
  
• Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides
  ClinicalTrials.gov Identifier: NCT00187733 - Recruiting
  Healthy
  
• Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel
  ClinicalTrials.gov Identifier: NCT00349661 - Recruiting
  Coronary Heart Disease
  
• Influence of Pacifiers on Breastfeeding Duration
  ClinicalTrials.gov Identifier: NCT00306956 - Recruiting
  Sudden Infant Death
  
• Influence of Paternal Age on Assisted Reproduction Outcome
  ClinicalTrials.gov Identifier: NCT00510861 - Completed
  We Will Retrospectively Assess Our Databases in Our Clinic:; Instituto Valenciano de Infertilidad in Valencia (Spain); Searching for Assisted Reproduction Procedures; (IUI, Standard IVF/ICSI Cycles and Ovum Donation IVF/ICSI Cycles); Who Were Referred to Our Unit to Cryopreserve Sperm During the Period; From January 2000 to December 2006.
  
• Influence of Persistent CMV-Infection on Immune Senescence
  ClinicalTrials.gov Identifier: NCT00461695 - Recruiting
  Immune Senescence
  
• Influence of Physical Training on Mitochondrial Function in Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00365495 - Active, not recruiting
  Type 2 Diabetes
  
• Influence of Pioglitazone for Renal Transplant Function in Diabetics
  ClinicalTrials.gov Identifier: NCT00507494 - Recruiting
  Diabetes Mellitus; Kidney Transplantation; Proteinuria
  
• Influence of Pravastatin on Carotid Artery Structure and Function in HIV-Infected Patients Under Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00147797 - Completed
  HIV Infection; Carotid Atherosclerosis; Dyslipidemia
  
• Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine
  ClinicalTrials.gov Identifier: NCT00000706 - Completed
  HIV Infections
  
• Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora - Follow-Up to 5 Years
  ClinicalTrials.gov Identifier: NCT00365469 - Recruiting
  Eczema; Asthma; Allergic Rhinitis
  
• Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological Responses
  ClinicalTrials.gov Identifier: NCT00318695 - Active, not recruiting
  Eczema; Asthma; Allergic Rhinitis
  
• Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00308945 - Completed
  Open-Angle Glaucoma
  
• Influence of Ribavirin and Interferon on Semen Quality, IRIS Study
  ClinicalTrials.gov Identifier: NCT00455832 - Recruiting
  Sperm Motility
  
• Influence Of Salmeterol/Fluticasone (50/500BD)On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IV
  ClinicalTrials.gov Identifier: NCT00527826 - Not yet recruiting
  COPD
  
• Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00204321 - Recruiting
  Renal Transplantation
  
• Influence of Social and Environmental Factors on Women's Reproductive Function in a Maya Community of Guatemala
  ClinicalTrials.gov Identifier: NCT00340782 - Active, not recruiting
  Early Pregnancy
  
• Influence of Spinal Manipulative Therapy Upon Stroop Task Performance
  ClinicalTrials.gov Identifier: NCT00335426 - Completed
  Motor Response Time
  
• Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis
  ClinicalTrials.gov Identifier: NCT00319007 - Recruiting
  Adenomatous Polyposis Coli
  
• Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00509704 - Recruiting
  Renal Cell Cancer
  
• Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00050180 - Active, not recruiting
  Healthy; HIV Infections
  
• Influence of the Psychophysiological Status of Elite Judo Athletes on Their Performance and Injury
  ClinicalTrials.gov Identifier: NCT00154557 - Recruiting
  Injury
  
• Influence of Therapeutic Hypothermia on Resting Energy Expenditure
  ClinicalTrials.gov Identifier: NCT00500825 - Recruiting
  Cardiopulmonary Resuscitation
  
• Influence of Theta Burst Stimulation and Carbidopa-Levodopa on Motor Performance in Stroke Patients
  ClinicalTrials.gov Identifier: NCT00366184 - Recruiting
  Stroke
  
• Influence of Thoracic Epidural Anesthesia on Skin Sympathetic Activity and Heart Rate Variability
  ClinicalTrials.gov Identifier: NCT00222391 - Completed
  Abdominal Surgery; Abdominothoracic Surgery
  
• INFLUENCE OF TOPICAL INDOMETHACIN ON HYPOTHENSIVE EFFECT OF BRIMONIDINE
  ClinicalTrials.gov Identifier: NCT00347035 - Terminated
  Glaucoma
  
• Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique
  ClinicalTrials.gov Identifier: NCT00231322 - Completed
  Hematuria; Hydronephrosis
  
• Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Muscle
  ClinicalTrials.gov Identifier: NCT00297960 - Completed
  Healthy Male Volunteers
  
• Influences of Cane Use on Voluntary Forward Stepping Movement and Associated Attentional Demands in Hemiplegic Patients
  ClinicalTrials.gov Identifier: NCT00172146 - Active, not recruiting
  Stroke
  
• Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID
  ClinicalTrials.gov Identifier: NCT00006335 - Active, not recruiting
  Severe Combined Immunodeficiency
  
• Influences on HIV Infected Subjects' Willingness to Participate in Research and Ability to Give Informed Consent
  ClinicalTrials.gov Identifier: NCT00001717 - Completed
  HIV Infections
  
• Influenza in People With Weakened Immune Systems
  ClinicalTrials.gov Identifier: NCT00533182 - Recruiting
  Influenza, Human; Immunocompromised Host
  
• Influenza Vaccination and Oral Anticoagulant Therapy
  ClinicalTrials.gov Identifier: NCT00222638 - Completed
  Anticoagulants; Influenza Vaccines
  
• Influenza Vaccination in Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00419224 - Completed
  Influenza
  
• Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00307710 - Completed
  Lymphoma
  
• Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study
  ClinicalTrials.gov Identifier: NCT00371098 - Completed
  Coronary Artery Disease
  
• Influenza Vaccination of Nursing Home Workers.
  ClinicalTrials.gov Identifier: NCT00359554 - Terminated
  Influenza Disease
  
• Influenza Vaccine GSK1247446A With Formulations
  ClinicalTrials.gov Identifier: NCT00540228 - Recruiting
  Influenza
  
• Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load
  ClinicalTrials.gov Identifier: NCT00025922 - Completed
  HIV Infection
  
• Influenza Vaccine in Lung Transplant Patients
  ClinicalTrials.gov Identifier: NCT00205270 - Recruiting
  Influenza
  
• Influenza Vaccine in Pediatric Transplant Subjects
  ClinicalTrials.gov Identifier: NCT00133510 - Active, not recruiting
  Influenza
  
• Influenza Vaccine in Premature Infants
  ClinicalTrials.gov Identifier: NCT00455169 - Recruiting
  Influenza; Infant, Premature
  
• Influenza Vaccine Postpartum Questionnaire
  ClinicalTrials.gov Identifier: NCT00401700 - Recruiting
  Influenza; Vaccine; Pregnancy
  
• Information or Physical Activity for Chronic LBP
  ClinicalTrials.gov Identifier: NCT00410319 - Active, not recruiting
  Low Back Pain
  
• Informed Choice Regarding Invasive Prenatal Testing
  ClinicalTrials.gov Identifier: NCT00514553 - Recruiting
  Pregnancy - Prenatal Testing
  
• Infrared Camera for Brain Mapping During Surgery
  ClinicalTrials.gov Identifier: NCT00001554 - Completed
  Epilepsy; Neurologic Manifestations
  
• Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia
  ClinicalTrials.gov Identifier: NCT00066430 - Completed
  Anal Cancer; high-grade squamous intraepithelial lesion
  
• Infrared Imaging (Breast Scan IR) for Early Breast Cancer Detection
  ClinicalTrials.gov Identifier: NCT00195026 - Recruiting
  Breast Cancer
  
• Infrared Non-Cutting Laser Therapy for Acne
  ClinicalTrials.gov Identifier: NCT00110643 - Completed
  Acne Vulgaris
  
• Infrared Thermography in Finding Skin Lesions in Patients With Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00265902 - Active, not recruiting
  Sarcoma
  
• Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
  ClinicalTrials.gov Identifier: NCT00539318 - Recruiting
  Gastrointestinal Cancer
  
• INFUSE® Bone Graft/ PEEK Interbody Spacer/ Anterior Cervical Plate Pivotal Clinical Trial
  ClinicalTrials.gov Identifier: NCT00485173 - Recruiting
  Degenerative Disc Disease (DDD)
  
• Infusion Laboratory: Protocol 1 - Selegeline - 2
  ClinicalTrials.gov Identifier: NCT00000337 - Completed
  Cocaine-Related Disorders
  
• Infusion Laboratory: Protocol 2 (Lisuride) - 3
  ClinicalTrials.gov Identifier: NCT00000338 - Active, not recruiting
  Cocaine-Related Disorders
  
• Infusion Laboratory: Protocol 3 (Risperidone) - 4
  ClinicalTrials.gov Identifier: NCT00000339 - Active, not recruiting
  Cocaine-Related Disorders
  
• Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13
  ClinicalTrials.gov Identifier: NCT00000348 - Active, not recruiting
  Cocaine-Related Disorders
  
• Infusion Laboratory: Protocol 5 (Flupenthixol) - 14
  ClinicalTrials.gov Identifier: NCT00000349 - Active, not recruiting
  Cocaine-Related Disorders
  
• Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies
  ClinicalTrials.gov Identifier: NCT00423124 - Recruiting
  Hematological Malignancies
  
• Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers
  ClinicalTrials.gov Identifier: NCT00089596 - Completed
  Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome
  
• Ingested Interferon Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00005665 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Inguinal Hernia Study Using Surgisis IHM
  ClinicalTrials.gov Identifier: NCT00393887 - Recruiting
  Inguinal Hernia
  
• Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis
  ClinicalTrials.gov Identifier: NCT00263315 - Completed
  Aspergillosis
  
• Inhalation SLIT Cisplatin for the Treatment of Osteosarcoma Metastatic to the Lung
  ClinicalTrials.gov Identifier: NCT00102531 - Recruiting
  Osteosarcoma
  
• Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
  ClinicalTrials.gov Identifier: NCT00144846 - Recruiting
  acute wheezing obstructive airways disease
  
• Inhaled Beclomethasone to Prevent Chronic Lung Disease
  ClinicalTrials.gov Identifier: NCT00000576 - Completed
  Bronchopulmonary Dysplasia; Hyaline Membrane Disease; Lung Diseases
  
• Inhaled Bicarbonate Therapy in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00177645 - Suspended
  Cystic Fibrosis
  
• Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (test drug) in Moderate Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00048022 - Completed
  Asthma
  
• Inhaled Corticosteroids After a Pediatric Emergency Visit for Asthma
  ClinicalTrials.gov Identifier: NCT00294398 - Recruiting
  Asthma
  
• Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs
  ClinicalTrials.gov Identifier: NCT00020124 - Completed
  Lung Cancer; Malignant Mesothelioma; Metastatic Cancer; Thymoma and Thymic Carcinoma
  
• Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases
  ClinicalTrials.gov Identifier: NCT00004930 - Completed
  lung metastases; Non-small cell lung cancer; Small Cell Lung Cancer
  
• Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients with Non-Small-Cell Lung Carcinoma (NSCLC)
  ClinicalTrials.gov Identifier: NCT00082472 - Active, not recruiting
  NSCLC
  
• Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants
  ClinicalTrials.gov Identifier: NCT00261937 - Not yet recruiting
  Bronchiolitis
  
• Inhaled Iloprost for Sarcoidosis Associated Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00403650 - Recruiting
  Sarcoidosis; Pulmonary Arterial Hypertension
  
• Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
  ClinicalTrials.gov Identifier: NCT00409526 - Recruiting
  Pulmonary Hypertension
  
• Inhaled Iloprost in Adults with Abnormal Pulmonary Pressure and Associated with Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00109681 - Completed
  Pulmonary Fibrosis; Pulmonary Hypertension
  
• Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer
  ClinicalTrials.gov Identifier: NCT00003009 - Completed
  unspecified adult solid tumor, protocol specific
  
• Inhaled Mannitol and Ciliary Beat Frequency in COPD Patients
  ClinicalTrials.gov Identifier: NCT00446121 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain
  ClinicalTrials.gov Identifier: NCT00020618 - Completed
  Pain; unspecified adult solid tumor, protocol specific; Quality of Life
  
• Inhaled Nitric Oxide and Neuroprotection in Premature Infants
  ClinicalTrials.gov Identifier: NCT00515281 - Not yet recruiting
  Prematurity; Bronchopulmonary Dysplasia; Intraventricular Hemorrhage; Periventricular Leukomalacia
  
• Inhaled Nitric Oxide and Transfusion Therapy for Patients with Sickle Cell Anemia and Secondary Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00023296 - Active, not recruiting
  Sickle Cell Anemia; Pulmonary Hypertension
  
• Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
  ClinicalTrials.gov Identifier: NCT00142051 - Recruiting
  Sickle Cell Disease
  
• Inhaled Nitric Oxide in Neonates with Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation
  ClinicalTrials.gov Identifier: NCT00041548 - Completed
  Lung Disease; Hypoxemia; Respiratory Acidosis
  
• Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00060450 - Completed
  Ischemia-Reperfusion Injury
  
• Inhaled Nitric Oxide in Pulmonary Embolism
  ClinicalTrials.gov Identifier: NCT00565253 - Recruiting
  Pulmonary Embolism
  
• Inhaled Nitric Oxide Study for Respiratory Failure in Newborns.
  ClinicalTrials.gov Identifier: NCT00005776 - Terminated
  Hypertension, Pulmonary; Respiratory Insufficiency; Infant, Newborn, Diseases; Meconium Aspiration; Persistent Fetal Circulation Syndrome; ...
  
• Inhaled NO for the Prevention of Chronic Lung Disease
  ClinicalTrials.gov Identifier: NCT00006401 - Active, not recruiting
  Lung Diseases; Bronchopulmonary Dysplasia
  
• Inhaled NO in Prevention of Chronic Lung Disease
  ClinicalTrials.gov Identifier: NCT00000548 - Active, not recruiting
  Bronchopulmonary Dysplasia; Lung Diseases
  
• Inhaled Prostacyclin for ARDS and Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00314548 - Recruiting
  Adult Respiratory Distress Syndrome; Pulmonary Hypertension
  
• Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00066365 - Recruiting
  metastatic osteosarcoma; recurrent osteosarcoma; lung metastases
  
• Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
  ClinicalTrials.gov Identifier: NCT00017121 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma; lung metastases
  
• Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting
  ClinicalTrials.gov Identifier: NCT00484575 - Recruiting
  Myocardial Reperfusion Injury; Atrial Fibrillation
  
• Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.
  ClinicalTrials.gov Identifier: NCT00308243 - Recruiting
  Cystic Fibrosis
  
• Inhaled Steroid Reduces Systemic Inflammation in COPD
  ClinicalTrials.gov Identifier: NCT00175565 - Completed
  Chronic Obstructive Pulmonary Disease; Emphysema; Chronic Bronchitis
  
• Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00189722 - Completed
  Asthma, Bronchial; Bronchial Asthma
  
• Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
  ClinicalTrials.gov Identifier: NCT00332826 - Recruiting
  Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Asthma
  
• Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma
  ClinicalTrials.gov Identifier: NCT00327808 - Completed
  Asthma
  
• Inhibition of Aldosterone in Patients With Chronic Renal Disease
  ClinicalTrials.gov Identifier: NCT00430924 - Recruiting
  Kidney Failure, Chronic
  
• Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients
  ClinicalTrials.gov Identifier: NCT00222131 - Active, not recruiting
  Indigestion
  
• Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
  ClinicalTrials.gov Identifier: NCT00367562 - Completed
  IGA Nephropathy
  
• Inion OTPS Biodegradable Fixation System for the Ankle
  ClinicalTrials.gov Identifier: NCT00300989 - Completed
  Surgery
  
• Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer
  ClinicalTrials.gov Identifier: NCT00312819 - Recruiting
  Non-Small Cell Lung Cancer
  
• Initial Combination With Pioglitazone Study
  ClinicalTrials.gov Identifier: NCT00397631 - Recruiting
  Type 2 Diabetes Mellitus
  
• Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism
  ClinicalTrials.gov Identifier: NCT00307840 - Completed
  Secondary Hyperparathyroidism
  
• Initial Evaluation of Photorefractive Keratectomy in U.S. Army Personnel
  ClinicalTrials.gov Identifier: NCT00413673 - Active, not recruiting
  Myopia
  
• Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination with Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3
  ClinicalTrials.gov Identifier: NCT00001993 - Completed
  HIV Infections
  
• Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors.
  ClinicalTrials.gov Identifier: NCT00091585 - Completed
  Neoplasms
  
• Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
  ClinicalTrials.gov Identifier: NCT00364819 - Recruiting
  Primary Biliary Cirrhosis
  
• Initial Versus Delayed Operation for Treatment of Complicated Appendicitis In Children
  ClinicalTrials.gov Identifier: NCT00540189 - Not yet recruiting
  Perforated Appendicitis
  
• INITIATE Plus (INITiation of Insulin to reach A1C TargEt) Study
  ClinicalTrials.gov Identifier: NCT00101751 - Completed
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Initiating Acamprosate Within Versus Post-Detoxification in the Rehabilitative Treatment of Alcohol Dependence.
  ClinicalTrials.gov Identifier: NCT00360594 - Recruiting
  Alcohol Use Disorder
  
• Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department
  ClinicalTrials.gov Identifier: NCT00388739 - Not yet recruiting
  Asthma
  
• Initiation of Insulin Aspart in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00572806 - Completed
  Type 2 Diabetes Mellitus
  
• Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)
  ClinicalTrials.gov Identifier: NCT00453609 - Not yet recruiting
  Schizophrenia; Schizoaffective Disorder; Bipolar Disorder; Alcohol Dependence
  
• Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
  ClinicalTrials.gov Identifier: NCT00453804 - Active, not recruiting
  Bipolar Disorders; Schizophrenia; Schizoaffective Disorders; Alcohol Dependence
  
• Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation
  ClinicalTrials.gov Identifier: NCT00457067 - Completed
  Telangiectasia
  
• Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation
  ClinicalTrials.gov Identifier: NCT00457145 - Completed
  Telangiectasia
  
• Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00438477 - Active, not recruiting
  Breast Cancer
  
• Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
  ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
  Melanoma
  
• Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00461955 - Recruiting
  Multiple Myeloma
  
• Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00394030 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
  ClinicalTrials.gov Identifier: NCT00281216 - Recruiting
  Pulmonary Disease, Chronic Obstructive; Lung Diseases; Lung Diseases, Obstructive
  
• Inner-City Anti-IgE Therapy for Asthma
  ClinicalTrials.gov Identifier: NCT00377572 - Recruiting
  Asthma
  
• Inner-City Anti-IgE Therapy for Asthma Mechanistic Study
  ClinicalTrials.gov Identifier: NCT00377390 - Recruiting
  Asthma
  
• INNO-105 in Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00255333 - Terminated
  Tumors
  
• INNO-206 in Patients With Small Cell Lung Cancer (SCLC)
  ClinicalTrials.gov Identifier: NCT00472771 - Not yet recruiting
  Small Cell Lung Cancer
  
• Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis
  ClinicalTrials.gov Identifier: NCT00277394 - Recruiting
  Deep Vein Thrombosis
  
• Innovation in Pulmonary Rehabilitation
  ClinicalTrials.gov Identifier: NCT00123422 - Not yet recruiting
  Pulmonary Emphysema; Pulmonary Disease
  
• Innovative Approaches to Tuberculosis Control
  ClinicalTrials.gov Identifier: NCT00472316 - Not yet recruiting
  Tuberculosis
  
• Innovative Strategies for Implementing New CHF Guideline Recommendations
  ClinicalTrials.gov Identifier: NCT00012974 - Active, not recruiting
  Heart Failure, Congestive
  
• Innovative Strategies For Risk Reduction Following CABG
  ClinicalTrials.gov Identifier: NCT00462436 - Recruiting
  Coronary Artery Disease; Type II Diabetes Mellitus
  
• Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00196235 - Completed
  Myocardial Infarction
  
• Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Eldery
  ClinicalTrials.gov Identifier: NCT00196300 - Completed
  Myocardial Infarction
  
• Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients
  ClinicalTrials.gov Identifier: NCT00196287 - Completed
  Myocardial Infarction
  
• Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Long-Term Prediction
  ClinicalTrials.gov Identifier: NCT00196261 - Completed
  Infarction, Myocardial
  
• Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabin/Cisplatin Plus Bevacizumab
  ClinicalTrials.gov Identifier: NCT00536640 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers
  ClinicalTrials.gov Identifier: NCT00061997 - Completed
  Non-small cell lung cancer; Small Cell Lung Cancer
  
• Inpatient Evaluation of Adults with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00001247 - Recruiting
  Psychotic Disorder; Schizophrenia; Schizoaffective; Paranoia; Psychosis
  
• Inpatient Influenza Surveillance
  ClinicalTrials.gov Identifier: NCT00419861 - Recruiting
  Influenza
  
• Inpatient Self Monitoring and Administration Study (ISMAS)
  ClinicalTrials.gov Identifier: NCT00506272 - Not yet recruiting
  Diabetes Mellitus; Hyperglycemia; Hypoglycemia
  
• InPractice Survey on the Treatment of Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00523796 - Recruiting
  Hypercholesterolemia
  
• INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer
  ClinicalTrials.gov Identifier: NCT00033527 - Active, not recruiting
  Small Cell Lung Cancer; Non-small cell lung cancer
  
• INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer
  ClinicalTrials.gov Identifier: NCT00008255 - Completed
  Small Cell Lung Cancer; Non-small cell lung cancer
  
• INSIGHTS ICD Registry
  ClinicalTrials.gov Identifier: NCT00279968 - Completed
  Ventricular Tachycardia; Ventricular Fibrillation
  
• InSite for Urinary Urge Incontinence
  ClinicalTrials.gov Identifier: NCT00547378 - Recruiting
  Urinary Incontinence, Urge; Overactive Bladder
  
• InSite for Urinary Urgency-Frequency
  ClinicalTrials.gov Identifier: NCT00549094 - Recruiting
  Urinary Bladder, Overactive
  
• Insomnia and Daytime Function in Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00530556 - Completed
  Sleep Disorders
  
• Insomnia and Drug Relapse Risk
  ClinicalTrials.gov Identifier: NCT00253890 - Recruiting
  Sleep Quality; Methadone Maintenance
  
• Insomnia and Osteoarthritis Study
  ClinicalTrials.gov Identifier: NCT00374556 - Recruiting
  Osteoarthritis; Insomnia
  
• Insomnia: Behavioral Treatments
  ClinicalTrials.gov Identifier: NCT00280020 - Recruiting
  Aging; Insomnia
  
• Inspiratory Flow Using the Osmohaler
  ClinicalTrials.gov Identifier: NCT00531414 - Not yet recruiting
  Asthma
  
• Inspiratory Muscle Training in Hypercapnic COPD
  ClinicalTrials.gov Identifier: NCT00291460 - Recruiting
  COPD; Respiratory Failure
  
• Inspiratory Muscle Training in Ventilator Dependent Patients
  ClinicalTrials.gov Identifier: NCT00419458 - Recruiting
  Failure to Wean; Respiratory Failure; Ventilator Dependent
  
• INST 0514C- Biologic Correlative Study
  ClinicalTrials.gov Identifier: NCT00455039 - Recruiting
  HER2 Breast Cancer
  
• INST 0603C Chart Review on Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
  ClinicalTrials.gov Identifier: NCT00322712 - Active, not recruiting
  Pancreatic Cancer
  
• INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
  ClinicalTrials.gov Identifier: NCT00276003 - Completed
  Non-Hodgkin's Lymphoma; Cancer
  
• INSTEAD Trial: INvestigation of STEnt Grafts in Patients With Type B Aortic Dissection
  ClinicalTrials.gov Identifier: NCT00525356 - Completed
  Aortic Diseases
  
• Instillation of Gemcitabine in Patients With Superficial Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00191477 - Active, not recruiting
  Bladder Neoplasms
  
• Instrument Applied and Manual Manipulation Induced EMG Response in Asymptomatic Subjects
  ClinicalTrials.gov Identifier: NCT00378963 - Recruiting
  EMG Response
  
• Instrument Development of Screening Prediabetes Patients
  ClinicalTrials.gov Identifier: NCT00308646 - Terminated
  Prediabetic State
  
• Instrument for Glaucoma Early Detection and Monitoring
  ClinicalTrials.gov Identifier: NCT00578110 - Not yet recruiting
  Glaucoma
  
• Instrument Utility for Suspected Asthma
  ClinicalTrials.gov Identifier: NCT00211575 - Active, not recruiting
  Asthma
  
• Insulin Action in Individuals With Type 2 Diabetes by Natural Fatty Acids or the Medication Pioglitazone
  ClinicalTrials.gov Identifier: NCT00179400 - Recruiting
  Type 2 Diabetes Mellitus
  
• Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow
  ClinicalTrials.gov Identifier: NCT00018304 - Completed
  Hypertension
  
• Insulin Analogues and Severe Hypoglycaemia
  ClinicalTrials.gov Identifier: NCT00346996 - Not yet recruiting
  Type 1 Diabetes
  
• Insulin and Biogenic Amines in Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00005194 - Completed
  Cardiovascular Diseases; Hypertension; Heart Diseases; Obesity; Myocardial Infarction; Insulin Resistance
  
• Insulin and the Polycystic Ovary Syndrome--Weight Reduction Study
  ClinicalTrials.gov Identifier: NCT00436865 - Recruiting
  Polycystic Ovary Syndrome; Obesity
  
• Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Pediatric Population
  ClinicalTrials.gov Identifier: NCT00071448 - Completed
  Diabetes Mellitus, Insulin-Dependent
  
• Insulin Cardioplegia for Poor Left Ventricular Function
  ClinicalTrials.gov Identifier: NCT00188994 - Recruiting
  Left Ventricular Dysfunction
  
• Insulin Detemir plus Insulin Aspart vs. Insulin Glargine plus Insulin Aspart as Mealtime Insulin in Type II Diabetes
  ClinicalTrials.gov Identifier: NCT00097084 - Completed
  Diabetes Mellitus, Type II
  
• Insulin Glargine "All to Target" Trial
  ClinicalTrials.gov Identifier: NCT00384085 - Recruiting
  Diabetes Mellitus, Type 2
  
• Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)
  ClinicalTrials.gov Identifier: NCT00562172 - Recruiting
  Type 2 Diabetes Mellitus
  
• Insulin Glargine During and After the Period of Fasting in Ramadan
  ClinicalTrials.gov Identifier: NCT00258804 - Completed
  Diabetes Mellitus, Type 2
  
• Insulin Glargine in Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00272090 - Completed
  Diabetes Mellitus, Type 1
  
• Insulin Glargine in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00268645 - Completed
  Diabetes Mellitus, Type 2
  
• Insulin Glargine in Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00272077 - Completed
  Diabetes Mellitus, Type 2
  
• Insulin Glargine in Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00311818 - Completed
  Type 2 Diabetes Mellitus
  
• Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-Study: "HALT"(Hypoglycaemia Avoidance W
  ClinicalTrials.gov Identifier: NCT00390728 - Completed
  Diabetes Mellitus, Type 1
  
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
  ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Insulin Glargine Plus Insulin Glulisine MDI Versus Premix Insulin Treatment in Subjects with Diabetes Mellitus (Type 1 or Type 2) Evaluating Differences in Patient Reported Outcomes
  ClinicalTrials.gov Identifier: NCT00135941 - Completed
  Diabetes Mellitus, Type 2
  
• Insulin Glargine v Rosiglitazone as Add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy
  ClinicalTrials.gov Identifier: NCT00358124 - Completed
  Type 2 Diabetes Mellitus
  
• Insulin Glargine Vs Standard Insulin Therapy
  ClinicalTrials.gov Identifier: NCT00222521 - Completed
  Cystic Fibrosis Related Diabetes
  
• Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as Add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin
  ClinicalTrials.gov Identifier: NCT00384215 - Completed
  Diabetes Mellitus, Type 2
  
• Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus
  ClinicalTrials.gov Identifier: NCT00565162 - Completed
  Diabetes Mellitus
  
• Insulin Glulisine Administered in a Fixed Bolus Regimen Vs Variable Bolus Regimen Based on Carbohydrate Counting in Adult Subjects with Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin
  ClinicalTrials.gov Identifier: NCT00135057 - Completed
  Diabetes Mellitus, Type 2
  
• Insulin Glulisine Administered Premeal Vs Postmeal in Adult Subjects with Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin
  ClinicalTrials.gov Identifier: NCT00135096 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Insulin Glulisine in Healthy Lean and Obese Subjects
  ClinicalTrials.gov Identifier: NCT00311077 - Completed
  Diabetes Mellitus
  
• Insulin Glulisine in Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00297583 - Completed
  Type 1 Diabetes Mellitus
  
• Insulin Glulisine in Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00310297 - Completed
  Type 2 Diabetes Mellitus
  
• Insulin Glulisine in Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00360698 - Recruiting
  Diabetes Mellitus, Type 2
  
• Insulin Glulisine, Diabetes Mellitus Type 1
  ClinicalTrials.gov Identifier: NCT00397553 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00467376 - Recruiting
  Diabetes Mellitus
  
• Insulin Infusion in the Hospital Wards
  ClinicalTrials.gov Identifier: NCT00412347 - Completed
  Hyperglycemia
  
• Insulin NovoRapid Vs. Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose
  ClinicalTrials.gov Identifier: NCT00145353 - Active, not recruiting
  Type 1 diabetes mellitus
  
• Insulin on Post Burn Hypermetabolism
  ClinicalTrials.gov Identifier: NCT00137254 - Active, not recruiting
  Burns
  
• Insulin Resistance : Heart Failure
  ClinicalTrials.gov Identifier: NCT00486967 - Recruiting
  Congestive Heart Failure; Heart Failure
  
• Insulin Resistance and Atherosclerosis in a Sample of Women With Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00544102 - Recruiting
  Systemic Lupus Erythematosus; Insulin Resistance; Atherosclerosis; Abnormal Glucose Metabolism; Cardiac Risk Factors
  
• Insulin Resistance and Blood Pressure Regulation in Blacks
  ClinicalTrials.gov Identifier: NCT00005164 - Completed
  Cardiovascular Diseases; Hypertension; Heart Diseases; Insulin Resistance
  
• Insulin Resistance and Breast Cancer
  ClinicalTrials.gov Identifier: NCT00304941 - Recruiting
  Breast Cancer; Insulin Resistance
  
• Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00212290 - Completed
  Insulin Resistance; Type 2 Diabetes Mellitus
  
• Insulin Resistance and Hypertensive Disorders in Pregnancy
  ClinicalTrials.gov Identifier: NCT00412230 - Recruiting
  Hypertension Syndromes in Pregnancy; Diabetes Mellitus in Pregnancy
  
• Insulin Resistance and Insulin Secretion
  ClinicalTrials.gov Identifier: NCT00073294 - Completed
  Diabetes Mellitus, Type 2
  
• Insulin Resistance and Testosterone in Women with Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00123110 - Recruiting
  Metabolic Syndrome; Postmenopause
  
• Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?
  ClinicalTrials.gov Identifier: NCT00259168 - Recruiting
  Insulin Resistance; Impaired Fasting Glucose
  
• Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy
  ClinicalTrials.gov Identifier: NCT00188240 - Recruiting
  Hepatitis C; Hepatitis B
  
• Insulin Resistance Atherosclerosis Study (IRAS)
  ClinicalTrials.gov Identifier: NCT00005135 - Active, not recruiting
  Cardiovascular Diseases; Atherosclerosis; Diabetes Mellitus; Heart Diseases; Obesity; Insulin Resistance
  
• Insulin Resistance in Non-Alcoholic Steatohepatitis
  ClinicalTrials.gov Identifier: NCT00252499 - Recruiting
  Insulin Resistance; Fatty Liver
  
• Insulin Resistance in Patients With Mood Disorder
  ClinicalTrials.gov Identifier: NCT00242619 - Recruiting
  Depression; Bipolar Disorder; Insulin Resistance
  
• Insulin Resistance in Severely Obese Patients
  ClinicalTrials.gov Identifier: NCT00275223 - Recruiting
  Obesity; Insulin Resistance; Diabetes
  
• Insulin Resistance in Women With Prolactinoma
  ClinicalTrials.gov Identifier: NCT00481299 - Completed
  Prolactinoma; Insulin Resistance; Hyperlipidemia
  
• Insulin Resistance Intervention After Stroke (IRIS) Trial
  ClinicalTrials.gov Identifier: NCT00091949 - Recruiting
  Stroke; Myocardial Infarction; Diabetes
  
• Insulin Secretion in Diabetes
  ClinicalTrials.gov Identifier: NCT00469833 - Not yet recruiting
  Diabetes; Hyperglycemia
  
• Insulin Secretory Defects in Pima Indians at High Risk for NIDDM
  ClinicalTrials.gov Identifier: NCT00410800 - Recruiting
  NIDDM
  
• Insulin Sensitizers on Mitochondrial ATP Production and Mitochondrial ATP Production and Mitochondrial Protein Synthesis on Insulin Resistant Type 2 Diabetes and Obesity
  ClinicalTrials.gov Identifier: NCT00443755 - Recruiting
  Type 2 Diabetes; Insulin Resistance
  
• Insulin Therapy in COPD Exacerbations
  ClinicalTrials.gov Identifier: NCT00467636 - Not yet recruiting
  Chronic Obstructive Pulmonary Disease; Hyperglycaemia
  
• Insulin Treatment in Cancer Cachexia
  ClinicalTrials.gov Identifier: NCT00329615 - Completed
  Cancer Cachexia
  
• Insulin Treatment Variation in Southwestern Diabetics
  ClinicalTrials.gov Identifier: NCT00148304 - Active, not recruiting
  Diabetes; Insulin; Blood Glucose Monitoring
  
• Insulin, Androgen, and Risk in African-American Women
  ClinicalTrials.gov Identifier: NCT00005380 - Completed
  Cardiovascular Diseases; Diabetes Mellitus; Hypertension; Heart Diseases; Hyperinsulinism; Insulin Resistance
  
• Insulin, Neurogenetics and Memory in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00018382 - Completed
  Alzheimer Disease
  
• INSURE: INcidence Free SUrvival Before and After Implantable Cardioverter Defibrillator (ICD) Replacement
  ClinicalTrials.gov Identifier: NCT00180440 - Recruiting
  Ventricular Fibrillation
  
• InSync III Marquis Model 7279 Cardioverter Defibrillator Cardiac Resynchronization System
  ClinicalTrials.gov Identifier: NCT00271232 - Completed
  Heart Failure
  
• InSync Implantable Cardioverter Defibrillator Registry: Cardiac Resynchronization Therapy
  ClinicalTrials.gov Identifier: NCT00289302 - Completed
  Heart Failure; Cardiomyopathy
  
• InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) Registry
  ClinicalTrials.gov Identifier: NCT00273182 - Recruiting
  Heart Failure; Cardiomyopathy
  
• Intacs for Keratoconus
  ClinicalTrials.gov Identifier: NCT00347230 - Recruiting
  Keratoconus
  
• Intake Promoting Effects of Large Portions in Children
  ClinicalTrials.gov Identifier: NCT00436878 - Recruiting
  Food Intake
  
• Integrase Inhibitor (MK-0518) Viral Decay
  ClinicalTrials.gov Identifier: NCT00520897 - Not yet recruiting
  HIV Infections
  
• Integrated Behavioral Therapy for Treating Children With Selective Mutism
  ClinicalTrials.gov Identifier: NCT00458198 - Recruiting
  Mutism
  
• Integrated Biomarker And Imaging Study - 2
  ClinicalTrials.gov Identifier: NCT00268996 - Completed
  Coronary Artery Disease
  
• Integrated Care for Cancer Patients
  ClinicalTrials.gov Identifier: NCT00135980 - Recruiting
  Neoplasms
  
• Integrated Intervention for Substance Abusers with Depressive Disorders
  ClinicalTrials.gov Identifier: NCT00018655 - Completed
  Substance-Related Disorders
  
• Integrated Microfluidic System for Oral Diagnostics
  ClinicalTrials.gov Identifier: NCT00277745 - Completed
  Healthy Individuals or Moderate to Severe Periodontitis
  
• Integrated Multidisciplinary Care for Parkinson's Disease: a Cluster Controlled Trial
  ClinicalTrials.gov Identifier: NCT00518791 - Recruiting
  Parkinson's Disease
  
• Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00316290 - Recruiting
  Depression; Attention Deficit Disorder With Hyperactivity
  
• Integrated Treatment for Chronic Pain and PTSD
  ClinicalTrials.gov Identifier: NCT00127413 - Recruiting
  Posttraumatic Stress Disorder; Pain
  
• Integrated Treatment for Cocaine and Mood Disorders - 1
  ClinicalTrials.gov Identifier: NCT00227812 - Completed
  Cocaine Dependence; Depressive Disorder, Major
  
• Integrated Treatment Program for Hypochondriasis in Primary Care Settings
  ClinicalTrials.gov Identifier: NCT00368212 - Recruiting
  Hypochondriasis; Somatoform Disorders
  
• Integrated Treatment to Persons With Mental Disorders and co-Occurring Substance Use Disorders
  ClinicalTrials.gov Identifier: NCT00447733 - Recruiting
  Anxiety Disorders; Mood Disorders; Substance Use Disorders
  
• Integrating Buprenorphine Into HIV Treatment
  ClinicalTrials.gov Identifier: NCT00241930 - Recruiting
  Opiate Dependence; HIV Infections
  
• Integrating Buprenorphine Into the SFGH AIDS Program
  ClinicalTrials.gov Identifier: NCT00263458 - Recruiting
  Opioid-Related Disorders; HIV Infections
  
• Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans with Post-Traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00118534 - Recruiting
  Mental Health; Substance-Related Disorders; Stress Disorders, Post-Traumatic; Tobacco Use Disorder
  
• Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics
  ClinicalTrials.gov Identifier: NCT00157638 - Completed
  Diabetes; Hypertension; Hyperlipidemia; Constipation; Pain
  
• Integrating Mindfulness-Based Skills Training Into Brief Outpatient Treatment for Substance Abusing Youth
  ClinicalTrials.gov Identifier: NCT00244699 - Completed
  Substance Abuse; Drug Addiction
  
• Integrating the Genetic and Metabolic Faces of Obesity
  ClinicalTrials.gov Identifier: NCT00285844 - Recruiting
  Insulin Resistance; Obesity; Metabolic Syndrome
  
• Integrative Therapy in Alcoholism
  ClinicalTrials.gov Identifier: NCT00159107 - Recruiting
  Alcoholism
  
• Intelligent Control Approach to Anemia Management
  ClinicalTrials.gov Identifier: NCT00572533 - Recruiting
  End-Stage Renal Disease
  
• Intensification With Enfuvirtide in Naive HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00302822 - Recruiting
  HIV Infections; AIDS
  
• Intensified AA With PBPC Support in Breast Tumors With Evidence of a HRD
  ClinicalTrials.gov Identifier: NCT00448266 - Not yet recruiting
  Breast Cancer
  
• Intensified Chemotherapy in CRC After Resection of Liver Metastases
  ClinicalTrials.gov Identifier: NCT00208260 - Completed
  Colorectal Cancer; Liver Metastases; Chemotherapy
  
• Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria
  ClinicalTrials.gov Identifier: NCT00320008 - Active, not recruiting
  Type 2 Diabetes
  
• Intensified Post Remission Therapy Containing PEG-Asparaginase
  ClinicalTrials.gov Identifier: NCT00184041 - Recruiting
  Acute Lymphoblastic Leukemia
  
• Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Micoemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00369278 - Recruiting
  Renal Transplantation
  
• Intensity Modulated Radiation Therapy - Gyne Cancer
  ClinicalTrials.gov Identifier: NCT00188578 - Recruiting
  Cervix Neoplasms; Uterine Neoplasms; Vaginal Neoplasms
  
• Intensity Modulated Radiation Therapy - Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00188513 - Recruiting
  Prostatic Neoplasms
  
• Intensity Modulated Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00188877 - Recruiting
  Nasopharyngeal Neoplasms
  
• Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy
  ClinicalTrials.gov Identifier: NCT00508703 - Active, not recruiting
  Uterine Cancer; Cervical Cancer; Endometrial Cancer
  
• Intensity Modulated Versus Interstitial - Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00407875 - Not yet recruiting
  Prostate Cancer
  
• Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Androgen Deprivation Therapy for Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00544830 - Recruiting
  Prostate Cancer
  
• Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00392535 - Recruiting
  Prostate Cancer
  
• Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00331760 - Recruiting
  Cervical Cancer; Endometrial Cancer
  
• Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00084591 - Active, not recruiting
  stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
  
• Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00084552 - Recruiting
  sexual dysfunction and infertility; sexuality and reproductive issues; adenocarcinoma of the prostate; stage II prostate cancer
  
• Intensity-Modulated Radiation Therapy, Docetaxel, and Hormone Therapy in Treating Patients With High-Risk Locally Advanced Prostate Cancer With Pelvic Lymph Node Metastasis
  ClinicalTrials.gov Identifier: NCT00482807 - Recruiting
  Prostate Cancer
  
• Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00576979 - Recruiting
  Leukemia
  
• Intensity-Modulated Radiation Therapy, Fludarabine, and Melphalan Followed by a Donor Stem Cell Transplant in Treating Patients With Hematological Cancer
  ClinicalTrials.gov Identifier: NCT00544466 - Recruiting
  Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
  ClinicalTrials.gov Identifier: NCT00423293 - Recruiting
  Anal Cancer
  
• Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00573989 - Not yet recruiting
  Head and Neck Cancer
  
• Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
  ClinicalTrials.gov Identifier: NCT00226096 - Active, not recruiting
  CVA (Cerebrovascular Accident); Cerebral Hemorrhage; Intracranial Hemorrhages
  
• Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas
  ClinicalTrials.gov Identifier: NCT00165139 - Active, not recruiting
  Neuroblastoma; Ewings Sarcoma; Non-Rhabdomyosarcoma Soft Tissue Sarcoma
  
• Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
  ClinicalTrials.gov Identifier: NCT00126191 - Recruiting
  Burkitt Lymphoma; Non-Hodgkins Lymphoma; Atypical Burkitt Lymphoma
  
• Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00005823 - Active, not recruiting
  Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; ...
  
• Intensive Glycemic Control and Skeletal Health Study (ACCORD-BONE) - Ancillary Study to the ACCORD Trial
  ClinicalTrials.gov Identifier: NCT00324350 - Active, not recruiting
  Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Hypertension; Diabetes Mellitus; Coronary Disease
  
• Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and Efficacy
  ClinicalTrials.gov Identifier: NCT00505505 - Recruiting
  Subarachnoid Hemorrhage; Traumatic Brain Injury; Intracranial Hemorrhage
  
• Intensive Insulin Therapy in Non-Diabetic Patients With Acute Myocardial Infarction and Hyperglycaemia
  ClinicalTrials.gov Identifier: NCT00362778 - Completed
  Diabetes; Hyperglycemia; Acute Myocardial Infarction
  
• Intensive Intervention - 6
  ClinicalTrials.gov Identifier: NCT00217984 - Not yet recruiting
  Tobacco Use Disorder; alcohol & drug use
  
• Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension
  ClinicalTrials.gov Identifier: NCT00407680 - Recruiting
  Type 2 Diabetes Mellitus; Hypertension
  
• Intensive Monitoring of Brain Injured Patients
  ClinicalTrials.gov Identifier: NCT00163774 - Recruiting
  Traumatic Brain Injury
  
• Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma
  ClinicalTrials.gov Identifier: NCT00077389 - Recruiting
  childhood hepatoblastoma; stage IV childhood liver cancer
  
• Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-desacetyl Rifapentine
  ClinicalTrials.gov Identifier: NCT00023387 - Completed
  Tuberculosis
  
• Intensive Pharmacokinetics of the Nelfinavir Rifabutin Interaction in Patients with HIV-Related Tuberculosis Treated with a Rifabutin-Based Regimen
  ClinicalTrials.gov Identifier: NCT00023400 - Completed
  HIV Infections; Tuberculosis
  
• Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients with HIV-Related Tuberculosis Treated with a Rifabutin-Based Regimen
  ClinicalTrials.gov Identifier: NCT00018083 - Recruiting
  Tuberculosis; HIV Infections
  
• Intensive Rehabilitation of Patients With Severe Traumatic Brain Injury - Development of a Didactic Model
  ClinicalTrials.gov Identifier: NCT00419939 - Not yet recruiting
  Craniocerebral Trauma; Brain Injury,Traumatic
  
• Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00538395 - Active, not recruiting
  Breast Cancer
  
• Intensive Strength Training in Children With Cerebral Palsy - Effect on Hand Function
  ClinicalTrials.gov Identifier: NCT00467207 - Recruiting
  Cerebral Palsy
  
• Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis
  ClinicalTrials.gov Identifier: NCT00344526 - Completed
  Primary Systemic Amyloidosis (AL)
  
• Intensive vs. Conventional Renal Support in Acute Renal Failure. Acute Renal Failure Trial Network(ATN Study).
  ClinicalTrials.gov Identifier: NCT00076219 - Active, not recruiting
  Acute Renal Failure
  
• Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)
  ClinicalTrials.gov Identifier: NCT00235703 - Completed
  Upper Respiratory Infections
  
• Interaction Between ABT-335, Rosuvastatin and Warfarin
  ClinicalTrials.gov Identifier: NCT00487136 - Completed
  Healthy
  
• Interaction Between Anaesthetics and Methylene Blue
  ClinicalTrials.gov Identifier: NCT00513032 - Completed
  Hyperparathyroidism
  
• Interaction between Cocaine and Quetiapine - 1
  ClinicalTrials.gov Identifier: NCT00087750 - Active, not recruiting
  Cocaine-Related Disorders
  
• Interaction Between Fluvoxamine and Sildenafil
  ClinicalTrials.gov Identifier: NCT00175981 - Completed
  Healthy
  
• Interaction Between HIV and Lymphatic Filariasis
  ClinicalTrials.gov Identifier: NCT00295698 - Completed
  HIV Infection; Lymphatic Filariasis
  
• Interaction Between Nalbuphine and Morphine in PCA
  ClinicalTrials.gov Identifier: NCT00155233 - Recruiting
  Postoperative Pain
  
• Interaction Between Patient and Healthcare Provider: Response to Acupuncture in Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00059345 - Active, not recruiting
  Osteoarthritis
  
• Interaction Between Rimonabant and Cyclosporine and Tacrolimus
  ClinicalTrials.gov Identifier: NCT00525681 - Recruiting
  Renal Transplantation
  
• Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals
  ClinicalTrials.gov Identifier: NCT00218049 - Completed
  Cocaine Abuse; Cocaine-Related Disorders
  
• Interaction of Chronic Sleep Restriction and Circadian Misalignment on Sleep and Neuro-Cognitive Performance
  ClinicalTrials.gov Identifier: NCT00438438 - Recruiting
  Healthy
  
• Interaction of Cobalamin Status With Nitrous Oxide in Relation to Postoperative Cognitive Changes in the Elderly
  ClinicalTrials.gov Identifier: NCT00212147 - Recruiting
  Avitaminosis; Delirium, Dementia, Amnestic, Cognitive Disorders
  
• Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00288444 - Recruiting
  Lung Cancer; Soft Tissue Sarcoma; Colorectal Carcinoma; Breast Cancer; Prostate Cancer
  
• Interaction of Right and Left Brain Hemispheres in Learning Precision Hand Movements
  ClinicalTrials.gov Identifier: NCT00295568 - Recruiting
  Interhemispheric Inhibition
  
• Interaction of Stress and Progesterone Levels on Cocaine Cue Induced Craving in Cocaine Dependent Individuals
  ClinicalTrials.gov Identifier: NCT00535002 - Not yet recruiting
  Cocaine Related Disorders
  
• Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00583063 - Recruiting
  Solid Tumors
  
• Interactions Between Cocaine and Ethanol and Disulfiram - 1
  ClinicalTrials.gov Identifier: NCT00094289 - Active, not recruiting
  Alcohol-Related Disorders; Cocaine-Related Disorders
  
• Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract Infections
  ClinicalTrials.gov Identifier: NCT00084201 - Completed
  Urinary Tract Infections
  
• Interactions Between HIV and Malaria in African Children
  ClinicalTrials.gov Identifier: NCT00527800 - Recruiting
  Malaria; HIV Infections
  
• Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers
  ClinicalTrials.gov Identifier: NCT00039975 - Completed
  HIV Infections; Cardiovascular Diseases; Hypertension
  
• Interactions Between Progesterone and Cocaine in Women. - 1
  ClinicalTrials.gov Identifier: NCT00218257 - Recruiting
  Cocaine Abuse; Cocaine-Related Disorders
  
• Interactions of Depressed Mothers with Their Infants
  ClinicalTrials.gov Identifier: NCT00044174 - Recruiting
  Healthy; Depression
  
• Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00000906 - Completed
  HIV Infections
  
• Interactive Computer Treatment for Panic Disorder
  ClinicalTrials.gov Identifier: NCT00063375 - Recruiting
  Panic Disorder
  
• Interactive Motivational Media for Perinatal Drug Abuse - 3
  ClinicalTrials.gov Identifier: NCT00230048 - Active, not recruiting
  Behavior Therapy; Substance-Related Disorders
  
• Interactive Multirisk-Factor Intervention for HTN Blacks
  ClinicalTrials.gov Identifier: NCT00207194 - Recruiting
  Hypertension
  
• Interactive Studies of Endstage Diabetic Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00175734 - Recruiting
  Diabetes
  
• Interactive Technologies to Increase Exercise Behavior
  ClinicalTrials.gov Identifier: NCT00200317 - Completed
  Cardiovascular Disease
  
• Interactive Voice Response System (IVRS) for Managing Symptoms of Patients Following Thoracic Surgery
  ClinicalTrials.gov Identifier: NCT00505024 - Recruiting
  Esophageal Cancer; Lung Cancer
  
• Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease
  ClinicalTrials.gov Identifier: NCT00449852 - Recruiting
  Coronary Artery Disease
  
• Interdisciplinary Case-Control Study of Bladder Cancer in Spain
  ClinicalTrials.gov Identifier: NCT00341861 - Active, not recruiting
  Bladder Cancer
  
• Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00341952 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Interdisciplinary Pressure Management & Mobility Program as an Alternative to Bed Rest (WOUND)
  ClinicalTrials.gov Identifier: NCT00569205 - Not yet recruiting
  Pressure Ulcer
  
• Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)
  ClinicalTrials.gov Identifier: NCT00420173 - Recruiting
  Cutaneous Lupus Erythematosus
  
• Interest in Spirituality and Oncology: Is It An International Phenomenon?
  ClinicalTrials.gov Identifier: NCT00429117 - Recruiting
  Spirituality; Stress
  
• Interest of a 30 Minutes' Intermittent Work Exercise Test in Patients With Chronic Obstructive Pulmonary Disease: Cardiac and Pulmonary Functions
  ClinicalTrials.gov Identifier: NCT00295113 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency
  ClinicalTrials.gov Identifier: NCT00554814 - Not yet recruiting
  Latent Iron Deficiency
  
• Interest of Circulating Endothelial Biomarkers in Vascular Pregnancy Complications
  ClinicalTrials.gov Identifier: NCT00485784 - Recruiting
  Pre-Eclampsia
  
• Interest of Gentamicin-Induced Readthrough in Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00376428 - Terminated
  Cystic Fibrosis
  
• Interest of Non Invasive Ventilation Versus Oxygen During the Intial Managment of Infant With Bronchiolitis
  ClinicalTrials.gov Identifier: NCT00513890 - Recruiting
  Bronchiolitis; Respiratory Distress
  
• Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00199680 - Recruiting
  Cervical Cancer
  
• Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
  ClinicalTrials.gov Identifier: NCT00323804 - Recruiting
  Hepatitis C, Chronic; Liver Fibrosis
  
• Interest of Using the Sevoflurane in the Prevention of Newborns Pain
  ClinicalTrials.gov Identifier: NCT00420693 - Recruiting
  Pain Measurement; Newborn
  
• Interferon Alfa After Radiation Therapy in Treating Young Patients With Glioma
  ClinicalTrials.gov Identifier: NCT00041145 - Recruiting
  Brain and Central Nervous System Tumors
  
• Interferon alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00045422 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
  
• Interferon alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00002847 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00470093 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Interferon alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma
  ClinicalTrials.gov Identifier: NCT00026416 - Active, not recruiting
  stage III adult soft tissue sarcoma; stage IVB adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage IIC adult soft tissue sarcoma; ...
  
• Interferon alfa and Thalidomide in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00026520 - Completed
  Stage IV Melanoma; Recurrent Melanoma
  
• Interferon alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003007 - Completed
  stage III multiple myeloma; refractory plasma cell neoplasm
  
• Interferon alfa Following Surgery in Treating Patients With Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00006249 - Active, not recruiting
  stage III melanoma
  
• Interferon Alfa in Treating Children With HIV-Related Cancer
  ClinicalTrials.gov Identifier: NCT00002621 - Active, not recruiting
  Leukemia; Lymphoma
  
• Interferon alfa in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003542 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00278174 - Completed
  Kidney Cancer
  
• Interferon alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002869 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
  
• Interferon alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas
  ClinicalTrials.gov Identifier: NCT00002965 - Active, not recruiting
  recurrent adult brain tumor
  
• Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma
  ClinicalTrials.gov Identifier: NCT00276536 - Completed
  Breast Cancer; Intraocular Melanoma; Kidney Cancer; Lymphoma; Melanoma (Skin); Multiple Myeloma and Plasma Cell Neoplasm; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• Interferon alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma
  ClinicalTrials.gov Identifier: NCT00002892 - Active, not recruiting
  stage III melanoma; Recurrent Melanoma; childhood skin cancer; stage II melanoma
  
• Interferon alfa Plus Radiation Therapy in Treating Patients With Stage III or Recurrent Melanoma That Has Been Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00005615 - Active, not recruiting
  stage III melanoma; Recurrent Melanoma
  
• Interferon alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003561 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
  
• Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00015912 - Active, not recruiting
  recurrent grade I follicular small cleaved cell lymphoma; recurrent grade II follicular mixed cell lymphoma
  
• Interferon alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00002882 - Active, not recruiting
  stage III melanoma
  
• Interferon alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00053820 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Interferon alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00002737 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer; Renal Cell Adenocarcinoma
  
• Interferon alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00027664 - Recruiting
  Stage IV Renal Cell Cancer
  
• Interferon alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002767 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma; Quality of Life
  
• Interferon alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00062010 - Active, not recruiting
  Recurrent Small Cell Lung Cancer
  
• Interferon alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non- Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003924 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Interferon alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006039 - Completed
  recurrent diffuse small lymphocytic/marginal zone lymphoma; stage III grade II follicular mixed cell lymphoma; ...
  
• Interferon alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
  ClinicalTrials.gov Identifier: NCT00004196 - Active, not recruiting
  stage I melanoma; stage II melanoma; stage III melanoma
  
• Interferon alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
  ClinicalTrials.gov Identifier: NCT00072046 - Active, not recruiting
  Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer
  
• Interferon alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
  ClinicalTrials.gov Identifier: NCT00003444 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Interferon alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00005966 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00275938 - Completed
  Chronic Hepatitis B
  
• Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
  ClinicalTrials.gov Identifier: NCT00001228 - Completed
  Islet Cell Adenoma; Zollinger Ellison Syndrome
  
• Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally
  ClinicalTrials.gov Identifier: NCT00436046 - Active, not recruiting
  Influenza
  
• Interferon ß-1b Treatment by Cyclical Administration
  ClinicalTrials.gov Identifier: NCT00270816 - Recruiting
  Multiple Sclerosis
  
• Interferon beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma
  ClinicalTrials.gov Identifier: NCT00085306 - Completed
  Recurrent Melanoma; Stage IV Melanoma; iris melanoma; ciliary body and choroid melanoma, medium/large size; extraocular extension melanoma; ...
  
• Interferon Gamma for Drug Resistant Tuberculosis
  ClinicalTrials.gov Identifier: NCT00001407 - Completed
  Pneumonia; Pulmonary Tuberculosis
  
• Interferon gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004016 - Completed
  Stage IV Melanoma; unspecified adult solid tumor, protocol specific; stage III melanoma; Recurrent Melanoma
  
• Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I
  ClinicalTrials.gov Identifier: NCT00001905 - Completed
  Leukocyte Adhesion Deficiency Syndrome
  
• Interferon Gamma with Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients with Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00148863 - Completed
  Hepatitis C, Chronic
  
• Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis
  ClinicalTrials.gov Identifier: NCT00043316 - Completed
  Cystic Fibrosis
  
• Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease
  ClinicalTrials.gov Identifier: NCT00172809 - Completed
  Chronic Hepatitis C; End Stage Renal Disease
  
• Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
  chronic phase chronic myelogenous leukemia
  
• Interferon-Alpha for Diabetes Mellitus Type 1
  ClinicalTrials.gov Identifier: NCT00024518 - Active, not recruiting
  Insulin-Dependent Diabetes Mellitus
  
• Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)
  ClinicalTrials.gov Identifier: NCT00167583 - Recruiting
  Behcet`s Disease; Panuveitis; Posterior Uveitis; Retinal Vasculitis
  
• Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma with Liver Metastases
  ClinicalTrials.gov Identifier: NCT00107861 - Completed
  Colorectal Carcinoma; Metastases
  
• Interferon-beta Treatment of Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00048347 - Recruiting
  Ulcerative Colitis
  
• Interferon-Gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-Responders
  ClinicalTrials.gov Identifier: NCT00538811 - Recruiting
  Hepatitis C; Genotype 3; Non-Responders; Relapsers
  
• Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes
  ClinicalTrials.gov Identifier: NCT00324389 - Active, not recruiting
  Hepatitis C
  
• Intergenerational Transmission of Terror
  ClinicalTrials.gov Identifier: NCT00320437 - Not yet recruiting
  Anxiety; Trauma; Stress Disorders
  
• Interhemispheric Plasticity in Humans
  ClinicalTrials.gov Identifier: NCT00120666 - Completed
  
  
• Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients
  ClinicalTrials.gov Identifier: NCT00578630 - Recruiting
  Neoplasms
  
• Interleukin 11, Thrombocytopenia, CML, Imatinib in CML Patients
  ClinicalTrials.gov Identifier: NCT00493181 - Active, not recruiting
  Leukemia; Chronic Myelogenous Leukemia; CML
  
• Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients
  ClinicalTrials.gov Identifier: NCT00057486 - Terminated
  HIV Infections; Cryptosporidiosis
  
• Interleukin IL-4 as a Marker of Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00256035 - Not yet recruiting
  Atherosclerosis in Iscahemic Heart Disease.
  
• Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
  ClinicalTrials.gov Identifier: NCT00339157 - Active, not recruiting
  Systemic-Onset Juvenile Idiopathic Arthritis
  
• Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004157 - Active, not recruiting
  Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; kidney tumor
  
• Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00004244 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer; Stage IV Melanoma; Recurrent Melanoma
  
• Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00026143 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides
  ClinicalTrials.gov Identifier: NCT00052377 - Completed
  Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
  
• Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00054405 - Completed
  recurrent neuroblastoma
  
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of the HER2/neu Protein
  ClinicalTrials.gov Identifier: NCT00004074 - Active, not recruiting
  Cancer
  
• Interleukin-12 Followed by Interferon alfa in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003451 - Active, not recruiting
  Cancer
  
• Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003575 - Completed
  AIDS-related small noncleaved cell lymphoma; AIDS-related immunoblastic large cell lymphoma; AIDS-related peripheral/systemic lymphoma; ...
  
• Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00072098 - Recruiting
  stage IV colon cancer; Stage IV rectal cancer; liver metastases; recurrent rectal cancer; recurrent colon cancer
  
• Interleukin-12 Gene Therapy in Treating Patients With Skin Metastases
  ClinicalTrials.gov Identifier: NCT00028652 - Completed
  skin metastases
  
• Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections
  ClinicalTrials.gov Identifier: NCT00001911 - Completed
  Atypical Mycobacterium Infection
  
• Interleukin-12 in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003330 - Completed
  unspecified adult solid tumor, protocol specific
  
• Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00003017 - Completed
  recurrent cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma; stage IV cervical cancer; cervical adenosquamous cell carcinoma
  
• Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00019188 - Completed
  Epidemic Kaposi's Sarcoma; Recurrent Kaposi's Sarcoma
  
• Interleukin-12 in Treating Patients With Cancer in the Abdomen
  ClinicalTrials.gov Identifier: NCT00003046 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; Colorectal Cancer; Colon Cancer; Rectal Cancer
  
• Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003107 - Completed
  Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; kidney tumor
  
• Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004893 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Interleukin-12 in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003149 - Completed
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00016289 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00003210 - Completed
  Lymphocytic Lymphoma; Myeloid Leukemia; Hodgkin's Disease; Plasma Cell Tumor; Skin Cancer
  
• Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer
  ClinicalTrials.gov Identifier: NCT00003439 - Completed
  ovarian epithelial cancer; Pancreatic Cancer; Colon Cancer; Gastric Cancer; Prostate Cancer; Rectal Cancer; Endometrial Cancer; Colorectal Cancer; ...
  
• Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003412 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00005604 - Completed
  unspecified adult solid tumor, protocol specific
  
• Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004260 - Completed
  Lymphoma
  
• Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00028535 - Active, not recruiting
  recurrent breast cancer; recurrent gastric cancer; recurrent non-small cell lung cancer; recurrent ovarian epithelial cancer; ...
  
• Interleukin-13 PE38QQR Immunotoxin and Radiation Therapy With or Without Temozolomide in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00105014 - Recruiting
  adult anaplastic astrocytoma; adult giant cell glioblastoma; adult gliosarcoma; Mixed Gliomas
  
• Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy
  ClinicalTrials.gov Identifier: NCT00038259 - Active, not recruiting
  HIV Infections
  
• Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN alfa-2b), and Ribavirin (RBV) Treatment in Patients with Hepatitis C and HIV Coinfection
  ClinicalTrials.gov Identifier: NCT00015652 - Completed
  HIV Infections; Hepatitis C
  
• Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00032188 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00416871 - Active, not recruiting
  Kidney Cancer
  
• Interleukin-2 and Interleukin-12 in Treating Patients With Refractory or Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00020163 - Active, not recruiting
  Breast Cancer; Kidney Cancer; Lung Cancer; Ovarian Cancer; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00085579 - Completed
  stage III melanoma; Stage IV Melanoma
  
• Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer
  ClinicalTrials.gov Identifier: NCT00058045 - Completed
  AIDS-related peripheral/systemic lymphoma
  
• Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00016237 - Completed
  extensive stage small cell lung cancer; stage IV non-small cell lung cancer; Stage IV Renal Cell Cancer; Squamous Cell Lung Cancer; ...
  
• Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003962 - Completed
  Leukemia; Lymphoma; Multiple Myeloma
  
• Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006033 - Completed
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Interleukin-2 Immunotoxin Therapy in Treating Patients With Indolent Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003615 - Active, not recruiting
  Lymphoma
  
• Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00009698 - Active, not recruiting
  childhood acute myeloid leukemia in remission; recurrent childhood acute myeloid leukemia; ...
  
• Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003743 - Active, not recruiting
  disseminated neuroblastoma
  
• Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00006864 - Active, not recruiting
  Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer
  
• Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00018941 - Completed
  Kidney Cancer
  
• Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002845 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00002846 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Interleukin-2 in Treating Patients With Mycosis Fungoides
  ClinicalTrials.gov Identifier: NCT00002687 - Active, not recruiting
  Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
  
• Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome
  ClinicalTrials.gov Identifier: NCT00005788 - Active, not recruiting
  Lymphocytic Lymphoma; Mycosis Fungoides/Sezary Syndrome; Skin Cancer
  
• Interleukin-2 in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002746 - Active, not recruiting
  atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003148 - Active, not recruiting
  recurrent adult acute myeloid leukemia
  
• Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003126 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery
  ClinicalTrials.gov Identifier: NCT00003604 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002649 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00019357 - Completed
  unspecified adult solid tumor, protocol specific
  
• Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children with Weakened Immune Systems
  ClinicalTrials.gov Identifier: NCT00006066 - Active, not recruiting
  HIV Infections
  
• Interleukin-2 Plus Antiretroviral Therapy for HIV-Infected Patients with Low CD4+ Counts (SILCAAT Study)
  ClinicalTrials.gov Identifier: NCT00013611 - Active, not recruiting
  HIV Infection
  
• Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00006022 - Completed
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003991 - Active, not recruiting
  adult acute myeloid leukemia in remission; Quality of Life
  
• Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00002504 - Active, not recruiting
  Lymphoma; Leukemia
  
• Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002994 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Interleukin-2 Therapy for HIV Infection - Supplemental Procedures
  ClinicalTrials.gov Identifier: NCT00001354 - Completed
  Acquired Immunodeficiency Syndrome; HIV Infection
  
• Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00005038 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver
  ClinicalTrials.gov Identifier: NCT00039234 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma; liver metastases
  
• Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC)
  ClinicalTrials.gov Identifier: NCT00418496 - Recruiting
  Renal Cancer
  
• Interleukin-2, Interferon alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00053807 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003181 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00514085 - Not yet recruiting
  Melanoma (Skin)
  
• Interleukin-7 and Peptide Vaccine to Treat Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00088322 - No longer recruiting
  Melanoma
  
• Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00091338 - Completed
  Melanoma (Skin)
  
• Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00492440 - Recruiting
  Kidney Cancer; Melanoma (Skin)
  
• Interleukin-7 in Treating Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00062049 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment
  ClinicalTrials.gov Identifier: NCT00105417 - Completed
  
  
• INTERMAP: International Population Study on Macronutrients and BP
  ClinicalTrials.gov Identifier: NCT00005271 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Intermittent and Daily Dosing for Episodic (Periodic) Asthma
  ClinicalTrials.gov Identifier: NCT00337675 - Recruiting
  Asthma
  
• Intermittent Antimalaria Treatment With SP in African Children
  ClinicalTrials.gov Identifier: NCT00168948 - Active, not recruiting
  Malaria; Anemia
  
• Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
  ClinicalTrials.gov Identifier: NCT00488982 - Recruiting
  Prostate Cancer
  
• Intermittent Cold and Dry Air Underneath Football Shoulder Pads
  ClinicalTrials.gov Identifier: NCT00349804 - Active, not recruiting
  Body Temperature Regulation
  
• Intermittent Cold Blood Vs Crystalloid Cardioplegia in Aortic Valve Surgery
  ClinicalTrials.gov Identifier: NCT00257777 - Recruiting
  Aortic Valve Disease; Coronary Artery Disease
  
• Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy.
  ClinicalTrials.gov Identifier: NCT00223665 - Recruiting
  Prostate Cancer
  
• Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00549822 - Recruiting
  Breast Cancer
  
• Intermittent Liposomal Amphotericin B Primary Prophylaxis
  ClinicalTrials.gov Identifier: NCT00451711 - Not yet recruiting
  Acute Myeloid Leukemia
  
• Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis
  ClinicalTrials.gov Identifier: NCT00473460 - Completed
  Pulmonary Disease; Acute Excacerbation of Chronic Bronchitis (AECB)
  
• Intermittent Positive-Pressure Breathing Effects in Patients With High Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00476866 - Terminated
  Central Cord Injury Syndrome; Central Spinal Cord Syndrome
  
• Intermittent Preventative Treatment with Sulfadoxine-Pyrimethamine in Gambian Multigravidae
  ClinicalTrials.gov Identifier: NCT00120809 - Completed
  Malaria
  
• Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants
  ClinicalTrials.gov Identifier: NCT00285662 - Recruiting
  Malaria; Anemia
  
• Intermittent Preventive Treatment (IPTp) Versus Rapid Diagnostic Testing (RDT) and Treatment of Malaria in Pregnancy
  ClinicalTrials.gov Identifier: NCT00432367 - Not yet recruiting
  Malaria; Anaemia; Pregnancy
  
• Intermittent Preventive Treatment During Pregnancy in Benin
  ClinicalTrials.gov Identifier: NCT00274235 - Recruiting
  Malaria
  
• Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia
  ClinicalTrials.gov Identifier: NCT00270530 - Completed
  Placental Malaria Infection; HIV Infections; Stillbirth; Prematurity; Neonatal Deaths
  
• Intermittent Preventive Treatment with Antimalarials in Kenyan Infants
  ClinicalTrials.gov Identifier: NCT00111163 - Active, not recruiting
  Malaria; Anemia
  
• Intermittent ST Depression and Prognosis After Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00005217 - Completed
  Cardiovascular Diseases; Myocardial Infarction; Heart Diseases
  
• Intermittent Therapy in HIV-1 Infected Patients with Successful Viral Suppression Under HAART
  ClinicalTrials.gov Identifier: NCT00122551 - Terminated
  HIV Infections
  
• Intermittent Treatment With Sulfadoxine-Pyrimethamine for Malaria Control in Infants
  ClinicalTrials.gov Identifier: NCT00206739 - Active, not recruiting
  Malaria; Anemia
  
• Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
  ClinicalTrials.gov Identifier: NCT00500578 - Recruiting
  Hematological Malignancies
  
• Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda
  ClinicalTrials.gov Identifier: NCT00339456 - Active, not recruiting
  HIV
  
• Intermittent Versus Continuous Medication in the Treatment of HIV
  ClinicalTrials.gov Identifier: NCT00001967 - Completed
  HIV Infection
  
• Intermittent Versus Continuous Renal Replacement Therapy for Acute Renal Failure
  ClinicalTrials.gov Identifier: NCT00322933 - Terminated
  Renal Insufficiency, Acute; Renal Replacement Therapy
  
• Intermittent vs. Continuous HAART to Treat Chronic HIV Infection
  ClinicalTrials.gov Identifier: NCT00025909 - Completed
  HIV Infection
  
• Internal and Familial Resources and Motherhood. Follow Up of Mothers With Twins and Preterm Infants Versus Mothers With Single Full Term Infants
  ClinicalTrials.gov Identifier: NCT00320840 - Not yet recruiting
  Twins; Preterm Infants
  
• Internal Jugular Vein Ultrasound Measures and Fluid Responsiveness in Post-Operative Cardiac Surgical Patients
  ClinicalTrials.gov Identifier: NCT00500981 - Active, not recruiting
  Fluid Therapy; Cardiac Surgical Procedures
  
• Internal Limiting Membrane Peeling for Large Macular Holes
  ClinicalTrials.gov Identifier: NCT00190190 - Recruiting
  Macular Hole
  
• Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
  ClinicalTrials.gov Identifier: NCT00290654 - Recruiting
  Breast Cancer
  
• Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00466856 - Active, not recruiting
  Gastrointestinal Carcinoid Tumor; Head and Neck Cancer; Islet Cell Tumor; Metastatic Cancer; Neoplastic Syndrome; Pheochromocytoma
  
• Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00469963 - Active, not recruiting
  Liver Cancer
  
• Internal Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00573833 - Recruiting
  Prostate Cancer
  
• Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00003876 - Completed
  recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult brain stem glioma; ...
  
• Internal Radiation Therapy With or Without Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases
  ClinicalTrials.gov Identifier: NCT00096252 - Active, not recruiting
  brain metastases
  
• Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00436267 - Recruiting
  Metastatic Cancer; Pancreatic Cancer
  
• Internally v. Externally Guided BWSTT for Locomotor Recovery Post-Stroke
  ClinicalTrials.gov Identifier: NCT00125619 - Not yet recruiting
  Cerbrovascular accident
  
• International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC)
  ClinicalTrials.gov Identifier: NCT00335257 - Recruiting
  Contraception
  
• International Adoption and Stress Response Study
  ClinicalTrials.gov Identifier: NCT00203944 - Recruiting
  Stress
  
• International Collaborative Gaucher Group (ICGG) Gaucher Registry
  ClinicalTrials.gov Identifier: NCT00358943 - Recruiting
  Gaucher Disease; Cerebroside Lipidosis Syndrome; Glucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease
  
• International Cooperation for Post-Cherynobyl NIS Thyroid Tissue and Data Banks
  ClinicalTrials.gov Identifier: NCT00339274 - Recruiting
  Environment
  
• International Immune Tolerance Study
  ClinicalTrials.gov Identifier: NCT00212472 - Recruiting
  Hemophilia A With Inhibitors
  
• International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures
  ClinicalTrials.gov Identifier: NCT00182104 - Completed
  Heart Defect; Triscupid Atresia
  
• International Programs Collaborative Studies Coordinating Center
  ClinicalTrials.gov Identifier: NCT00005312 - Completed
  Cardiovascular Diseases; Heart Diseases; Lung Diseases
  
• International Registry for Severe Chronic Neutropenia
  ClinicalTrials.gov Identifier: NCT00004342 - Recruiting
  Neutropenia
  
• International Safety and Efficacy Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00112359 - Completed
  Cystic Fibrosis
  
• International SMA Patient Registry
  ClinicalTrials.gov Identifier: NCT00466349 - Recruiting
  Muscular Atrophy, Spinal
  
• International Study on Syncope of Uncertain Etiology
  ClinicalTrials.gov Identifier: NCT00120094 - Terminated
  Syncope
  
• INternational VErapamil SR Trandolapril STudy
  ClinicalTrials.gov Identifier: NCT00133692 - Completed
  Hypertension; Coronary Artery Disease
  
• Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy
  ClinicalTrials.gov Identifier: NCT00436631 - Recruiting
  Epilepsy
  
• Internet and Telephone Counseling for Smoking Cessation
  ClinicalTrials.gov Identifier: NCT00282009 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Internet Assisted Obesity Treatment
  ClinicalTrials.gov Identifier: NCT00265954 - Recruiting
  Overweight; Obesity
  
• Internet Diabetes Self-Management
  ClinicalTrials.gov Identifier: NCT00185601 - Active, not recruiting
  diabetes type 2
  
• Internet Diabetes Self-Management
  ClinicalTrials.gov Identifier: NCT00372463 - Active, not recruiting
  Type 2 Diabetes
  
• Internet Intervention to Improve Rural Diabetes Care
  ClinicalTrials.gov Identifier: NCT00403091 - Recruiting
  Diabetes Mellitus Type 2
  
• Internet Telehealth for Pediatric Asthma Case Management
  ClinicalTrials.gov Identifier: NCT00214383 - Recruiting
  Pediatric Asthma
  
• Internet Weight Control for Bingeing Adolescents
  ClinicalTrials.gov Identifier: NCT00125112 - Recruiting
  Obesity; Eating Disorder
  
• Internet-Based and Established Dyspnea Self-Management Programs in Chronic Obstructive Pulmonary Disease (COPD) Patients
  ClinicalTrials.gov Identifier: NCT00102401 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Internet-based Diabetes Education and Case Management
  ClinicalTrials.gov Identifier: NCT00105898 - Active, not recruiting
  Diabetes Mellitus
  
• Internet-Based Individualized Health Behavior Program or Internet-Based Standard Health Behavior Program in Preventing Cancer and Improving Physical Activity, Fitness, and Nutrition in Participants Who Are Physically Inactive With a Higher Body Mass Index
  ClinicalTrials.gov Identifier: NCT00128570 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations
  ClinicalTrials.gov Identifier: NCT00169312 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Internet-Based Program to Improve Asthma Management in Children
  ClinicalTrials.gov Identifier: NCT00377663 - Not yet recruiting
  Asthma
  
• Internet-Based System for Cancer Patients to Self-Report Toxicity
  ClinicalTrials.gov Identifier: NCT00578006 - Recruiting
  Cervical Cancer; Lung Cancer; Prostate Cancer; Vaginal Cancer; Ovarian Cancer
  
• Internet-Based Treatment for Children With Traumatic Brain Injuries and Their Families
  ClinicalTrials.gov Identifier: NCT00409448 - Recruiting
  Traumatic Brain Injury
  
• Internet-based Treatment of Early Childhood Fecal Incontinence
  ClinicalTrials.gov Identifier: NCT00067769 - Active, not recruiting
  Encopresis
  
• Internet-Based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma
  ClinicalTrials.gov Identifier: NCT00487214 - Completed
  Glaucoma, Open-Angle
  
• Internleukin-1 Trap to Treat Autoinflammatory Disease
  ClinicalTrials.gov Identifier: NCT00094900 - Recruiting
  Inflammation; Familial Mediterranean Fever; Still's Disease, Adult-Onset
  
• Interpersonal and Social Rhythm Therapy for Adolescents With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00576355 - Not yet recruiting
  Bipolar Disorder
  
• Interpersonal Psychotherapy for Depressed Adolescents Engaging in Non-Suicidal Self-Injury
  ClinicalTrials.gov Identifier: NCT00401102 - Recruiting
  Depression; Self-Injurious Behavior
  
• Interpersonal Psychotherapy for Depression in People With Heart Failure
  ClinicalTrials.gov Identifier: NCT00353223 - Recruiting
  Depression; Heart Failure, Congestive
  
• Interpersonal Psychotherapy for Depression in Pregnancy
  ClinicalTrials.gov Identifier: NCT00251043 - Recruiting
  Major Depression; Pregnant
  
• Interpersonal Psychotherapy for Severely Depressed Inpatients
  ClinicalTrials.gov Identifier: NCT00325000 - Terminated
  Major Depression
  
• Interpersonal Psychotherapy for Treating Trauma-Related Mental Disorders in Low-Income Women
  ClinicalTrials.gov Identifier: NCT00348036 - Not yet recruiting
  Post-Traumatic Stress Disorder; Depression
  
• Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent Mothers
  ClinicalTrials.gov Identifier: NCT00436150 - Recruiting
  Depression
  
• Interpretation of Transnasal Esophagoscopy Findings
  ClinicalTrials.gov Identifier: NCT00372918 - Recruiting
  Larynx Disease
  
• Interprofessional Collaborative Communication in Acute Care Hospital Teams
  ClinicalTrials.gov Identifier: NCT00466297 - Recruiting
  Disease; Delivery of Healthcare
  
• Interruption of Dorsal Visual Stream Using TMS
  ClinicalTrials.gov Identifier: NCT00418652 - Recruiting
  Healthy
  
• Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin
  ClinicalTrials.gov Identifier: NCT00000580 - Completed
  Hepatitis B; Hepatitis, Viral, Human; Liver Diseases
  
• INTERSALT: International Study of Sodium, Potassium, and Blood Pressure
  ClinicalTrials.gov Identifier: NCT00005763 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone,Plus Systemic Dexamethasone
  ClinicalTrials.gov Identifier: NCT00519584 - Recruiting
  Pain
  
• InterStim Prospective Database
  ClinicalTrials.gov Identifier: NCT00441935 - Recruiting
  Urinary Retention; Urinary Incontinence; Pelvic Pain
  
• Interstitial Brachytherapy Alone Versus External Beam Radiation Therapy After Breast Conserving Surgery for Low-Risk Invasive Carcinoma and Low-Risk Ductal Carcinoma in Situ (DCIS) of the Female Breast
  ClinicalTrials.gov Identifier: NCT00402519 - Recruiting
  Breast Cancer
  
• Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00063882 - Recruiting
  stage II prostate cancer; adenocarcinoma of the prostate
  
• Interstitial Cystitis
  ClinicalTrials.gov Identifier: NCT00056251 - Completed
  Interstitial Cystitis
  
• Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00024570 - Active, not recruiting
  Malignant Glioma; Glioblastoma Multiforme; Anaplastic Astrocytoma; Mixed Oligoastrocytoma
  
• Intervening With Children/Adolescents With FAS/ARND
  ClinicalTrials.gov Identifier: NCT00164528 - Completed
  Treatment; Control
  
• Intervention Centered on Adolescents’ Physical Activity and Sedentary Behavior (ICAPS)
  ClinicalTrials.gov Identifier: NCT00498459 - Completed
  Physical Inactivity; Overweight; Cardiovascular Disease
  
• Intervention Development for Newly Diagnosed Youth With HIV
  ClinicalTrials.gov Identifier: NCT00255892 - Completed
  Adolescents; HIV
  
• Intervention for Hispanic Children with Asthma
  ClinicalTrials.gov Identifier: NCT00005711 - Completed
  Asthma; Lung Diseases
  
• Intervention for Male STDs in India
  ClinicalTrials.gov Identifier: NCT00170534 - Recruiting
  Sexually Transmitted Infection
  
• Intervention for Newly Diagnosed
  ClinicalTrials.gov Identifier: NCT00510237 - Not yet recruiting
  HIV; Adolescents
  
• Intervention for Resistant Pregnant Smokers
  ClinicalTrials.gov Identifier: NCT00005697 - Completed
  Cardiovascular Diseases; Lung Diseases, Obstructive; Chronic Obstructive Pulmonary Disease
  
• Intervention for Stroke Survivors and Their Spousal Caregivers
  ClinicalTrials.gov Identifier: NCT00178529 - Completed
  Cerebrovascular Accident
  
• Intervention for Support Persons to Help Smokers Quit
  ClinicalTrials.gov Identifier: NCT00379054 - Active, not recruiting
  Smoking Cessation
  
• Intervention Study of Face Mask and Hand Sanitizer to Reduce Influenza Transmission
  ClinicalTrials.gov Identifier: NCT00490633 - Active, not recruiting
  Influenza
  
• Intervention Study to Control High Blood Pressure for Korean American
  ClinicalTrials.gov Identifier: NCT00473681 - Active, not recruiting
  High Blood Pressure
  
• Intervention Study to Improve Adherence in Asthma
  ClinicalTrials.gov Identifier: NCT00516633 - Completed
  Asthma
  
• Intervention to Decrease Anxiety in Parents of Infants in the Neonatal Intensive Care Unit (NICU)
  ClinicalTrials.gov Identifier: NCT00186472 - Completed
  Anxiety; Acute Stress Disorder; Posttraumatic Stress Disorder; Depression
  
• Intervention to Improve Asthma Management/Prevention
  ClinicalTrials.gov Identifier: NCT00005734 - Completed
  Asthma; Lung Diseases
  
• Intervention to Improve Care at Life's End
  ClinicalTrials.gov Identifier: NCT00234286 - Suspended
  Death; Pain; Dyspnea
  
• Intervention to Improve Expression of End of Life Preferences for Homeless Persons
  ClinicalTrials.gov Identifier: NCT00546884 - Recruiting
  Healthy
  
• Intervention to Improve Follow-up of Abnormal Pap Test
  ClinicalTrials.gov Identifier: NCT00575510 - Recruiting
  Cervical Cancer
  
• Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes
  ClinicalTrials.gov Identifier: NCT00232375 - Completed
  GAD Ab Positive Clinically Type 2 Diabetic Patients
  
• Interventional Management of Stroke (IMS) III Trial
  ClinicalTrials.gov Identifier: NCT00359424 - Recruiting
  Acute Ischemic Stroke
  
• Interventional Management of Stroke (IMS) Study
  ClinicalTrials.gov Identifier: NCT00243906 - Completed
  Stroke
  
• Interventions for Depressed Low Income Mothers and Their Infants
  ClinicalTrials.gov Identifier: NCT00105573 - Recruiting
  Depression
  
• Interventions for HIV+ Mothers With Problem Drinking
  ClinicalTrials.gov Identifier: NCT00183209 - Completed
  Substance Use Disorders
  
• Interventions to Decrease the Risk of Mother-to-Child Transmission of HIV in India
  ClinicalTrials.gov Identifier: NCT00341796 - Completed
  HIV-1
  
• Interventions to Educate An Underserved Population About Inherited Disease Risks
  ClinicalTrials.gov Identifier: NCT00441077 - Active, not recruiting
  Healthy Volunteers
  
• Interventions to Improve Asthma Management/Prevention at School
  ClinicalTrials.gov Identifier: NCT00005736 - Completed
  Asthma; Lung Diseases
  
• Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk
  ClinicalTrials.gov Identifier: NCT00201136 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Interviewing Children About Past Events: Evaluating the NICHD Interview Protocol
  ClinicalTrials.gov Identifier: NCT00343018 - Completed
  Memory
  
• Intestinal Inflammation and Carbohydrate Digestion in Autistic Children
  ClinicalTrials.gov Identifier: NCT00227487 - Recruiting
  Autism; Inflammation
  
• Intestinal Permeability in Children/Adolescents With Functional Dyspepsia
  ClinicalTrials.gov Identifier: NCT00363597 - Recruiting
  Functional Dyspepsia
  
• Intimal Thickening and Antioxidants in Hispanics and Anglos (Los Angeles Atherosclerosis Study)
  ClinicalTrials.gov Identifier: NCT00005372 - Completed
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases
  
• Intra Ocular Pressure During Robotic Prostatectomy
  ClinicalTrials.gov Identifier: NCT00369057 - Recruiting
  Visual Acuity; Visual Disturbance; Intraocular Pressure
  
• Intra-abdominal Infection Study
  ClinicalTrials.gov Identifier: - Recruiting
  Conditions: Abscess, Intra-Abdominal; Peritonitis
  
• Intra-abdominal Infection Study
  ClinicalTrials.gov Identifier: NCT00044928 - Completed
  Abscess, Intra-Abdominal; Peritonitis
  
• Intra-Arterial Catheter Directed Therapy for Severe Graft Vs. Host Disease (GVHD)
  ClinicalTrials.gov Identifier: NCT00146978 - Completed
  Graft vs Host Disease
  
• Intra-Arterial Microplasmin Administration in Patients with Acute Intracranial Vertebrobasilar Artery Occlusion
  ClinicalTrials.gov Identifier: NCT00123266 - Recruiting
  Acute vertebrobasilar artery occlusion
  
• Intra-Arterial Microplasmin Administration in Patients with Acute Peripheral Arterial Occlusion
  ClinicalTrials.gov Identifier: NCT00123292 - Recruiting
  acute peripheral arterial occlusion
  
• Intra-Arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)
  ClinicalTrials.gov Identifier: NCT00371371 - Recruiting
  Peripheral Vascular Diseases; Arterial Occlusive Diseases; Leg Ulcer; Gangrene; Ischemia
  
• Intra-Articular Injection of Botulinum Toxin Type A for Shoulder Pain
  ClinicalTrials.gov Identifier: NCT00211718 - Recruiting
  Arthritis; Shoulder Pain
  
• Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study
  ClinicalTrials.gov Identifier: NCT00522184 - Completed
  Rheumatoid Arthritis
  
• Intra-articularInjection of Botulinum Toxin Type
  ClinicalTrials.gov Identifier: NCT00211679 - Recruiting
  Arthritis; Pain
  
• Intra-Atrial vs. Extra-Cardiac Technique During Fontan Operation
  ClinicalTrials.gov Identifier: NCT00266942 - Terminated
  Congenital Disorders
  
• Intra-Cardiac Echocardiography Guided Cardioversion to Help Interventional Procedures (ICE-CHIP) Study
  ClinicalTrials.gov Identifier: NCT00281073 - Recruiting
  Atrial Fibrillation
  
• Intra-Individual Comparison of Sirolimus and Paclitaxel Coated Stent (FRE-RACE Study)
  ClinicalTrials.gov Identifier: NCT00130546 - Recruiting
  Coronary Artery Disease
  
• Intra-op Lidocaine and Ketamine Effect on Postoperative Bowel Function
  ClinicalTrials.gov Identifier: NCT00229567 - Terminated
  Colorectal Cancer
  
• Intra-Renal Infusion of BNP in Enhancing Renal Function in Human CHF With Cardiorenal Syndrome
  ClinicalTrials.gov Identifier: NCT00348556 - Recruiting
  Cardiorenal Syndrome
  
• Intraaortic Balloon Pump in Cardiogenic Shock II
  ClinicalTrials.gov Identifier: NCT00491036 - Not yet recruiting
  Myocardial Infarction; Shock, Cardiogenic
  
• Intraarticular Analgesia After Total Hip Arthroplasty, a Randomised Study
  ClinicalTrials.gov Identifier: NCT00289419 - Active, not recruiting
  Arthroplasty, Replacement, Hip
  
• Intraarticular Analgesia After Total Knee Arthroplasty, a Randomised Study
  ClinicalTrials.gov Identifier: NCT00269529 - Completed
  Arthroplasty, Replacement, Knee
  
• Intraarticular Injection of Infliximab
  ClinicalTrials.gov Identifier: NCT00521963 - Not yet recruiting
  Arthritis
  
• Intraarticular Opioids Vs Glucocorticosteroids in Gonarthritis
  ClinicalTrials.gov Identifier: NCT00244153 - Recruiting
  Rheumatic Disease
  
• Intracellular and Renal/Myocardial Tissue Concentrations of CsA and Rejection Frequency Following Transplantation.
  ClinicalTrials.gov Identifier: NCT00139009 - Completed
  Renal transplant recipients; Heart transplantation
  
• Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells.
  ClinicalTrials.gov Identifier: NCT00000830 - Completed
  HIV Infections; Pregnancy
  
• Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00452959 - Recruiting
  Recurrent Anaplastic Astrocytoma; Recurrent Anaplastic Oligodendroglioma; Recurrent Anaplastic Oligo-Astrocytoma; Recurrent Glioblastoma Multiforme
  
• Intracervical Block Versus Placebo to Assess Pain Control During Hysterosalpingogram
  ClinicalTrials.gov Identifier: NCT00372658 - Completed
  Infertility
  
• Intracoronary Infusion of BM-Derived Mononuclear Cells in Patients With Large Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00497211 - Recruiting
  Myocardial Infarction
  
• Intracoronary Stem Cells in Large Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00389545 - Active, not recruiting
  Myocardial Infarction
  
• Intradermal Influenza Vaccine Study in Elders
  ClinicalTrials.gov Identifier: NCT00504231 - Not yet recruiting
  Influenza
  
• Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients
  ClinicalTrials.gov Identifier: NCT00204607 - Completed
  Malignant Melanoma
  
• Intradialytic Parenteral Nutrition in Hemodialysis Patients
  ClinicalTrials.gov Identifier: NCT00501956 - Recruiting
  Malnutrition; Hemodialysis Patients
  
• Intragastric and Peritoneal Microdialysis in Infants With Necrotizing Enterocolitis (NEC).
  ClinicalTrials.gov Identifier: NCT00332592 - Not yet recruiting
  Necrotizing Enterocolitis
  
• Intralesional PV-10 Chemoablation of Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00219843 - Completed
  Melanoma
  
• Intralesional Resection in Treating Patients With Chrondosarcoma of the Bone
  ClinicalTrials.gov Identifier: NCT00096213 - Active, not recruiting
  Chondrosarcoma
  
• Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases
  ClinicalTrials.gov Identifier: NCT00204581 - Recruiting
  Melanoma
  
• Intralumenal Effects on Cholesterol Absorption/Synthesis
  ClinicalTrials.gov Identifier: NCT00328211 - Recruiting
  Healthy
  
• Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed with Dementia
  ClinicalTrials.gov Identifier: NCT00095719 - Completed
  Dementia; Alzheimer's Disease
  
• Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00073320 - Completed
  Schizophrenia
  
• Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00088465 - Active, not recruiting
  Schizophrenic Disorders
  
• Intramuscular Peramivir for the Treatment of Uncomplicated Influenza
  ClinicalTrials.gov Identifier: NCT00486980 - Not yet recruiting
  Influenza
  
• Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis
  ClinicalTrials.gov Identifier: NCT00314366 - Recruiting
  Coronary Artery Disease
  
• Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus
  ClinicalTrials.gov Identifier: NCT00496821 - Completed
  Respiratory Syncytial Virus Infections
  
• Intranasal Civamide for Episodic Cluster Headache
  ClinicalTrials.gov Identifier: NCT00069082 - Active, not recruiting
  Episodic Cluster Headache
  
• Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00345735 - Active, not recruiting
  Cancer; Pain
  
• Intranasal Fentanyl Versus Placebo for Catheterization During a Voiding Cystourethrogram in Children
  ClinicalTrials.gov Identifier: NCT00405444 - Recruiting
  Pain
  
• Intranasal Insulin for Prevention of Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00223613 - Recruiting
  Type 1 Diabetes
  
• Intranasal Insulin Treatment in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00575666 - Recruiting
  Schizophrenia
  
• Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair
  ClinicalTrials.gov Identifier: NCT00451724 - Recruiting
  Laceration
  
• Intranasal Lorazepam versus Intramuscular Paraldehyde in Paediatric Convulsions
  ClinicalTrials.gov Identifier: NCT00116064 - Completed
  Status Epilepticus; Convulsions
  
• Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures
  ClinicalTrials.gov Identifier: NCT00326612 - Not yet recruiting
  Seizures
  
• Intranasal Oxytocin in the Treatment of Autism
  ClinicalTrials.gov Identifier: NCT00490802 - Recruiting
  Autism
  
• Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS
  ClinicalTrials.gov Identifier: NCT00002083 - Completed
  HIV Infections; Peripheral Nervous System Disease
  
• Intranasal rFla-MBP Vaccine Dose-Ranging
  ClinicalTrials.gov Identifier: NCT00124865 - Active, not recruiting
  Diarrhea
  
• Intranasal Steroids and the Nasal Ocular Response
  ClinicalTrials.gov Identifier: NCT00473915 - Active, not recruiting
  Seasonal Allergic Rhinitis
  
• Intraoccular Pressure During Prone Spine Surgery
  ClinicalTrials.gov Identifier: NCT00176722 - Recruiting
  Spine Surgery
  
• Intraocular Bevacizumab (Avastin) for Rubeosis Iridis
  ClinicalTrials.gov Identifier: NCT00557232 - Completed
  Glaucoma; Rubeosis Iridis
  
• Intraocular Pressure (IOP) Changes Associated With Muslim Prayer Postural Changes
  ClinicalTrials.gov Identifier: NCT00454025 - Recruiting
  Glaucoma
  
• Intraocular Pressure Accuracy and Variability of the Barraquer Tonometer
  ClinicalTrials.gov Identifier: NCT00409669 - Recruiting
  Elevated Intraocular Pressure
  
• Intraocular Pressure During Abdominal Aortic Aneurysm Repair
  ClinicalTrials.gov Identifier: NCT00450294 - Recruiting
  Perioperative Blindness; Intraocular Pressure; Ischemic Optic Neuropathy
  
• Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
  ClinicalTrials.gov Identifier: NCT00417703 - Recruiting
  Choroidal Neovascularization
  
• Intraocular Steroid After Cataract Surgery Study
  ClinicalTrials.gov Identifier: NCT00478764 - Completed
  Cataract
  
• Intraoperative Fluid Management Based on Arterial Pulse Pressure Variation During High-Risk Surgery
  ClinicalTrials.gov Identifier: NCT00479011 - Terminated
  Surgery
  
• Intraoperative Goal-Directed Fluid Management
  ClinicalTrials.gov Identifier: NCT00554944 - Recruiting
  Obesity
  
• Intraoperative Hygiene Measures and Surgical Site Infections
  ClinicalTrials.gov Identifier: NCT00555815 - Completed
  Surgery; Surgical Site Infection; Hygiene; Discipline; Colorectal Surgery
  
• Intraoperative Lidocaine Infusion for Analgesia (ILIA)
  ClinicalTrials.gov Identifier: NCT00382499 - Not yet recruiting
  Elective Total Abdomincal Hysterectomy
  
• Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue
  ClinicalTrials.gov Identifier: NCT00581698 - Active, not recruiting
  Melanoma
  
• Intraoperative Nitrous Oxide and Postoperative Pain for Patients With Current Opioid Treatment
  ClinicalTrials.gov Identifier: NCT00210158 - Completed
  Chronic Pain
  
• Intraoperative Pathway in DIEP Flap Breast Reconstruction
  ClinicalTrials.gov Identifier: NCT00543764 - Recruiting
  Breast Cancer
  
• Intraoperative Three Dimensional Fluoroscopy Compared to Standard Fluoroscopy for the Assessment of Reduction of Ankle Fractures With Syndesmosis Disruption
  ClinicalTrials.gov Identifier: NCT00556010 - Not yet recruiting
  Ankle Injuries
  
• Intraoperative Use of the BP Device for Detecting Positive Margins During Lumpectomy Procedure
  ClinicalTrials.gov Identifier: NCT00380952 - Recruiting
  Breast Cancer
  
• Intraoral Grafting of Ex Vivo Produced Oral Mucosal Composites
  ClinicalTrials.gov Identifier: NCT00000111 - Active, not recruiting
  Mouth Diseases
  
• Intraperitoneal Aerosolized Delivery of a Local Anesthetic for Post Operative Pain Management. A Double Blind, Randomised Controlled Clinical Trial.
  ClinicalTrials.gov Identifier: NCT00286286 - Active, not recruiting
  Pain, Postoperative; Postoperative Pain; Abdominal Pain; Obesity; Pneumoperitoneum
  
• Intraperitoneal and Intravenous Gemcitabine, Radiotherapy and Surgery for Advanced Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00006288 - Completed
  Pancreatic Cancer
  
• Intraperitoneal Bupivicaine Infusion Using the On-Q Pain Pump After Laparoscopic Surgery
  ClinicalTrials.gov Identifier: NCT00533845 - Recruiting
  Postoperative Pain
  
• Intraperitoneal Floxuridine in Gastric Carcinoma
  ClinicalTrials.gov Identifier: NCT00058916 - Recruiting
  Stomach Neoplasms
  
• Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
  ClinicalTrials.gov Identifier: NCT00349505 - Recruiting
  Epithelial Ovarian Carcinoma; Figo Stage IIIC
  
• Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00458809 - Recruiting
  Carcinoma of the Appendix; Colorectal Cancer; Peritoneal Cavity Cancer
  
• Intraperitoneal Mesh With 3cm Overlap Versus a Rives-Stoppa Repair With a 6cm Overlap in Hernia Umbilicalis
  ClinicalTrials.gov Identifier: NCT00323141 - Recruiting
  Hernia, Umbilical
  
• Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin
  ClinicalTrials.gov Identifier: NCT00181701 - Recruiting
  Ovarian Carcinoma
  
• Intraperitoneal Paclitaxel, Doxorubicin, and Cisplatin in Treating Patients With Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00575952 - Not yet recruiting
  Endometrial Cancer; Ovarian Cancer
  
• Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women with Platinum-Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00102622 - Active, not recruiting
  Ovarian Cancer
  
• Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
  ClinicalTrials.gov Identifier: NCT00066404 - Active, not recruiting
  Cancer
  
• Intrapleural Docetaxel in Treating Patients Who Are Undergoing Surgery for Malignant Pleural Effusion
  ClinicalTrials.gov Identifier: NCT00114205 - Completed
  Malignant Pleural Effusion
  
• Intrapleural Minocycline After Simple Aspiration for the Prevention of Primary Spontaneous Pneumothorax
  ClinicalTrials.gov Identifier: NCT00418392 - Recruiting
  Pneumothorax
  
• Intrapleural Minocycline Following Simple Aspiration for Primary Spontaneous Pneumothorax
  ClinicalTrials.gov Identifier: NCT00520221 - Completed
  Pneumothorax
  
• Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study
  ClinicalTrials.gov Identifier: NCT00342433 - Active, not recruiting
  Prostate Cancer
  
• Intrapulmonary Pharmacokinetics of Antibiotics
  ClinicalTrials.gov Identifier: NCT00315601 - Active, not recruiting
  Healthy
  
• Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity
  ClinicalTrials.gov Identifier: NCT00221611 - Completed
  Cerebral Palsy
  
• Intrathecal and Systemic Chemotherapy Combined With Radiation Therapy in Treating Young Patients With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors
  ClinicalTrials.gov Identifier: NCT00084838 - Recruiting
  childhood rhabdoid tumor of the central nervous system
  
• Intrathecal Baclofen Therapy and Paroxysmal Dysautonomia in Severe Brain-Injured Patients
  ClinicalTrials.gov Identifier: NCT00221689 - Terminated
  Traumatic Brain Injury; Cerebral Anoxia; Coma; Hypertonia; Dysautonomia
  
• Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors
  ClinicalTrials.gov Identifier: NCT00003462 - Active, not recruiting
  leptomeningeal metastases
  
• Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I
  ClinicalTrials.gov Identifier: NCT00215527 - Recruiting
  Mucopolysaccharidosis I; Lysosomal Storage Diseases; Spinal Cord Compression
  
• Intrathecal Gemcitabine in Treating Patients With Cancer and Neoplastic Meningitis
  ClinicalTrials.gov Identifier: NCT00039143 - Recruiting
  leptomeningeal metastases
  
• Intrathecal Gemcitabine to Treat Neoplastic Meningitis
  ClinicalTrials.gov Identifier: NCT00074607 - Completed
  Meningitis; Neoplasms
  
• Intrathecal Mafosfamide
  ClinicalTrials.gov Identifier: NCT00062881 - Completed
  Malignant Meningeal Neoplasms
  
• Intrathecal Magnesium and Postoperative Analgesia
  ClinicalTrials.gov Identifier: NCT00560092 - Recruiting
  Total Hip Replacement
  
• Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
  ClinicalTrials.gov Identifier: NCT00058370 - Recruiting
  Adult Medulloblastoma; untreated childhood medulloblastoma
  
• Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00416923 - Active, not recruiting
  Lymphoma; Metastatic Cancer
  
• Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy
  ClinicalTrials.gov Identifier: NCT00379665 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00081211 - Completed
  Head and Neck Cancer
  
• Intratumoral Transferrin-CRM107 Compared With Best Standard Chemotherapy in Treating Patients With Progressive and/or Recurrent Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00087230 - Recruiting
  adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma
  
• Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00235482 - Completed
  Malignant Melanoma
  
• Intrauterine Embryo Development With ANECOVA Device
  ClinicalTrials.gov Identifier: NCT00480103 - Recruiting
  Healthy
  
• Intrauterine Environment in Polycystic Ovary Syndrome (PCOS) Probands
  ClinicalTrials.gov Identifier: NCT00364949 - Recruiting
  Polycystic Ovary Syndrome
  
• Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome
  ClinicalTrials.gov Identifier: NCT00566644 - Recruiting
  Endometrial Cancer; Hereditary Non-Polyposis Colon Cancer (hmsh2, hmlh1, hpms1, hpms2)
  
• Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection
  ClinicalTrials.gov Identifier: NCT00305227 - Recruiting
  Urinary Tract Infection
  
• Intravaginal Treatment of Distrubances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi
  ClinicalTrials.gov Identifier: NCT00140764 - Completed
  Bacterial Vaginosis; Trichomonas Vaginitis; Genitourinary symptoms
  
• Intravascular Ultrasound for Hepatocellular Carcinoma Staging
  ClinicalTrials.gov Identifier: NCT00474734 - Recruiting
  Hepatocellular Carcinoma
  
• Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke
  ClinicalTrials.gov Identifier: NCT00123305 - Recruiting
  Acute ischemic stroke
  
• Intravenous Allopurinol in Heart Failure
  ClinicalTrials.gov Identifier: NCT00181155 - Recruiting
  Congestive Heart Failure
  
• Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00281255 - Recruiting
  Cardiovascular Diseases; Cardiomyopathy, Dilated; Heart Diseases; Heart Failure, Congestive
  
• Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms
  ClinicalTrials.gov Identifier: NCT00343174 - Completed
  Brain Infarction; Cerebral Ischemia; Acute Stroke
  
• Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
  ClinicalTrials.gov Identifier: NCT00366834 - Active, not recruiting
  Nausea; Vomiting
  
• Intravenous and Topical Analgesics for Procedural Pain in Neonates
  ClinicalTrials.gov Identifier: NCT00213200 - Completed
  Pain; Infant, Newborn
  
• Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors
  ClinicalTrials.gov Identifier: NCT00555984 - Recruiting
  Brain Neoplasms
  
• Intravenous azithromycin plus intravenous ceftriaxone followed by oral azithromycin with intravenous levofloxacin followed by oral levofloxacin for the treatment of moderate to severely ill hospitalized patients with community acquired pneumonia.
  ClinicalTrials.gov Identifier: NCT00035347 - Completed
  Pneumonia
  
• Intravenous CG7870 in Combination with Docetaxel in Patients with Metastatic Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00103428 - Terminated
  Prostate Cancer
  
• Intravenous Clarithromycin in Septic Syndrome
  ClinicalTrials.gov Identifier: NCT00297674 - Completed
  Sepsis; Ventilator Associated Pneumonia
  
• Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
  ClinicalTrials.gov Identifier: NCT00002692 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; adenocarcinoma of the rectum; recurrent rectal cancer; childhood gastrointestinal cancer; ...
  
• Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00505375 - Not yet recruiting
  Type 1 Diabetes Mellitus
  
• Intravenous Edotecarin in Patients with Advanced Gastric Cancer that has Progressed or Recurred After Prior Fluoropyrimidine-based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00087503 - Completed
  Gastric Cancer
  
• Intravenous Fish Oil in Critically Ill Cardiac Patients
  ClinicalTrials.gov Identifier: NCT00516178 - Not yet recruiting
  Coronary Artery Disease; Myocardial Infarction
  
• Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
  ClinicalTrials.gov Identifier: NCT00195637 - Active, not recruiting
  Hereditary Inclusion Body Myopathy
  
• Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis
  ClinicalTrials.gov Identifier: NCT00306033 - Completed
  Myasthenia Gravis
  
• Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  ClinicalTrials.gov Identifier: NCT00001287 - Completed
  Demyelinating Diseases; Paraproteinemias
  
• Intravenous Immunoglobulin (IVIG) in Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00115778 - Recruiting
  Hypogammaglobulinemia; Lung Transplantation
  
• Intravenous Immunoglobulin After Relapse in Vasculitis
  ClinicalTrials.gov Identifier: NCT00307658 - Terminated
  ANCA + Vasculitides Relapsing Either Under Corticosteroid; and Immunosuppressant Therapies or After One Year; Post Treatment.
  
• Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract
  ClinicalTrials.gov Identifier: NCT00511212 - Recruiting
  Peritonitis; Postoperative Complications
  
• Intravenous Immunoglobulin Therapy in Optic Neuritis
  ClinicalTrials.gov Identifier: NCT00000117 - Completed
  Optic Neuritis
  
• Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer
  ClinicalTrials.gov Identifier: NCT00039052 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; recurrent non-small cell lung cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer; ...
  
• Intravenous Iron in Patients With Anemia of Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00204256 - Active, not recruiting
  Kidney Failure, Chronic
  
• Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00384657 - Not yet recruiting
  Chronic Kidney Disease; Chronic Heart Failure; Anemia
  
• Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients
  ClinicalTrials.gov Identifier: NCT00337116 - Recruiting
  Unstable Angina; Myocardial Infarction
  
• Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00335244 - Recruiting
  Heart Defects, Congenital; Hypertension, Pulmonary
  
• Intravenous Levodopa for the Diagnosis of Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00001928 - Completed
  Parkinson Disease
  
• Intravenous Lidocaine and Acute Rehabilitation
  ClinicalTrials.gov Identifier: NCT00330941 - Completed
  Pain, Postoperative; Opioid Consumption, Postoperative; Postoperative Fatigue
  
• Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage
  ClinicalTrials.gov Identifier: NCT00124150 - Recruiting
  Subarachnoid Hemorrhage
  
• Intravenous Mepolizumab In Children With Eosinophilic Esophagitis
  ClinicalTrials.gov Identifier: NCT00358449 - Recruiting
  Esophagitis; Eosinophilic
  
• Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
  ClinicalTrials.gov Identifier: NCT00086658 - Completed
  Hypereosinophilic Syndrome; Hypereosinophilia
  
• Intravenous Metoclopramide for the Treatment of Post Concussive Headache: a Randomized Placebo Controlled Trial
  ClinicalTrials.gov Identifier: NCT00237705 - Recruiting
  Post Concussive Headache; Post Concussive Syndrome
  
• Intravenous micronutrient therapy (IVMT) for Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00067405 - Active, not recruiting
  Fibromyalgia
  
• Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Haemodialysis Patients
  ClinicalTrials.gov Identifier: NCT00259025 - Completed
  Renal Failure, Chronic
  
• Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With ICD-Pacemaker
  ClinicalTrials.gov Identifier: NCT00534300 - Recruiting
  Ventricular Tachycardia; Sudden Cardiac Death
  
• Intravenous NTG to Preserve Gastric Microcirculation During Gastric Tube Reconstruction
  ClinicalTrials.gov Identifier: NCT00335010 - Completed
  Esophageal Neoplasms; Microcirculation
  
• Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma
  ClinicalTrials.gov Identifier: NCT00110123 - Recruiting
  liver metastases; ciliary body and choroid melanoma, medium/large size; iris melanoma; extraocular extension melanoma; recurrent intraocular melanoma
  
• Intravenous Pantoloc In Aspirin-Induced Ulcer Bleeding
  ClinicalTrials.gov Identifier: NCT00153725 - Completed
  Cardiovascular Disease; Cerebrovascular Disorders
  
• Intravenous Pertussis Immune Globulin in Patients with Severe Childhood Pertussis Infection
  ClinicalTrials.gov Identifier: NCT00004422 - Active, not recruiting
  Pertussis; Whooping Cough
  
• Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery
  ClinicalTrials.gov Identifier: NCT00569855 - Recruiting
  Open-Heart Surgery; Cardiopulmonary Bypass
  
• Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL) in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00388999 - Recruiting
  Multiple Myeloma
  
• Intravenous Remifentanil as Patient Controlled Analgesia (Pca) in Labour
  ClinicalTrials.gov Identifier: NCT00202722 - Recruiting
  Labour Pain
  
• Intravenous Saline Pre-Hydration in Patients Undergoing Outpatient Colonoscopy
  ClinicalTrials.gov Identifier: NCT00308152 - Recruiting
  Colonoscopy; Conscious Sedation
  
• Intravenous Streptokinase in Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00000507 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Infarction; Myocardial Ischemia
  
• Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke
  ClinicalTrials.gov Identifier: NCT00283088 - Recruiting
  Stroke
  
• Intravenous Tigecycline Versus Intravenous Levofloxacin To Treat Subjects Hospitalized With Community-Acquired Pneumonia
  ClinicalTrials.gov Identifier: NCT00081575 - Completed
  Pneumonia
  
• Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00082823 - Active, not recruiting
  Cancer
  
• Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00083213 - Active, not recruiting
  Cancer
  
• Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis
  ClinicalTrials.gov Identifier: NCT00462020 - Recruiting
  Perforated Appendicitis
  
• Intravenous Versus Oral Administration of Prednisolone in Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00311961 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas
  ClinicalTrials.gov Identifier: NCT00158691 - Completed
  Head and Neck Cancer
  
• Intravenous Voriconazole in Patients With Renal Compromise
  ClinicalTrials.gov Identifier: NCT00332410 - Recruiting
  Renal Transplant
  
• Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis.
  ClinicalTrials.gov Identifier: NCT00175045 - Completed
  Esophagitis; Reflux
  
• Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00267488 - Active, not recruiting
  Endometrial Cancer; Recurrent; Persistent
  
• Intravenous-Morphin and Glucagon-Usage Enhanced MR Cholangiography
  ClinicalTrials.gov Identifier: NCT00155376 - Recruiting
  Liver Disease
  
• Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies
  ClinicalTrials.gov Identifier: NCT00001261 - Completed
  Dermatomyositis; Inclusion Body Myositis; Polymyositis
  
• Intravenousimmunoglobulin (IVIg) for the Treatment of Stiff-man Syndrome (SMS)
  ClinicalTrials.gov Identifier: NCT00001550 - Completed
  Muscle Rigidity; Spasm; Stiff Man Syndrome
  
• Intraventricular rt-PA in Patients with Intraventricular Hemorrhage
  ClinicalTrials.gov Identifier: NCT00029315 - Recruiting
  Cerebral Hemorrhage
  
• Intravesical Chemotherapy Treatment of Superficial Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00491114 - Completed
  Bladder Neoplasms
  
• Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder
  ClinicalTrials.gov Identifier: NCT00343356 - Completed
  Bladder Neoplasms
  
• Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.
  ClinicalTrials.gov Identifier: NCT00191711 - Completed
  Superficial Bladder Cancer
  
• Intravitreal Avastin in Branch Retinal Vein Occlusion(BRVO) :A Randomized Sham Controlled Study
  ClinicalTrials.gov Identifier: NCT00370851 - Recruiting
  Retinal Disease
  
• Intravitreal Avastin in Proliferative Retinopathies
  ClinicalTrials.gov Identifier: NCT00564148 - Recruiting
  Retinal Neovascularization
  
• Intravitreal Avastin Versus Intravitreal Avastin and Triamcinolone in Central Retinal Vein Occlusion(CRVO)
  ClinicalTrials.gov Identifier: NCT00370630 - Recruiting
  Retinovascular Disease
  
• Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
  ClinicalTrials.gov Identifier: NCT00406172 - Recruiting
  Cystoid Macular Edema
  
• Intravitreal Bevacizumab for Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00347165 - Recruiting
  Age Related Macular Degeneration
  
• Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00556348 - Completed
  Age Related Macular Degeneration
  
• Intravitreal Bevacizumab for Choroidal Neovascularization Secondary to Angioid Streaks: a Six Month Follow-up Case Report
  ClinicalTrials.gov Identifier: NCT00406250 - Recruiting
  Angioid Streaks; Choroidal Neovascularization
  
• Intravitreal Bevacizumab for Idiopathic Perifoveal Telangiectasia
  ClinicalTrials.gov Identifier: NCT00451763 - Recruiting
  Retina; Telangiectasis
  
• Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
  ClinicalTrials.gov Identifier: NCT00407121 - Completed
  Vogt Koyanagi Harada Disease; Serpiginous Choroiditis; Multifocal Choroiditis
  
• Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
  ClinicalTrials.gov Identifier: NCT00370721 - Recruiting
  Diabetic Retinopathy
  
• Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
  ClinicalTrials.gov Identifier: NCT00383812 - Recruiting
  Polypoidal Choroidal Vasculopathy
  
• Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
  ClinicalTrials.gov Identifier: NCT00423059 - Completed
  Diabetic Retinopathy
  
• Intravitreal Bevacizumab for Retinal Disorders
  ClinicalTrials.gov Identifier: NCT00403026 - Recruiting
  Wet AMD; Macular Oedema; Proliferative Diabetic Retinopathy
  
• Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy
  ClinicalTrials.gov Identifier: NCT00418431 - Recruiting
  Central Serous Chorioretinopathy
  
• Intravitreal Bevacizumab for Treatment of Neovascular Glaucoma
  ClinicalTrials.gov Identifier: NCT00384631 - Recruiting
  Neovascular; Glaucoma
  
• Intravitreal Bevacizumab Vs Photocoagulation for Proliferative Diabetic Retinopathy
  ClinicalTrials.gov Identifier: NCT00347698 - Recruiting
  Diabetic Retinopathy
  
• Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD
  ClinicalTrials.gov Identifier: NCT00370370 - Active, not recruiting
  Neovascular Age-Related Macular Degeneration
  
• Intravitreal Injections of rhuFab V2 in Combination with Visudyne in Subjects with Age Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00056823 - Completed
  Age-Related Maculopathy
  
• Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy
  ClinicalTrials.gov Identifier: NCT00155454 - Recruiting
  Diabetes Mellitus; Diabetic Retinopathy; Vitreous Hemorrhage
  
• Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy
  ClinicalTrials.gov Identifier: NCT00123279 - Completed
  vitreomacular traction maculopathy
  
• Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy
  ClinicalTrials.gov Identifier: NCT00540930 - Active, not recruiting
  Uveal Melanoma; Radiation Retinopathy; Radiation Maculopathy
  
• Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema
  ClinicalTrials.gov Identifier: NCT00403039 - Recruiting
  Retinal Vein Occlusion
  
• Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy
  ClinicalTrials.gov Identifier: NCT00403325 - Recruiting
  Central Serous Chorioretinopathy
  
• Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00476918 - Recruiting
  Diabetic Retinopathy; Diabetic Macular Edema
  
• Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00407849 - Recruiting
  Diabetic Retinopathy
  
• Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab for Refractory Diabetic Macular Edema (IBEME Study)
  ClinicalTrials.gov Identifier: NCT00468351 - Active, not recruiting
  Diabetic Macular Edema
  
• Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00367133 - Active, not recruiting
  Diabetic Macular Edema
  
• Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion
  ClinicalTrials.gov Identifier: NCT00370266 - Recruiting
  Branch Retinal Vein Occlusion
  
• Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)
  ClinicalTrials.gov Identifier: NCT00167518 - Completed
  Diabetic Macular Oedema
  
• Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders
  ClinicalTrials.gov Identifier: NCT00101764 - Active, not recruiting
  
  
• Intravitreous Pegaptanib Sodium Injection in patients with Exudative Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00088192 - Completed
  Macular Degeneration
  
• Intrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy Patients
  ClinicalTrials.gov Identifier: NCT00195052 - Recruiting
  Epilepsy
  
• INTRINSIC RV
  ClinicalTrials.gov Identifier: NCT00148967 - Completed
  Tachycardia
  
• Introduction of Hypo-Osmolar ORS for Routine Use
  ClinicalTrials.gov Identifier: NCT00244777 - Completed
  Diarrhoea
  
• Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue
  ClinicalTrials.gov Identifier: NCT00131820 - Active, not recruiting
  Typhoid; Paratyphoid Fever
  
• Intron-A/Aldara Combination Therapy For BCC
  ClinicalTrials.gov Identifier: NCT00581425 - Recruiting
  Basal Cell Carcinoma Excluding Scalp and Face
  
• Invaplex 50 Vaccine Dose-Ranging
  ClinicalTrials.gov Identifier: NCT00082069 - Active, not recruiting
  Diarrhea
  
• Invasive Fungal Infections Surveillance Initiative
  ClinicalTrials.gov Identifier: NCT00177944 - Recruiting
  Fungal Infection
  
• Invasive Infections in Children With Hemoglobinopathies
  ClinicalTrials.gov Identifier: NCT00456443 - Completed
  Thalassemia; Sickle Cell Anemia
  
• Invasive Prenatal Testing Decisions in Pregnancy After Infertility
  ClinicalTrials.gov Identifier: NCT00341822 - Recruiting
  Pregnancy
  
• Investigate olfactory functioning as a possible proxy for neurotoxic exposure in cohorts of deployed and non-deployed Gulf War-era veterans.
  ClinicalTrials.gov Identifier: NCT00007514 - Completed
  Persian Gulf Syndrome; Occupational Exposure
  
• Investigate Risperidone for the Treatment of Schizophrenia in Adolescents
  ClinicalTrials.gov Identifier: NCT00088075 - Completed
  Schizophrenia
  
• Investigate the Diagnostic Value and Possibilities of OCT in Non-Melanoma Skin Cancer.
  ClinicalTrials.gov Identifier: NCT00390351 - Recruiting
  Skin Neoplasms
  
• Investigating Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00342251 - Recruiting
  Age-Related Macular Degeneration
  
• Investigating Anidulafungin in Children with Fever and Neutropenia
  ClinicalTrials.gov Identifier: NCT00063466 - Completed
  Fever; Neutropenia
  
• Investigating Best Practices for Children With Cerebral Palsy: A Pilot Study of Two Approaches
  ClinicalTrials.gov Identifier: NCT00430131 - Recruiting
  Cerebral Palsy
  
• Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury.
  ClinicalTrials.gov Identifier: NCT00320281 - Recruiting
  Spinal Cord Injury; Pain
  
• Investigating Cytokine Genes of Stem Cell Donors
  ClinicalTrials.gov Identifier: NCT00353821 - Active, not recruiting
  Stem Cell Transplantation
  
• Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
  ClinicalTrials.gov Identifier: NCT00468286 - Active, not recruiting
  Prostate Cancer
  
• Investigating Endothelial Precursor Cells (EPCs)
  ClinicalTrials.gov Identifier: NCT00067067 - Completed
  Central Nervous System
  
• Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies
  ClinicalTrials.gov Identifier: NCT00492466 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Investigating Severe Acute Respiratory Syndrome (SARS)
  ClinicalTrials.gov Identifier: NCT00066209 - Completed
  SARS Virus
  
• Investigating the Anti-HIV & Anti-Inflammatory Effect of Chloroquine
  ClinicalTrials.gov Identifier: NCT00308620 - Recruiting
  HIV Infections
  
• Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-Operative Chemotherapy in Breast Cancer
  ClinicalTrials.gov Identifier: NCT00525759 - Recruiting
  Breast Cancer
  
• Investigating the Cognitive Processes that Underlie Social Knowledge and Behavior
  ClinicalTrials.gov Identifier: NCT00061334 - Recruiting
  Healthy
  
• Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa
  ClinicalTrials.gov Identifier: NCT00065455 - Recruiting
  Retinitis Pigmentosa
  
• Investigating the Effectiveness of Telepsychiatry for Treating Major Depression in a Chinese American Nursing Home
  ClinicalTrials.gov Identifier: NCT00505518 - Recruiting
  Major Depressive Disorder
  
• Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants
  ClinicalTrials.gov Identifier: NCT00127465 - Completed
  Breast Neoplasms; Prostatic Neoplasms; Laryngeal Neoplasms; Cervix Neoplasms
  
• Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler
  ClinicalTrials.gov Identifier: NCT00426920 - Not yet recruiting
  Diabetes Mellitus
  
• Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function
  ClinicalTrials.gov Identifier: NCT00419237 - Completed
  Hepatic Impairment
  
• Investigating the Regulation of Reproductive Hormones in Adult Men
  ClinicalTrials.gov Identifier: NCT00392457 - Active, not recruiting
  Kallmann Syndrome; Hypogonadism; Gonadal Disorder
  
• Investigating the Role of Norepinephrine in Emotional Processing through Alpha-2 Adrenergic Receptor Modulation
  ClinicalTrials.gov Identifier: NCT00109642 - Recruiting
  
  
• Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion
  ClinicalTrials.gov Identifier: NCT00090831 - Recruiting
  Healthy
  
• Investigating the Safety of srTMS in the Treatment of Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00063284 - Recruiting
  Parkinson Disease
  
• Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.
  ClinicalTrials.gov Identifier: NCT00156806 - Completed
  -breast cancer
  
• Investigating the Use of Interleukin-12 and Interleukin-2 to Treat Children with Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00065494 - Recruiting
  Neuroblastoma
  
• Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00065676 - Recruiting
  Diabetes Mellitus; Obesity
  
• Investigating the Use of Talampanel in Patients with Recurrent High-Grade Gliomas
  ClinicalTrials.gov Identifier: NCT00061685 - Recruiting
  Glioma; Glioblastoma; Astrocytoma; Oligodendroglioma
  
• Investigating Voriconazole to Prevent Systemic Fungal Infection
  ClinicalTrials.gov Identifier: NCT00062920 - Completed
  Neutropenia; Leukemia; Lymphoma; Aplastic Anemia
  
• Investigation in Myositis-Associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
  ClinicalTrials.gov Identifier: NCT00504348 - Recruiting
  Interstitial Pneumonitis; Polymyositis; Dermatomyositis
  
• Investigation into Delay to Diagnosis of Alzheimer's Disease with Exelon (InDDEx)
  ClinicalTrials.gov Identifier: NCT00000174 - Completed
  Alzheimer Disease; Cognition Disorders
  
• Investigation Into Effects Upon Counterregulatory Responses to Hypoglycemia During Intensive Treatment of T1DM
  ClinicalTrials.gov Identifier: NCT00580710 - Recruiting
  Type 1 Diabetes; Hypoglycemia
  
• Investigation Into How the Body Takes up the Test Drug and Distributes it Into Various Body Organs and Tissues, How it Processes the Drug and How it Ultimately Removes it
  ClinicalTrials.gov Identifier: NCT00432302 - Recruiting
  Tumors
  
• Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
  ClinicalTrials.gov Identifier: NCT00436787 - Recruiting
  Venous Thrombosis; Pulmonary Embolism
  
• Investigation into the Use of Ultrasound Technique in the Evaluation of Heart Disease
  ClinicalTrials.gov Identifier: NCT00001632 - Completed
  Healthy; Hypertrophic Cardiomyopathy; Left Ventricular Hypertrophy
  
• Investigation of a Combination Treatment of Escitalopram and rTMS
  ClinicalTrials.gov Identifier: NCT00232700 - Recruiting
  Major Depressive Disorder
  
• Investigation of a Long Acting Follicle Stimulating Hormone in Women Undergoing Assisted Reproductive Technology (ART)
  ClinicalTrials.gov Identifier: NCT00505752 - Recruiting
  Infertility
  
• Investigation Of A New Medication (GW642444) In Asthmatic Patients
  ClinicalTrials.gov Identifier: NCT00354874 - Active, not recruiting
  Asthma
  
• Investigation of a Novel Approach to Improve Treatment Success Rates for Tuberculosis Patients in Senegal
  ClinicalTrials.gov Identifier: NCT00412009 - Completed
  Tuberculosis
  
• Investigation of Acceptable Dose of Mobilisation and Tactile Stimulation to Enhance Upper Limb Recovery After Stroke
  ClinicalTrials.gov Identifier: NCT00360997 - Recruiting
  Stroke
  
• Investigation of Cardiac Function and Cardiovascular Risk Factors in Marathon Runners- The Munich Marathon Study
  ClinicalTrials.gov Identifier: NCT00500773 - Active, not recruiting
  Modes of Exercise and Myocardial and Endothelial Function; Microcirculation; Subclinical Endorgan Damage; Obesity
  
• Investigation of Cervix Tumor Oxygenation and Microvasculature Using Magnetic Resonance Techniques
  ClinicalTrials.gov Identifier: NCT00242034 - Recruiting
  Cervix Cancer
  
• Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer
  ClinicalTrials.gov Identifier: NCT00582920 - Recruiting
  Osseous Lesions From Metastatic Breast Cancer
  
• Investigation of Clofarabine in Acute Leukemias
  ClinicalTrials.gov Identifier: NCT00098033 - Active, not recruiting
  Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia
  
• Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia
  ClinicalTrials.gov Identifier: NCT00230659 - Completed
  Telangiectasia, Hereditary Hemorrhagic
  
• Investigation of Cognitive Function Before and After Induced Ventricular Fibrillation in Electrophysiological (EP) Study
  ClinicalTrials.gov Identifier: NCT00176176 - Recruiting
  Ventricular Fibrillation; Ventricular Tachycardia
  
• Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 Diabetics
  ClinicalTrials.gov Identifier: NCT00499954 - Completed
  Type 1 Diabetes
  
• Investigation of Correlation Between Interstitial and Arterial Blood Glucose Concentrations in Septic Patients
  ClinicalTrials.gov Identifier: NCT00463645 - Completed
  Severe Sepsis
  
• Investigation of Early Hormonotherapy Efficacy of Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00375687 - Recruiting
  Prostate Cancer
  
• Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients with Ragweed Allergy
  ClinicalTrials.gov Identifier: NCT00110786 - Completed
  Type I Hypersensitivity
  
• Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis
  ClinicalTrials.gov Identifier: NCT00387478 - Suspended
  Type I Hypersensitivity
  
• Investigation of Genetic Risk of Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00412438 - Recruiting
  Atrial Fibrillation
  
• Investigation of Genetic Risk of Cardiovascular Disease in Prospective Cohort Study
  ClinicalTrials.gov Identifier: NCT00262691 - Recruiting
  Healthy; Coronary Disease; Myocardial Infarction; Cerebral Infarction
  
• Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)
  ClinicalTrials.gov Identifier: NCT00408824 - Recruiting
  Healthy; Metabolic Syndrome X; Hyperlipidemia; Hypertension; Diabetes Mellitus
  
• Investigation of Heart Failure Status Over Time Using Respiratory Parameters
  ClinicalTrials.gov Identifier: NCT00494117 - Recruiting
  Heart Failure, Congestive; Sleep Apnea Syndromes
  
• Investigation of Heart Function in Patients with Heart Valve Defects
  ClinicalTrials.gov Identifier: NCT00001314 - Completed
  
  
• Investigation of Leukocyte Trafficking Into Skin Blisters During Cardiopulmonary Bypass
  ClinicalTrials.gov Identifier: NCT00131040 - Completed
  Coronary artery bypass grafting; Ishcemic Heart disease; Angina Pectoris
  
• Investigation of Macular Pigment Augmentation on Dark Adaptation
  ClinicalTrials.gov Identifier: NCT00478439 - Not yet recruiting
  Aging; Age-Related Macular Degeneration
  
• Investigation of Multi-Purpose Solution-Based Corneal Staining and Ocular Comfort
  ClinicalTrials.gov Identifier: NCT00349843 - Completed
  Myopia
  
• Investigation of Muscle Activity Pattern of Gluteus Medius and Tensor Fascia Lata in Patients With PFPS
  ClinicalTrials.gov Identifier: NCT00451438 - Completed
  Patellofemoral Pain Syndrome
  
• Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs
  ClinicalTrials.gov Identifier: NCT00230672 - Recruiting
  Telangiectasia, Hereditary Hemorrhagic
  
• Investigation of Protein Biomarkers of Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00323180 - Active, not recruiting
  Prostate Cancer
  
• Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test
  ClinicalTrials.gov Identifier: NCT00258635 - Completed
  Type I Hypersensitivity
  
• Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00005300 - Completed
  Anemia, Sickle Cell; Blood Disease
  
• Investigation of Southern Tick-Associated Rash Illness (STARI)
  ClinicalTrials.gov Identifier: NCT00358761 - Recruiting
  Southern Tick-Associated Rash Illness
  
• Investigation of Subatmospheric Pressure Dressing on Pressure Ulcer Healing
  ClinicalTrials.gov Identifier: NCT00011531 - Completed
  Diabetic Foot Ulcers
  
• Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of QMF Twisthaler (Indacaterol Maleate/Mometasone Furoate)
  ClinicalTrials.gov Identifier: NCT00557440 - Recruiting
  Asthma
  
• Investigation of the Added Value of a Big Toe Hinged Brace for the Treatment of Hallux Rigidus
  ClinicalTrials.gov Identifier: NCT00284284 - Recruiting
  Hallux Rigidus
  
• Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease
  ClinicalTrials.gov Identifier: NCT00215787 - Recruiting
  Nasal Polyps; Gastroesophageal Reflux
  
• Investigation of the Clinical Performance of Silicone Hydrogel Contact Lenses During Continuous Wear
  ClinicalTrials.gov Identifier: NCT00346593 - Completed
  Myopia
  
• Investigation of the Cylex® ImmuKnow® Assay
  ClinicalTrials.gov Identifier: NCT00569842 - Recruiting
  Leukemia; Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Hodgkin's Disease; Multiple Myeloma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Aplastic Anemia; Chronic Myelogenous Leukemia
  
• Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients
  ClinicalTrials.gov Identifier: NCT00255918 - Completed
  Schizophrenia; Psychotic Disorders
  
• Investigation of the Effect of Acupuncture Needling on Connective Tissue Using Ultrasound Elastography
  ClinicalTrials.gov Identifier: NCT00005770 - Active, not recruiting
  Healthy
  
• Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity
  ClinicalTrials.gov Identifier: NCT00564642 - Recruiting
  Hepatitis
  
• Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis
  ClinicalTrials.gov Identifier: NCT00049764 - Completed
  Sepsis
  
• Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malaria
  ClinicalTrials.gov Identifier: NCT00329134 - Recruiting
  Malaria
  
• Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
  ClinicalTrials.gov Identifier: NCT00494169 - Recruiting
  Hypogonadism; Kallmann Syndrome; Puberty, Delayed; Puberty, Precocious; Hypothalamic Amenorrhea; Anosmia
  
• Investigation of the Human Immune Response in Normal Subjects and Patients with Disorders of the Immune System and Cancer
  ClinicalTrials.gov Identifier: NCT00001582 - Recruiting
  Communicable Disease; Immunologic Deficiency Syndrome; Neoplasm
  
• Investigation of the Incidence of Complications After Vaginal and Abdominal Hysterectomy
  ClinicalTrials.gov Identifier: NCT00181311 - Recruiting
  Hysterectomy
  
• Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)
  ClinicalTrials.gov Identifier: NCT00268879 - Active, not recruiting
  Irritable Bowel Syndrome
  
• Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5ml in Adults Aged 18 - 67 Years
  ClinicalTrials.gov Identifier: NCT00161785 - Completed
  Tick-Borne Encephalitis
  
• Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00223028 - Completed
  Renal Transplantation
  
• Investigation of the Steady State Pharmacokinetics of Tacrolimus, Mycophenolate Mofetil and Fluvastatin After Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00223015 - Completed
  Renal Transplantation
  
• Investigation of V520 in a HIV Vaccine Dose Refinement Study
  ClinicalTrials.gov Identifier: NCT00350623 - Terminated
  HIV Infections
  
• Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.
  ClinicalTrials.gov Identifier: NCT00154037 - Completed
  Healthy subjects
  
• Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.
  ClinicalTrials.gov Identifier: NCT00154011 - Completed
  Healthy subjects
  
• Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs
  ClinicalTrials.gov Identifier: NCT00494767 - Completed
  Obesity
  
• Investigation on the Role of Corticosteroids and Beta-Agonists on Cytokine Production in COPD Patients
  ClinicalTrials.gov Identifier: NCT00263380 - Recruiting
  COPD
  
• Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor
  ClinicalTrials.gov Identifier: NCT00454649 - Recruiting
  Neoplasms
  
• Investigational Cancer Drug in Women with Metastatic Breast Cancer whose Cancer has Gotten Worse after Anthracycline and Taxane Therapy
  ClinicalTrials.gov Identifier: NCT00067314 - Completed
  Breast Neoplasms; Neoplasm Metastasis
  
• Investigational compound versus Placebo in the Treatment of Painful Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00058968 - Completed
  Diabetic Neuropathy, Painful
  
• Investigational Drug in Combination with Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis
  ClinicalTrials.gov Identifier: NCT00076869 - Completed
  Aspergillosis
  
• Investigational Drug in Patients with Hypercholesterolemia or in Patients with Sitosterolemia
  ClinicalTrials.gov Identifier: NCT00092833 - Active, not recruiting
  Hypercholesterolemia, Familial; Lipid Metabolism, Inborn Errors
  
• Investigational Drug in Patients with Metastatic Colorectal Cancer who Failed Treatment with a 5-FU/Leucovorin Regimen
  ClinicalTrials.gov Identifier: NCT00078468 - Completed
  Colorectal Neoplasms
  
• Investigational Drug Study in Patients with Elevated Cholesterol and Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00092599 - Completed
  Hypercholesterolemia; Coronary Disease
  
• Investigational Drug versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00082537 - Active, not recruiting
  Neutropenia; Fever
  
• Investigational Drug versus an Approved Drug in Patients with Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00092703 - Completed
  Osteoarthritis
  
• Investigational Drug versus an Approved Drug in Patients with Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00092742 - Completed
  Rheumatoid Arthritis
  
• Investigational Drug with Neoadjuvant Hormone Therapy in Patients with High Risk Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00075192 - Completed
  Prostate Cancer
  
• Investigational HIV Vaccine Proof-of-Concept Study
  ClinicalTrials.gov Identifier: NCT00095576 - Terminated
  AIDS; HIV Infections
  
• Investigational Parkinson's Disease In Patients Not Well Controlled On L-Dopa
  ClinicalTrials.gov Identifier: NCT00381472 - Completed
  Parkinson's Disease
  
• Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate 500 (SB-500) System in Canada
  ClinicalTrials.gov Identifier: NCT00537849 - Not yet recruiting
  Prostate Cancer
  
• Investigational Study of Psychological Intervention in Recipients of Lung Transplant (INSPIRE)
  ClinicalTrials.gov Identifier: NCT00113139 - Active, not recruiting
  Lung Diseases; Depression
  
• Investigational Treatment of Chronic Migraine With Noninvasive Brain Stimulation (tDCS).
  ClinicalTrials.gov Identifier: NCT00521196 - Recruiting
  Migraine
  
• Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People
  ClinicalTrials.gov Identifier: NCT00052195 - Active, not recruiting
  Tuberculosis; HIV Infections
  
• Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity
  ClinicalTrials.gov Identifier: NCT00414531 - Recruiting
  Myotoxicity of Atorvastatin Treatment
  
• Investigations on the Influence of Bariatric Surgery on the Metabolism and Absorption of Atorvastatin
  ClinicalTrials.gov Identifier: NCT00331565 - Recruiting
  Morbid Obesity
  
• Investigator Initiated Study of the Effects of Androgen Therapy on Carbohydrate and Lipid Metabolism In Elderly Men
  ClinicalTrials.gov Identifier: NCT00365794 - Recruiting
  Aging; Obesity; Insulin Resistance; Hypogonadism
  
• Involved Field Radiotherapy for Non-Gastric Marginal Zone Lymphoma
  ClinicalTrials.gov Identifier: NCT00377195 - Recruiting
  Non-Gastric Marginal Zone Lymphoma
  
• Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00014326 - Recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma
  
• Involvement of Endogenous Digitalis-Like Compounds in Breast Cancer
  ClinicalTrials.gov Identifier: NCT00310882 - Recruiting
  Breast Neoplasms; Fibrocystic Disease of Breast; Mammaplasty
  
• Involving Community Pharmacies in Improving Asthma Outcomes in an Urban Pediatric Population
  ClinicalTrials.gov Identifier: NCT00424125 - Recruiting
  Asthma
  
• Iodine I 131 in Treating Patients With Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00416949 - Recruiting
  Head and Neck Cancer
  
• Iodine I 131 Metaiodobenzylguanidine and Arsenic Trioxide in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
  ClinicalTrials.gov Identifier: NCT00107289 - Recruiting
  metastatic pheochromocytoma; recurrent pheochromocytoma; regional pheochromocytoma; recurrent neuroblastoma
  
• Iodine I 131 Metaiodobenzylguanidine, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell or Bone Marrow Transplant for Relapsed or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00253435 - Recruiting
  Brain and Central Nervous System Tumors
  
• Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00450827 - Recruiting
  Neuroblastoma
  
• Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
  ClinicalTrials.gov Identifier: NCT00445965 - Recruiting
  Brain and Central Nervous System Tumors; Intraocular Melanoma; Lung Cancer; Melanoma (Skin); Metastatic Cancer; Neuroblastoma; Ovarian Cancer; Retinoblastoma; Sarcoma; Small Intestine Cancer
  
• Iodine I 131 Monoclonal Antibody BC8, Fludarabine, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Advanced Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00119366 - Recruiting
  adult acute myeloid leukemia; childhood acute myeloid leukemia
  
• Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00128635 - Completed
  adult glioblastoma; adult gliosarcoma; adult giant cell glioblastoma; recurrent adult brain tumor
  
• Iodine I 131 Tositumomab and Fludarabine in Treating Older Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00110071 - Recruiting
  adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00073931 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00416312 - Recruiting
  Lymphoma
  
• Iodine I 131 Tositumomab, Etoposide, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00073918 - Recruiting
  adult non-Hodgkin's lymphoma
  
• Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00107380 - Recruiting
  contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ...
  
• Iodine I 131 With or Without Thyroid-Stimulating Hormone in Treating Patients Who Have Undergone Surgery for Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00415233 - Recruiting
  Head and Neck Cancer
  
• Iodine I-131 Iodocholesterol, its use in adrenal screening
  ClinicalTrials.gov Identifier: NCT00037843 - Completed
  Adrenal Gland Diseases; Adrenal Gland Neoplasms
  
• Iodine Status in Pregnant Women and Their Newborns: is Congenital Hypothyroidism Related to Iodine Deficiency in Pregnancy?
  ClinicalTrials.gov Identifier: NCT00505479 - Recruiting
  Congenital Hypothyroidism; Pregnancy; Iodine Deficiency
  
• Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)
  ClinicalTrials.gov Identifier: NCT00209404 - Completed
  Coronary Artery Disease
  
• Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)
  ClinicalTrials.gov Identifier: NCT00390585 - Recruiting
  Renal Insufficiency, Chronic; Angioplasty, Transluminal, Percutaneous Coronary; Coronary Arteriosclerosis
  
• Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00030381 - Completed
  primary systemic amyloidosis
  
• Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis
  ClinicalTrials.gov Identifier: NCT00230867 - Completed
  Herpes Labialis
  
• Iontophoretic Application of Acyclovir Gel to Treat Cold Sores
  ClinicalTrials.gov Identifier: NCT00469300 - Active, not recruiting
  Herpes Labialis
  
• IOP Assessed by DCT and GAT
  ClinicalTrials.gov Identifier: NCT00552019 - Recruiting
  Uveitis; Intraocular Pressure
  
• IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00527501 - Recruiting
  Open-Angle Glaucoma; Ocular Hypertension
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy
  ClinicalTrials.gov Identifier: NCT00382226 - Recruiting
  Glaucoma
  
• Iowa WISEWOMAN Project
  ClinicalTrials.gov Identifier: NCT00153374 - Active, not recruiting
  CVD risk
  
• Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00556881 - Recruiting
  Adult Malignant Fibrous Histiocytoma of Bone; Childhood Malignant Fibrous Histiocytoma of Bone; Kidney Cancer; Lymphoma; Melanoma (Skin); Neuroblastoma; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00357461 - Active, not recruiting
  Melanoma (Skin)
  
• IPM Procedures With or Without Fluoroscopy: Outcome Comparison
  ClinicalTrials.gov Identifier: NCT00371618 - Completed
  Low Back Pain; Neck Pain
  
• iPod and Other MP3 Players on ICDs and Pacemakers in Children
  ClinicalTrials.gov Identifier: NCT00542854 - Recruiting
  Heart Block; Bradycardia; Tachycardia; Arrhythmia
  
• Ipratropium Spray for Drooling Saliva in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00296946 - Completed
  Parkinson's Disease
  
• IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.
  ClinicalTrials.gov Identifier: NCT00361114 - Recruiting
  Malaria
  
• IPT of Malaria With SP in Different Zones of Drug Resistance in Rwanda
  ClinicalTrials.gov Identifier: NCT00372632 - Recruiting
  Non HIV Infected Pregnant Women
  
• IPTi in Mozambican Infants for Malaria Prevention
  ClinicalTrials.gov Identifier: NCT00209794 - Active, not recruiting
  Malaria
  
• IPTp Plus ITNs for Malaria Control in Pregnant Women
  ClinicalTrials.gov Identifier: NCT00209781 - Active, not recruiting
  Pregnancy
  
• IPV Screening in Health Care Clinics in Rural South Carolina
  ClinicalTrials.gov Identifier: NCT00164567 - Active, not recruiting
  Partner Abuse
  
• IPV Versus nCPAP in Transient Respiratory Distress of the Newborn
  ClinicalTrials.gov Identifier: NCT00556738 - Recruiting
  Respiratory Distress Syndrome, Newborn
  
• IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00488839 - Recruiting
  Multiple Sclerosis
  
• IRAD2 : Patients With Respiratory Failure at Home
  ClinicalTrials.gov Identifier: NCT00230984 - Active, not recruiting
  Chronic Respiratory Failure; Nutritional Depletion
  
• Irbesartan and Atenolol in Hypertensive Heart Disease
  ClinicalTrials.gov Identifier: NCT00389168 - Completed
  Hypertension
  
• Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol
  ClinicalTrials.gov Identifier: NCT00549133 - Completed
  Hypertension; Diabetes Mellitus Type 2
  
• Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients with Hypertension and Permanent Pacemakers
  ClinicalTrials.gov Identifier: NCT00225667 - Not yet recruiting
  Atrial Fibrillation; Hypertension
  
• Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria
  ClinicalTrials.gov Identifier: NCT00334581 - Recruiting
  Hypertension
  
• Irbesartan in Heart Failure with Preserved Systolic Function (I-Preserve)
  ClinicalTrials.gov Identifier: NCT00095238 - Active, not recruiting
  Congestive Heart Failure
  
• Irbesartan in Hypertension
  ClinicalTrials.gov Identifier: NCT00265967 - Active, not recruiting
  Hypertension
  
• Irbesartan in the Treatment of Hypertensive Patients with Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00110422 - Completed
  Metabolic Syndrome X; Hypertension
  
• Irbesartan in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00317915 - Completed
  Type 2 Diabetes; Microalbuminuria; Hypertension
  
• Irbesartan vs. Placebo in Combination with Ramipril for Treatment of Albuminuria
  ClinicalTrials.gov Identifier: NCT00095290 - Completed
  Albuminuria
  
• Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions
  ClinicalTrials.gov Identifier: NCT00350038 - Completed
  Hypertension; Dyslipidemia
  
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
  ClinicalTrials.gov Identifier: NCT00095394 - Completed
  Hypertension
  
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients with Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00095550 - Completed
  Hypertension
  
• Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00263003 - Completed
  Hypertension
  
• Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
  ClinicalTrials.gov Identifier: NCT00443612 - Recruiting
  Hypertension
  
• Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00181688 - Active, not recruiting
  Ovarian Cancer; Peritoneal Carcinoma; Tubal Carcinoma
  
• Iressa 2nd Line Phase III Study in Japan
  ClinicalTrials.gov Identifier: NCT00252707 - Completed
  Non-Small Cell Lung Cancer
  
• Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00233636 - Completed
  Head and Neck Cancer; Carcinoma, Squamous Cell
  
• Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer
  ClinicalTrials.gov Identifier: NCT00479089 - Recruiting
  Bladder Cancer; Urothelial Cancer
  
• Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00173875 - Completed
  Non-Small Cell Lung Cancer
  
• Iressa as Second Line Therapy in Advanced NSCLC-Asia
  ClinicalTrials.gov Identifier: NCT00478049 - Active, not recruiting
  NSCLC
  
• Iressa Case Control Study in Japan
  ClinicalTrials.gov Identifier: NCT00252759 - Completed
  Non-Small Cell Lung Cancer
  
• IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00234416 - Completed
  Pancreatic Cancer
  
• Iressa Expanded Access Program (EAP)
  ClinicalTrials.gov Identifier: NCT00034879 - Completed
  Carcinoma, Non-Small-Cell Lung; Metastases, Neoplasm
  
• Iressa Follow-Up Trial
  ClinicalTrials.gov Identifier: NCT00357734 - Completed
  Lung Cancer; Breast Cancer
  
• IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma
  ClinicalTrials.gov Identifier: NCT00242749 - Completed
  Cancer of Head and Neck
  
• Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00193336 - Completed
  Lung Cancer
  
• Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00234442 - Active, not recruiting
  Brain Neoplasms; Non Small Cell Lung Cancer
  
• Iressa Study in Patients With Salivary Gland Cancer
  ClinicalTrials.gov Identifier: NCT00509002 - Active, not recruiting
  Salivary Gland Cancer
  
• Iressa to Treat Solid Tumors in Children
  ClinicalTrials.gov Identifier: NCT00050739 - Completed
  Tumors
  
• Iressa v BSC (Best Supportive Care) in First Line NSCLC
  ClinicalTrials.gov Identifier: NCT00259064 - Completed
  NSCLC
  
• Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
  ClinicalTrials.gov Identifier: NCT00242801 - Completed
  NSCLC
  
• Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC
  ClinicalTrials.gov Identifier: NCT00234468 - Active, not recruiting
  Non Small Cell Lung Carcinoma
  
• Iressa/Docetaxel in Non-Small-Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00048087 - Terminated
  Non-small cell lung cancer
  
• IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00229723 - Active, not recruiting
  Neoplasms, Squamous Cell
  
• IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure
  ClinicalTrials.gov Identifier: NCT00242788 - Completed
  Colorectal Cancer
  
• IRIDIA Therapeutical Impact of a Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly
  ClinicalTrials.gov Identifier: NCT00224575 - Recruiting
  Myocardial Ischemia; Veterans
  
• Irinotecan (Camptosar) in Patients With Advanced Sarcomas
  ClinicalTrials.gov Identifier: NCT00509860 - Recruiting
  Sarcoma
  
• Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084877 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Irinotecan and ABT-888 in Treating Patients With Metastatic or Unresectable Cancer
  ClinicalTrials.gov Identifier: NCT00576654 - Not yet recruiting
  Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• Irinotecan and Capecitabine in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003867 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer; Colon Cancer; Rectal Cancer; Breast Cancer
  
• Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00083148 - Active, not recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00469898 - Recruiting
  Lung Cancer
  
• Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00077285 - Recruiting
  childhood rhabdomyosarcoma; childhood soft tissue sarcoma; Muscle Cancer
  
• Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00387660 - Recruiting
  Lung Cancer
  
• Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00104793 - Active, not recruiting
  extensive stage small cell lung cancer
  
• Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00084721 - Completed
  Colon Cancer; Diarrhea; Rectal Cancer
  
• Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
  ClinicalTrials.gov Identifier: NCT00336856 - Recruiting
  Colon Cancer; Rectum Cancer
  
• Irinotecan and Cetuximab in Treating Patients With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00275041 - Active, not recruiting
  Recurrent Breast Cancer; Stage IV Breast Cancer; Male Breast Cancer
  
• Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
  ClinicalTrials.gov Identifier: NCT00499369 - Recruiting
  Colorectal Cancer
  
• Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00353015 - Recruiting
  Gastrointestinal Cancer; Carcinoma, Neuroendocrine
  
• Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer
  ClinicalTrials.gov Identifier: NCT00066391 - Active, not recruiting
  penile squamous cell carcinoma; stage III penile cancer; stage IV penile cancer
  
• Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00004919 - Active, not recruiting
  unspecified childhood solid tumor, protocol specific; Drug Toxicity
  
• Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003950 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00053144 - Active, not recruiting
  Myeloid Leukemia
  
• Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00040807 - Active, not recruiting
  Head and Neck Cancer
  
• Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00079118 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00042939 - Active, not recruiting
  adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
  ClinicalTrials.gov Identifier: NCT00087282 - Completed
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; recurrent adult primary liver cancer
  
• Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00182806 - Recruiting
  Lung Cancer
  
• Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00054288 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00002939 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
  ClinicalTrials.gov Identifier: NCT00020761 - Active, not recruiting
  stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
  
• Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00112892 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00318903 - Completed
  Esophageal Cancer; Cancer of the Esophagus; Esophagus Cancer; Esophageal Neoplasm; Cancer of Esophagus
  
• Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00311584 - Recruiting
  Brain and Central Nervous System Tumors
  
• Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00062127 - Completed
  unspecified adult solid tumor, protocol specific
  
• Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors
  ClinicalTrials.gov Identifier: NCT00389584 - Active, not recruiting
  Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Long-Term Effects Secondary to Cancer Therapy in Adults; Long-Term Effects Secondary to Cancer Therapy in Children; Poor Performance Status; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00005036 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00320320 - Terminated
  Colorectal Neoplasms; Metastases
  
• Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00004005 - Active, not recruiting
  adult solid tumor; carcinoma of unknown primary; childhood solid tumor; Colon Cancer; Rectal Cancer
  
• Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024141 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
  ClinicalTrials.gov Identifier: NCT00004068 - Active, not recruiting
  high-grade childhood cerebral astrocytoma; untreated childhood brain stem glioma; untreated childhood cerebellar astrocytoma; ...
  
• Irinotecan in Combination with 5-FU, Leucovorin (FOLFIRI) Plus Bevacizumab in Patients with Colorectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00106054 - Terminated
  Colorectal Cancer; Neoplasm Metastasis; Liver Cancer
  
• Irinotecan in Combination with Leucovorin and Fluorouracil to Treat Cancer
  ClinicalTrials.gov Identifier: NCT00021515 - Completed
  Cancer
  
• Irinotecan in Treating Aging Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00026195 - Completed
  unspecified adult solid tumor, protocol specific
  
• Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants
  ClinicalTrials.gov Identifier: NCT00008424 - Completed
  unspecified childhood solid tumor, protocol specific
  
• Irinotecan in Treating Children With Refractory or Progressive Solid Tumors
  ClinicalTrials.gov Identifier: NCT00016861 - Completed
  unspecified childhood solid tumor, protocol specific
  
• Irinotecan in Treating Children With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004078 - Completed
  Ewing's family of tumors; childhood brain tumor; childhood rhabdomyosarcoma; childhood solid tumor; Neuroblastoma; Osteosarcoma
  
• Irinotecan in Treating Patients With Advanced Cancer of the Stomach
  ClinicalTrials.gov Identifier: NCT00003137 - Completed
  stage IV gastric cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; intestinal adenocarcinoma of the stomach; ...
  
• Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer
  ClinicalTrials.gov Identifier: NCT00003276 - Active, not recruiting
  recurrent gallbladder cancer; unresectable gallbladder cancer
  
• Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00004922 - Completed
  newly diagnosed carcinoma of unknown primary; Neuroendocrine Carcinoma; recurrent carcinoma of unknown primary; stage III Merkel cell carcinoma; ...
  
• Irinotecan in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004051 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Irinotecan in Treating Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003843 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Irinotecan in Treating Patients With Esophageal or Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00003748 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; ...
  
• Irinotecan in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003544 - Completed
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00100828 - Recruiting
  medullary thyroid cancer; recurrent thyroid cancer
  
• Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004182 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00002933 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma
  ClinicalTrials.gov Identifier: NCT00276692 - Recruiting
  Sarcoma
  
• Irinotecan in Treating Patients With Newly Diagnosed or Relapsed Non- Hodgkin's Lymphoma or Leukemia
  ClinicalTrials.gov Identifier: NCT00005626 - Active, not recruiting
  Lymphoma; Leukemia
  
• Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00003616 - Completed
  Adult Oligodendroglioma; recurrent adult brain tumor; adult brain stem glioma; adult infiltrating astrocytoma; Mixed Gliomas
  
• Irinotecan in Treating Patients With Recurrent Glioma
  ClinicalTrials.gov Identifier: NCT00003134 - Active, not recruiting
  Adult Oligodendroglioma; recurrent adult brain tumor; adult brain stem glioma; Mixed Gliomas; adult infiltrating astrocytoma
  
• Irinotecan in Treating Patients With Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00003301 - Completed
  adult glioblastoma multiforme; adult anaplastic astrocytoma; recurrent adult brain tumor
  
• Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
  ClinicalTrials.gov Identifier: NCT00066612 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003245 - Completed
  Burkitt's Lymphoma; Lymphocytic Lymphoma; Myeloid Leukemia; Plasma Cell Tumors
  
• Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003351 - Completed
  stage IV breast cancer
  
• Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00053833 - Active, not recruiting
  recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; ...
  
• Irinotecan in Treating Patients with Refractory Solid Tumors and Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00037804 - Completed
  Unspecified adult solid tumor; Chemotherapy; Liver Dysfunction; Neoplasms, solid tumor
  
• Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis
  ClinicalTrials.gov Identifier: NCT00003368 - Completed
  Leukemia; Lymphoma; Eye Cancer
  
• Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00003719 - Active, not recruiting
  stage IVB adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage IV adult soft tissue sarcoma
  
• Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma
  ClinicalTrials.gov Identifier: NCT00287976 - Recruiting
  Liver Cancer
  
• Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00016952 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00002988 - Active, not recruiting
  recurrent adult brain tumor
  
• Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00002759 - Completed
  Leukemia; Lymphoma; Eye Cancer
  
• Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004095 - Active, not recruiting
  Bladder Cancer; Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer
  
• Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002902 - Completed
  unspecified adult solid tumor, protocol specific
  
• Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003710 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00027612 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003109 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00005951 - Completed
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; Mixed Gliomas
  
• Irinotecan Study For Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00136955 - Recruiting
  Cervix Neoplasms
  
• Irinotecan Versus Only Best Supportive Care for Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00144378 - Completed
  Stomach Neoplasm; Neoplasm Metastasis
  
• Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003900 - Completed
  stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00303745 - Active, not recruiting
  Colorectal Cancer
  
• Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00012389 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil
  ClinicalTrials.gov Identifier: NCT00389870 - Recruiting
  Colorectal Cancer
  
• Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00233623 - Completed
  Metastatic Colorectal Cancer
  
• Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00176774 - Active, not recruiting
  Colorectal Carcinoma
  
• Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00193375 - Active, not recruiting
  Lung Cancer
  
• Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00294931 - Active, not recruiting
  Carcinoma, Small Cell Lung
  
• Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00308529 - Active, not recruiting
  Carcinoma, Small Cell Lung; Lung Cancer
  
• Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00084604 - Active, not recruiting
  stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
  
• Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00520091 - Active, not recruiting
  Esophageal Cancer
  
• Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00354679 - Recruiting
  Esophageal Cancer
  
• Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Advanced Small Bowel Adenocarcinoma (Cancer)
  ClinicalTrials.gov Identifier: NCT00081198 - Not yet recruiting
  small intestine adenocarcinoma
  
• Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00080951 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
  
• Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00192712 - Active, not recruiting
  Pancreatic Cancer
  
• Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
  ClinicalTrials.gov Identifier: NCT00433550 - Recruiting
  Small Intestine Cancer
  
• Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00074321 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00093353 - Active, not recruiting
  Diarrhea; Drug Toxicity; disseminated neuroblastoma; recurrent neuroblastoma
  
• Irinotecan, Vincristine, and Iodine I 131 Metaiodobenzylguanidine in Treating Young Patients With Resistant or Relapsed High-Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00509353 - Recruiting
  Neuroblastoma
  
• Irinotecan/Cisplatin Plus Simvastatin in ED-SCLC
  ClinicalTrials.gov Identifier: NCT00452634 - Recruiting
  Small Cell Lung Cancer
  
• IRIS : Use of Implantable Defibrillator in High-Risk Patients Early After Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00157768 - Recruiting
  Acute Myocardial Infarction
  
• IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00316745 - Suspended
  Metastatic Colorectal Cancer
  
• IRIS PILOT - Extended Pilot Study With a Retinal Implant System
  ClinicalTrials.gov Identifier: NCT00427180 - Recruiting
  Retinitis Pigmentosa; CRD (Cone Rod Dystrophy); Choroideremia
  
• IRIS: Incontinence Research Intervention Study
  ClinicalTrials.gov Identifier: NCT00125177 - Recruiting
  Urinary Incontinence; Incontinence; Stress Urinary Incontinence; SUI; Stress Incontinence
  
• Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00033735 - Active, not recruiting
  recurrent pancreatic cancer; duct cell adenocarcinoma of the pancreas
  
• Irofulven in Treating Children With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003370 - Completed
  unspecified childhood solid tumor, protocol specific
  
• Irofulven in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003796 - Completed
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00005031 - Active, not recruiting
  recurrent endometrial cancer
  
• Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00062257 - Completed
  recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
  
• Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00053365 - Recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00019552 - Completed
  recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; ...
  
• Iron Balance Study of DFO and GT56-252 in Patients with Transfusional Iron Overload Secondary to Beta-Thalassemia
  ClinicalTrials.gov Identifier: NCT00069862 - Completed
  beta-Thalassemia
  
• Iron Chelation Therapy With Deferasirox in β-Thalassemia Major Pediatric Patients With Transfusional Iron Overload
  ClinicalTrials.gov Identifier: NCT00390858 - Active, not recruiting
  Transfusional Iron Overload in β-Thalassemia Major
  
• Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism
  ClinicalTrials.gov Identifier: NCT00535561 - Completed
  Iron Deficiency Anemia; Subclinical Hypothyroidism
  
• Iron Deficiency in Single Ventricle Patients
  ClinicalTrials.gov Identifier: NCT00459225 - Recruiting
  Anemia
  
• Iron Depletion Therapy for Type 2 DM and NAFLD
  ClinicalTrials.gov Identifier: NCT00230087 - Recruiting
  Non-Alcoholic Fatty Liver Disease; Diabetes Mellitus
  
• Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia
  ClinicalTrials.gov Identifier: NCT00512226 - Not yet recruiting
  Sickle Cell Anemia; Sickle Cell Thalassemia; Iron Overload; MRI
  
• Iron Overload in African Americans
  ClinicalTrials.gov Identifier: NCT00001455 - Completed
  Hemochromatosis; Iron Overload
  
• Iron Replacement in Blood Donors
  ClinicalTrials.gov Identifier: NCT00327067 - Recruiting
  Iron Deficiency
  
• Iron Sucrose in Stage 3/4 Kidney Disease
  ClinicalTrials.gov Identifier: NCT00202345 - Active, not recruiting
  Kidney Failure; Anemia
  
• Iron Supplementation Among Adolescent Girls in India
  ClinicalTrials.gov Identifier: NCT00198848 - Recruiting
  Iron deficiency anemia
  
• Iron Supplementation Among Low-Income Postpartum Women
  ClinicalTrials.gov Identifier: NCT00207610 - Active, not recruiting
  Anemia
  
• Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study
  ClinicalTrials.gov Identifier: NCT00386126 - Recruiting
  Heart Failure; Anemia
  
• Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in Zambia
  ClinicalTrials.gov Identifier: NCT00276224 - Completed
  Schistosomiasis; Helminthiases; Anaemia
  
• Iron Supplementation of Lead-Exposed Infants
  ClinicalTrials.gov Identifier: NCT00374790 - Not yet recruiting
  Lead Toxicity
  
• Iron Supplementation of Marginally Low Birth Weight Infants
  ClinicalTrials.gov Identifier: NCT00558454 - Recruiting
  Anemia, Iron-Deficiency
  
• Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.
  ClinicalTrials.gov Identifier: NCT00199277 - Not yet recruiting
  Colorectal Neoplasm; Iron deficiency anemia
  
• Iron-Chelating Therapy and Friedreich Ataxia
  ClinicalTrials.gov Identifier: NCT00224640 - Active, not recruiting
  Friedreich Ataxia
  
• Iron-Fortified Whole Maize Flour Trial
  ClinicalTrials.gov Identifier: NCT00386074 - Active, not recruiting
  Anaemia
  
• Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
  ClinicalTrials.gov Identifier: NCT00176475 - Recruiting
  Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm
  
• Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00176501 - Suspended
  Kidney Cancer
  
• Is Botox Effective in Relieving Pain From Knee Osteoarthritis?
  ClinicalTrials.gov Identifier: NCT00279903 - Recruiting
  Osteoarthritis, Knee
  
• Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium When Compared to Propofol or Midazolam in Cardiac Surgery Patients
  ClinicalTrials.gov Identifier: NCT00417664 - Active, not recruiting
  Delirium
  
• is Dietary Manipulation of Human Milk Total Fat and Caloric Content Feasible?
  ClinicalTrials.gov Identifier: NCT00408980 - Not yet recruiting
  Breastfeeding
  
• Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?
  ClinicalTrials.gov Identifier: NCT00284700 - Completed
  Helicobacter Pylori Infection; Iron Deficiency Anemia; Not Severely Malnourished; No Systemic Infection; Children
  
• Is Home Positioning Time Associated With Torticollis Rate of Recovery?
  ClinicalTrials.gov Identifier: NCT00347334 - Active, not recruiting
  Torticollis
  
• Is IFN-Beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta
  ClinicalTrials.gov Identifier: NCT00493116 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Is it Possible to Treat Cyanide Poisoning With HBO?
  ClinicalTrials.gov Identifier: NCT00399100 - Recruiting
  Carbon Monoxide Poisoning From Fire Accidents
  
• Is Monitoring Activity Important for Short- and Long-Term Weight Loss?
  ClinicalTrials.gov Identifier: NCT00544245 - Enrolling by invitation
  Overweight and Obesity
  
• Is Myopathy Part of Statin Therapy (IMPOSTER-16)
  ClinicalTrials.gov Identifier: NCT00127335 - Recruiting
  Myopathic Conditions
  
• Is Orthostatic Hypotension Associated With Nondipping Hypertension
  ClinicalTrials.gov Identifier: NCT00491231 - Recruiting
  Orthostatic Hypotension; Nondipping Hypertension
  
• Is Osteopathic Manipulative Treatment(OMT)Beneficial for Elderly Patients Hospitalized With Pneumonia?
  ClinicalTrials.gov Identifier: NCT00258661 - Completed
  Pneumonia
  
• Is Oxytocin Given During Surgical Procedure for Abortion Before 12 Weeks of Pregnancy Useful ?
  ClinicalTrials.gov Identifier: NCT00540748 - Recruiting
  First Trimester Abortion
  
• Is Paracetamol an Effective Treatment for Chronic Moderate Pain in the Newborn After Operative Vaginal Delivery?
  ClinicalTrials.gov Identifier: NCT00488540 - Recruiting
  Pain
  
• Is Pyridoxine Effective for the Prevention of Hand-Foot Syndrome (HFS) Associated With Capecitabine Therapy
  ClinicalTrials.gov Identifier: NCT00446147 - Completed
  Prevention
  
• Is Self-Reported Quality Assessment in Surgery Reliable?
  ClinicalTrials.gov Identifier: NCT00548535 - Recruiting
  Patients of Visceral- and Transplantation Surgery
  
• Is Sensory Stimulation Effective in Reducing Time Spent in a Coma or Vegetative State
  ClinicalTrials.gov Identifier: NCT00163878 - Recruiting
  Traumatic Brain Injury
  
• Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
  ClinicalTrials.gov Identifier: NCT00291720 - Recruiting
  Chronic Kidney Disease; Cardiovascular Disease
  
• Is the Routine Pressure Dressing After Thyroidectomy Necessary?
  ClinicalTrials.gov Identifier: NCT00400465 - Completed
  Thyroid Neoplasms; Thyroid Nodules; Graves Disease; Goiter
  
• Is There a Connection Between a Tight Achilles Tendon, Hyperpronation of the Foot and Pain in the Anterior Part of the Knee
  ClinicalTrials.gov Identifier: NCT00246558 - Completed
  Anterior Knee Pain Syndrome; Tight Achilles Tendon; Hyperpronation of the Foot
  
• Is There a Difference in Flicker Induced Vasodilatation Between Smokers and Non-Smokers?
  ClinicalTrials.gov Identifier: NCT00431730 - Recruiting
  Ocular Physiology; Retina; Blood Flow Velocity
  
• Is there a higher than expected occurrence of Amyotrophic Lateral Sclerosis (ALS) among deployed veterans as compared to non-deployed Gulf War veterans?
  ClinicalTrials.gov Identifier: NCT00007722 - Completed
  Amyotrophic Lateral Sclerosis
  
• Is There Hearing Loss After Acute Mastoiditis
  ClinicalTrials.gov Identifier: NCT00502450 - Not yet recruiting
  Acute Mastoiditis; Acute Otitis Media
  
• Is There Increased Polyethylene Wear and Increased Periprosthetic Bone Loss in Femur in Reverse Hybrid Technique Compared With Conventional Cemented Technique in Total Hip Replacement?
  ClinicalTrials.gov Identifier: NCT00526539 - Completed
  Osteoarthritis
  
• Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?
  ClinicalTrials.gov Identifier: NCT00502398 - Recruiting
  Pulmonary Artery Hypertension
  
• Is There is a Role of Prophylactic Therapy With Tamsulosin Before Extracorporeal Shock Wave Lithotripsy to Avoid Development of Steinstrasse ?
  ClinicalTrials.gov Identifier: NCT00489723 - Recruiting
  Kidney Stones
  
• Is Ultrasonography Comparable to MRI for the Detection of Morton Neuroma of the Foot?
  ClinicalTrials.gov Identifier: NCT00284414 - Recruiting
  Morton Neuroma
  
• Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy
  ClinicalTrials.gov Identifier: NCT00377091 - Not yet recruiting
  Pulmonary Embolism
  
• Isavuconazole for Primary Treatment of Invasive Aspergillosis
  ClinicalTrials.gov Identifier: NCT00412893 - Recruiting
  Invasive Fungal Infection; Aspergillosis
  
• Isavuconazole in the Treatment of Candidemia and Other Invasive Candida Infections
  ClinicalTrials.gov Identifier: NCT00413218 - Recruiting
  Mycoses; Candidiasis
  
• Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00283478 - Completed
  Non-Small Cell Lung Cancer
  
• Iscar for Supplemental Care in Stage IV Lung Cancer
  ClinicalTrials.gov Identifier: NCT00079794 - Active, not recruiting
  Lung Cancer
  
• Ischemia and Reperfusion Injury in the Human: An Observational Study
  ClinicalTrials.gov Identifier: NCT00229047 - Recruiting
  Ischemia
  
• Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)
  ClinicalTrials.gov Identifier: NCT00518245 - Recruiting
  Unstable Angina
  
• Ischemic Heart Disease Incidence and Indices of Body-fat Distribution
  ClinicalTrials.gov Identifier: NCT00005255 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia; Obesity
  
• Ischemic Injury and Ischemic Preconditioning in Diabetes
  ClinicalTrials.gov Identifier: NCT00184821 - Completed
  Diabetes Mellitus, Insulin-Dependent; Ischemia-Reperfusion Injury
  
• Ischemic Nerve Block to Improve Hand Function in Stroke Patients
  ClinicalTrials.gov Identifier: NCT00056706 - Completed
  Cerebrovascular Accident
  
• Ischemic Optic Neuropathy Decompression Trial (IONDT)
  ClinicalTrials.gov Identifier: NCT00000127 - Completed
  Ischemic Optic Neuropathy
  
• Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)
  ClinicalTrials.gov Identifier: NCT00000126 - Active, not recruiting
  Ischemic Optic Neuropathy
  
• Ischemic Preconditioning of Liver in Cadaver Donors
  ClinicalTrials.gov Identifier: NCT00245830 - Completed
  Liver Cirrhosis; Liver Transplantation
  
• Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022373 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00048321 - Completed
  Rheumatoid Arthritis
  
• ISIS 14803-CS2, Treatment with ISIS 14803, Administered IV in Patients with Chronic Hepatitis C Virus Infections
  ClinicalTrials.gov Identifier: NCT00035945 - Completed
  Hepatitis C, Chronic
  
• ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients with Mild to Moderate Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00063414 - Completed
  Ulcerative Colitis
  
• ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients with Mild to Moderate Active Ulcerative Colitis.
  ClinicalTrials.gov Identifier: NCT00063830 - Completed
  Ulcerative Colitis
  
• ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00005594 - Active, not recruiting
  stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00004193 - Completed
  recurrent colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent rectal cancer; ...
  
• ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003989 - Active, not recruiting
  Stage IV Melanoma; stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003892 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Islet Allotransplantation With Steroid Free Immunosuppression
  ClinicalTrials.gov Identifier: NCT00446264 - Completed
  Type 1 Diabetes; Hypoglycemia; Metabolic Lability
  
• Islet Cell Transplant
  ClinicalTrials.gov Identifier: NCT00160732 - Recruiting
  Diabetes Mellitus, Type 1
  
• Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients with Diabetes Mellitus: Steroid-Free Regimen
  ClinicalTrials.gov Identifier: NCT00021801 - Completed
  Type 1 Diabetes Mellitus
  
• Islet Cell Transplantation Alone and CD34+ Enriched Donor Bone Marrow Cell Infusion in Patients With Type 1 Diabetes Mellitus; Steroid Free Regimen
  ClinicalTrials.gov Identifier: NCT00315614 - Recruiting
  Type 1 Diabetes Mellitus
  
• Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression
  ClinicalTrials.gov Identifier: NCT00306098 - Recruiting
  Diabetes Mellitus, Type I
  
• Islet Cell Transplantation Alone in Patients with Type I Diabetes Mellitus: steroid-free immunosuppression
  ClinicalTrials.gov Identifier: NCT00021788 - Completed
  Diabetes Mellitus, Type 1
  
• Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00315588 - Recruiting
  Diabetes Mellitus, Type 1
  
• Islet Cell Transplants for Diabetes
  ClinicalTrials.gov Identifier: NCT00014911 - Active, not recruiting
  Diabetes Mellitus, Insulin-Dependent
  
• Islet Cell Transplants for Diabetes
  ClinicalTrials.gov Identifier: NCT00303134 - Suspended
  Diabetes Mellitus, Type 1
  
• Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging
  ClinicalTrials.gov Identifier: NCT00453817 - Recruiting
  Type 1 Diabetes Mellitus
  
• Islet Transplantation for Patients with Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00073281 - Completed
  Diabetes Mellitus, Type 1
  
• Islet Transplantation for Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00437398 - Recruiting
  Type 1 Diabetes Mellitus
  
• Islet Transplantation in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00434811 - Recruiting
  Type 1 Diabetes Mellitus
  
• Islet Transplantation in Type 1 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00214253 - Recruiting
  Type 1 Diabetes
  
• Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
  ClinicalTrials.gov Identifier: NCT00566813 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Islet Transplantation in Type 1 Diabetic Recipients of Kidney Transplants
  ClinicalTrials.gov Identifier: NCT00288977 - Recruiting
  Diabetes; Kidney Transplantation
  
• Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression
  ClinicalTrials.gov Identifier: NCT00133809 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Islet Transplantation Using Campath-1H and Infliximab Induction
  ClinicalTrials.gov Identifier: NCT00175266 - Active, not recruiting
  Type 1 Diabetes
  
• Islet Transplantation Using Efalizumab
  ClinicalTrials.gov Identifier: NCT00276250 - Recruiting
  Type 1 Diabetes Mellitus
  
• Isocyanate Antigens and T Cells That Cause Asthma
  ClinicalTrials.gov Identifier: NCT00005549 - Active, not recruiting
  Asthma; Lung Diseases
  
• Isocyanate Dermal Exposures in Autobody Shops
  ClinicalTrials.gov Identifier: NCT00005552 - Completed
  Asthma; Lung Diseases
  
• Isoflavones and Acute-phase Response in Chronic Renal Failure
  ClinicalTrials.gov Identifier: NCT00029796 - Completed
  Kidney Failure, Chronic
  
• Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00243048 - Completed
  Prostate Cancer
  
• Isoflavones and the Coronary Circulation in Men and Women With Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00287690 - Completed
  Coronary Artery Disease
  
• Isoflavones Compared With Lycopene Before Surgery in Treating Patients With Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00042731 - Completed
  stage I prostate cancer; stage II prostate cancer
  
• Isoflavones for Promoting Calcuim Absorption and Preventing Bone Loss in Post Menopausal Women
  ClinicalTrials.gov Identifier: NCT00244907 - Recruiting
  Osteoporosis; Osteopenia
  
• Isoflavones in Preventing Further Development of Cancer in Patients With Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00027950 - Completed
  stage I prostate cancer; stage II prostate cancer
  
• Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy
  ClinicalTrials.gov Identifier: NCT00036686 - Completed
  Breast Cancer
  
• Isoflurane at Subanesthetic Concentrations - 6
  ClinicalTrials.gov Identifier: NCT00000254 - Completed
  Opioid-Related Disorders; Substance-Related Disorders
  
• Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis
  ClinicalTrials.gov Identifier: NCT00552487 - Completed
  Hashimoto Disease; Adrenal Insufficiency
  
• Isolated Hepatic (Liver) Perfusion With Melphalan Followed By Temozolomide in Treating Patients With Unresectable Liver Metastases From Ocular (Eye) Melanoma
  ClinicalTrials.gov Identifier: NCT00066521 - Recruiting
  Intraocular Melanoma; Metastatic Cancer
  
• Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver
  ClinicalTrials.gov Identifier: NCT00019760 - Active, not recruiting
  Recurrent Colon Cancer; Liver Metastases; Stage IV Rectal Cancer; Recurrent Rectal Cancer; Stage IV Colon Cancer
  
• Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00103298 - Completed
  Colorectal Cancer; Metastatic Cancer
  
• Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
  ClinicalTrials.gov Identifier: NCT00019786 - Active, not recruiting
  Colorectal Cancer; Islet Cell Tumor; Liver Cancer; Metastatic Cancer; Neuroendocrine Carcinoma
  
• Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver
  ClinicalTrials.gov Identifier: NCT00089401 - Recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer; liver metastases
  
• Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00004250 - Active, not recruiting
  stage III adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma; ...
  
• Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg
  ClinicalTrials.gov Identifier: NCT00019968 - Completed
  Stage IVB Adult Soft Tissue Sarcoma; Stage IIB Adult Soft Tissue Sarcoma; Stage IIC Adult Soft Tissue Sarcoma; Recurrent Adult Soft Tissue Sarcoma; Stage IVA Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma
  
• Isolated Mild Fetal Ventriculomegaly and Neurodevelopmental Outcome
  ClinicalTrials.gov Identifier: NCT00256906 - Recruiting
  Lateral Ventricles
  
• Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs’ Girdle
  ClinicalTrials.gov Identifier: NCT00181025 - Recruiting
  Sarcoma of Pelvis
  
• Isolation and Characterization of Mammary Stem Cells
  ClinicalTrials.gov Identifier: NCT00340392 - Active, not recruiting
  Stem Cells
  
• Isolation and Culture of Circulating Tumor Cells From Peripheral Blood
  ClinicalTrials.gov Identifier: NCT00571389 - Recruiting
  Metastatic Cancer
  
• Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2)
  ClinicalTrials.gov Identifier: NCT00571753 - Not yet recruiting
  Pulmonary Tuberculosis
  
• Isoniazid Plus HAART to Prevent TB in HIV-Infected Persons
  ClinicalTrials.gov Identifier: NCT00463086 - Not yet recruiting
  Tuberculosis; Mycobacterial Diseases; HIV Infections
  
• Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00330304 - Recruiting
  Tuberculosis
  
• Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00552227 - Completed
  Diabetes Mellitus
  
• Isoproterenol Challenge to Detect Arrhythmogenic Right Ventricular Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00083395 - Completed
  Arrhythmic Right Ventricular Cardiomyopathy
  
• Isotonic Versus Hypotonic Fluid for Maintenance IV Therapy
  ClinicalTrials.gov Identifier: NCT00457873 - Recruiting
  Gastroenteritis; Bronchiolitis; Sepsis; Urinary Tract Infection
  
• Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00021359 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00002506 - Active, not recruiting
  recurrent non-small cell lung cancer; recurrent cervical cancer; recurrent squamous cell carcinoma of the lip and oral cavity; ...
  
• Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00026312 - Recruiting
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized resectable neuroblastoma; localized unresectable neuroblastoma
  
• Isotretinoin With or Without Vitamin E for Prevention of Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002586 - Active, not recruiting
  Non-small cell lung cancer; Small Cell Lung Cancer; Drug Toxicity
  
• Isotretinoin, Interferon alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00054561 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Isotretinoin, Interferon Alfa-2b, and Paclitaxel in Treating Patients With Stage IV, Recurrent, or Persistent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00138151 - Recruiting
  recurrent cervical cancer; stage IVB cervical cancer
  
• Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00176527 - Active, not recruiting
  Prostate Cancer
  
• Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00354250 - Active, not recruiting
  Kidney Cancer
  
• Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00363272 - Recruiting
  Brain and Central Nervous System Tumors; Lymphoma; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Israel Multicenter D-Serine Study (IMSER)
  ClinicalTrials.gov Identifier: NCT00138775 - Recruiting
  Schizophrenia, schizoaffective disorder
  
• Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
  ClinicalTrials.gov Identifier: NCT00205907 - Terminated
  Pulmonary Emphysema
  
• Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
  ClinicalTrials.gov Identifier: NCT00517998 - Recruiting
  Pulmonary Emphysema; Chronic Obstructive Pulmonary Disease
  
• ISSUE3: International Study on Syncope of Uncertain Etiology 3
  ClinicalTrials.gov Identifier: NCT00359203 - Recruiting
  Syncope
  
• Issues Surrounding Prenatal Genetic Testing for Achondroplasia
  ClinicalTrials.gov Identifier: NCT00001536 - Completed
  Achondroplasia; Dwarfism
  
• ISTAPS: A Stepped Primary Care Smoking Cessation Intervention
  ClinicalTrials.gov Identifier: NCT00125905 - Active, not recruiting
  Smoking cessation
  
• Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter
  ClinicalTrials.gov Identifier: NCT00326001 - Recruiting
  Atrial Flutter
  
• ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years
  ClinicalTrials.gov Identifier: NCT00286117 - Active, not recruiting
  Breast Cancer
  
• Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study
  ClinicalTrials.gov Identifier: NCT00421863 - Active, not recruiting
  Hypertension
  
• Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia
  ClinicalTrials.gov Identifier: NCT00370084 - Completed
  Gastroparesis
  
• Itopride in Functional Dyspepsia:a Dose Finding Study
  ClinicalTrials.gov Identifier: NCT00272103 - Completed
  Functional Dyspepsia
  
• Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00003883 - Active, not recruiting
  Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; kidney tumor
  
• Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease
  ClinicalTrials.gov Identifier: NCT00001280 - Completed
  
  
• Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
  ClinicalTrials.gov Identifier: NCT00356915 - Active, not recruiting
  Onychomycosis of the Toenail
  
• ITV Extension Study
  ClinicalTrials.gov Identifier: NCT00332930 - Completed
  HIV
  
• IUD Insertion After D&E Procedure
  ClinicalTrials.gov Identifier: NCT00475228 - Recruiting
  Contraception
  
• IUD Uterine Vascularization and Side Effects
  ClinicalTrials.gov Identifier: NCT00489463 - Completed
  Healthy
  
• IUdR/BUdR cell cycle labelling
  ClinicalTrials.gov Identifier: NCT00042250 - Terminated
  Hematologic Malignancies
  
• Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia
  ClinicalTrials.gov Identifier: NCT00383799 - Recruiting
  Ventricular Tachycardia; Wide QRS Tachycardia
  
• IV Busulfan With Allo-BMT Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00469144 - Recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndrome; Leukemia
  
• IV Cocaine Abuse: A Laboratory Model - 1
  ClinicalTrials.gov Identifier: NCT00000212 - Completed
  Cocaine-Related Disorders
  
• IV Cocaine Abuse: A Laboratory Model - 2
  ClinicalTrials.gov Identifier: NCT00000213 - Completed
  Cocaine-Related Disorders
  
• IV Cocaine Abuse: A Laboratory Model - 3
  ClinicalTrials.gov Identifier: NCT00000214 - Completed
  Cocaine-Related Disorders
  
• IV Cocaine Abuse: A Laboratory Model - 4
  ClinicalTrials.gov Identifier: NCT00000215 - Completed
  Cocaine-Related Disorders
  
• IV Double and Triple Concentrated Nicardipine for Stroke and ICH
  ClinicalTrials.gov Identifier: NCT00325793 - Recruiting
  Hypertension
  
• IV Iron vs No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy
  ClinicalTrials.gov Identifier: NCT00236951 - Active, not recruiting
  Anemia
  
• IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures
  ClinicalTrials.gov Identifier: NCT00510783 - Recruiting
  Tonic-Clonic Seizure (Primary or Secondarily Generalized); Grand Mal Seizure
  
• IV Levetiracetam for the Treatment of Neonatal Seizures: a Pharmacokinetic and Preliminary Efficacy and Safety Study
  ClinicalTrials.gov Identifier: NCT00461409 - Recruiting
  Seizures; Term Neonates
  
• IV Lidocaine for Opioid-Refractory Pain
  ClinicalTrials.gov Identifier: NCT00321347 - Recruiting
  Neoplasms; Pain
  
• IV Pantoprazole in Erosive Esophagitis
  ClinicalTrials.gov Identifier: NCT00133770 - Recruiting
  Esophagitis
  
• IV Zoledronic Acid After Forteo in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00361595 - Recruiting
  Osteoporosis
  
• IVIG - West Nile encephalitis: Safety and Efficacy
  ClinicalTrials.gov Identifier: NCT00068055 - Active, not recruiting
  West Nile Fever
  
• IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma
  ClinicalTrials.gov Identifier: NCT00294476 - Recruiting
  Cancer of Colon; Malignant Melanoma; Urologic Cancer
  
• IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff
  ClinicalTrials.gov Identifier: NCT00177970 - Recruiting
  Clostridium Difficile-Associated Diarrhea (CDAD)
  
• IVPCA in the Management of Pain Following Major Intracranial Surgery
  ClinicalTrials.gov Identifier: NCT00286221 - Not yet recruiting
  Intracranial Surgery
  
• IVR for Methadone Patients
  ClinicalTrials.gov Identifier: NCT00237406 - Completed
  Methadone Maintenance
  
• IVR Symptom Assessment in Non-Small Cell Lung Cancer Patients
  ClinicalTrials.gov Identifier: NCT00423436 - Recruiting
  Lung Cancer
  
• Ixabepilone Administered as an Enteric Coated Formulation.
  ClinicalTrials.gov Identifier: NCT00309049 - Completed
  Cancer
  
• Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00096317 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Ixabepilone and Liposomal Doxorubicin in Treating Patients With Advanced Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00182767 - Recruiting
  Breast Cancer; Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00058084 - Completed
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00070096 - Completed
  adult brain tumor; extragonadal germ cell tumor; ovarian germ cell tumor; Testicular Cancer
  
• Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00049400 - Active, not recruiting
  adult solid tumor; Leukemia; Lymphoma; small intestine cancer
  
• Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00021099 - Completed
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00045097 - Completed
  Male Breast Cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
  
• Ixabepilone in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00033618 - Active, not recruiting
  Head and Neck Cancer
  
• Ixabepilone in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00087139 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00182702 - Active, not recruiting
  Kidney Cancer
  
• Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00095979 - Recruiting
  endometrial adenocarcinoma; recurrent endometrial cancer; stage IV endometrial cancer
  
• Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00030706 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00052572 - Completed
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Ixabepilone in Treating Patients With Renal Cell Carcinoma (Kidney Cancer)
  ClinicalTrials.gov Identifier: NCT00033670 - Recruiting
  Kidney Cancer
  
• Ixabepilone in Treating Young Patients With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00331643 - Active, not recruiting
  Kidney Cancer; Neuroblastoma; Sarcoma
  
• Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy
  ClinicalTrials.gov Identifier: NCT00030108 - Recruiting
  Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Leukemia; Liver Cancer; ...
  
• Ixabepilone, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy and Chemotherapy
  ClinicalTrials.gov Identifier: NCT00331344 - Recruiting
  Prostate Cancer
  
• β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS
  ClinicalTrials.gov Identifier: NCT00528359 - Completed
  Schizophrenia